
<html lang="en"     class="pb-page"  data-request-id="cc8463dc-cbf2-42dc-ba2b-11a71d2ad6c9"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;issue:issue:10.1021/jmcmar.2010.53.issue-5;website:website:acspubs;article:article:10.1021/jm9016043;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Synthesis and Uptake of Fluorescence-Labeled Combi-molecules by P-Glycoprotein-Proficient and -Deficient Uterine Sarcoma Cells MES-SA and MES-SA/DX5" /></meta><meta name="dc.Creator" content="Anne-Laure  Larroque-Lombard" /></meta><meta name="dc.Creator" content="Margarita  Todorova" /></meta><meta name="dc.Creator" content="Nahid  Golabi" /></meta><meta name="dc.Creator" content="Christopher  Williams" /></meta><meta name="dc.Creator" content="Bertrand J.  Jean-Claude" /></meta><meta name="dc.Description" content="Here, we report on the first synthesis of fluorescent-labeled epidermal growth factor receptor−DNA targeting combi-molecules, and we studied the influence of P-glycoprotein status of human sarcoma ..." /></meta><meta name="Description" content="Here, we report on the first synthesis of fluorescent-labeled epidermal growth factor receptor−DNA targeting combi-molecules, and we studied the influence of P-glycoprotein status of human sarcoma ..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="February 12, 2010" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm9016043" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2010 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm9016043" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm9016043" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm9016043" /></link>
        
    
    

<title>Synthesis and Uptake of Fluorescence-Labeled Combi-molecules by P-Glycoprotein-Proficient and -Deficient Uterine Sarcoma Cells MES-SA and MES-SA/DX5 | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm9016043" /></meta><meta property="og:title" content="Synthesis and Uptake of Fluorescence-Labeled Combi-molecules by P-Glycoprotein-Proficient and -Deficient Uterine Sarcoma Cells MES-SA and MES-SA/DX5" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-5/jm9016043/production/images/large/jm-2009-016043_0008.jpeg" /></meta><meta property="og:description" content="Here, we report on the first synthesis of fluorescent-labeled epidermal growth factor receptor−DNA targeting combi-molecules, and we studied the influence of P-glycoprotein status of human sarcoma MES-SA cells on their growth inhibitory effect and cellular uptake. The results showed that 6, bearing a longer spacer between the quinazoline ring and the dansyl group, was more stable and more cytotoxic than 4. In contrast to the latter, it induced significant levels of DNA damage in human tumor cells. Moreover, in contrast to doxorubicin, a drug known to be actively effluxed by P-gp, the more stable combi-molecule 6 induced almost identical levels of drug uptake and DNA damage in P-gp-proficient and -deficient cells. Likewise, in contrast to doxorubicin, 4 and 6 exerted equal levels of antiproliferative activity against the two cell types. The results in toto suggest that despite their size, the antiproliferative effects of 4 and 6 were independent of P-gp status of the cells." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm9016043"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm9016043">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-14/achre4.2021.54.issue-14/20210720/achre4.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-29/aamick.2021.13.issue-29/20210728/aamick.2021.13.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-14/acncdm.2021.12.issue-14/20210721/acncdm.2021.12.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-7/amlcef.2021.3.issue-7/20210705/amlcef.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-29/acsodf.2021.6.issue-29/20210727/acsodf.2021.6.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-29/ascecg.2021.9.issue-29/20210726/ascecg.2021.9.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-29/ancham.2021.93.issue-29/20210727/ancham.2021.93.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-29/bichaw.2021.60.issue-29/20210727/bichaw.2021.60.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-27/cgeabj.2021.99.issue-27/20210726-01/cgeabj.2021.99.issue-27.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-7/cgdefu.2021.21.issue-7/20210707/cgdefu.2021.21.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-14/esthag.2021.55.issue-14/20210720/esthag.2021.55.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-29/iecred.2021.60.issue-29/20210728/iecred.2021.60.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-14/inocaj.2021.60.issue-14/20210719/inocaj.2021.60.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-29/jafcau.2021.69.issue-29/20210728/jafcau.2021.69.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-29/jacsat.2021.143.issue-29/20210728/jacsat.2021.143.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-7/jamsef.2021.32.issue-7/20210707/jamsef.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-29/langd5.2021.37.issue-29/20210727/langd5.2021.37.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-7/mpohbp.2021.18.issue-7/20210705/mpohbp.2021.18.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm9016043&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm9016043&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm9016043&amp;href=/doi/10.1021/jm9016043" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2010</span><span class="cit-fg-volume">, 53</span><span class="cit-fg-issue">, 5</span><span class="cit-fg-pageRange">, 2104-2113</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/53/5" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm901616h" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm901618d" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Synthesis and Uptake of Fluorescence-Labeled Combi-molecules by P-Glycoprotein-Proficient and -Deficient Uterine Sarcoma Cells MES-SA and MES-SA/DX5</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Anne-Laure++Larroque-Lombard">Anne-Laure Larroque-Lombard</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol "><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Margarita++Todorova">Margarita Todorova</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol "><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Nahid++Golabi">Nahid Golabi</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Christopher++Williams">Christopher Williams</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Bertrand+J.++Jean-Claude">Bertrand J. Jean-Claude</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-symbol">†</span> <span class="aff-text">Cancer Drug Research Laboratory, Department of Medicine, Division of Medical Oncology, McGill University Health Center/Royal Victoria Hospital, 687 Pine Avenue West Room M-719, Montreal, Quebec, H3A 1A1 Canada</span></div><div class="aff-info" id="aff2"><span class="aff-symbol">‡</span> <span class="aff-text">Chemical Computing Group Inc., 1010 Sherbrooke Street West, Suite 910, Montreal, Quebec H3A 2R7, Canada</span></div><div class="corresp-info"><strong>*</strong>To whom correspondence should be addressed. Tel: 514-934-1934 ext 35841. Fax: 514-843-1475. E-mail: <a href="/cdn-cgi/l/email-protection#a0cac1c3d1d5c5d38ecac5c1cec3ccc1d5c4c5e0d3d4c1c6c68ecdc3c7c9cccc8ec3c1"><span class="__cf_email__" data-cfemail="fb919a988a8e9e88d5919e9a9598979a8e9f9ebb888f9a9d9dd596989c929797d5989a">[email protected]</span></a></div><div class="corresp-fn" id="fn3">§The two authors contributed equally to this paper.</div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm9016043&amp;href=/doi/10.1021%2Fjm9016043" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2010</span></span><span class="cit-volume">, 53</span><span class="cit-issue">, 5</span><span class="cit-pageRange">, 2104–2113</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">February 12, 2010</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>30 October 2009</li><li><span class="item_label"><b>Published</b> online</span>12 February 2010</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 11 March 2010</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm9016043" title="DOI URL">https://doi.org/10.1021/jm9016043</a></div><div class="article_header-article-copyright"><strong>Copyright © 2010 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D2104%26pageCount%3D10%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DAnne-Laure%2BLarroque-Lombard%252C%2BMargarita%2BTodorova%252C%2BNahid%2BGolabi%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D53%26issueNum%3D5%26contentID%3Djm9016043%26title%3DSynthesis%2Band%2BUptake%2Bof%2BFluorescence-Labeled%2BCombi-molecules%2Bby%2BP-Glycoprotein-Proficient%2Band%2B-Deficient%2BUterine%2BSarcoma%2BCells%2BMES-SA%2Band%2BMES-SA%252FDX5%26numPages%3D10%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D2113%26publicationDate%3DMarch%2B2010">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm9016043"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">1011</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">10</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm9016043" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Synthesis and Uptake of Fluorescence-Labeled Combi-molecules by P-Glycoprotein-Proficient and -Deficient Uterine Sarcoma Cells MES-SA and MES-SA/DX5&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Anne-Laure&quot;,&quot;last_name&quot;:&quot;Larroque-Lombard&quot;},{&quot;first_name&quot;:&quot;Margarita&quot;,&quot;last_name&quot;:&quot;Todorova&quot;},{&quot;first_name&quot;:&quot;Nahid&quot;,&quot;last_name&quot;:&quot;Golabi&quot;},{&quot;first_name&quot;:&quot;Christopher&quot;,&quot;last_name&quot;:&quot;Williams&quot;},{&quot;first_name&quot;:&quot;Bertrand&quot;,&quot;last_name&quot;:&quot;J. Jean-Claude&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2010&quot;,&quot;month&quot;:&quot;02&quot;,&quot;day&quot;:&quot;12&quot;,&quot;issue&quot;:&quot;5&quot;,&quot;volume&quot;:&quot;53&quot;,&quot;pages&quot;:&quot;2104-2113&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm9016043&quot;},&quot;abstract&quot;:&quot;Here, we report on the first synthesis of fluorescent-labeled epidermal growth factor receptor−DNA targeting combi-molecules, and we studied the influence of P-glycoprotein status of human sarcoma MES-SA cells on their growth inhibitory effect and cellular uptake. The results showed that 6, bearing a longer spacer between the quinazoline ring and the dansyl group, was more stable and more cytotoxic than 4. In contrast to the latter, it induced significant levels of DNA damage in human tumor cells. Moreover, in contrast to doxorubicin, a drug known to be actively effluxed by P-gp, the more stable combi-molecule 6 induced almost identical levels of drug uptake and DNA damage in P-gp-proficient and -deficient cells. Likewise, in contrast to doxorubicin, 4 and 6 exerted equal levels of antiproliferative activity against the two cell types. The results in toto suggest that despite their size, the antiproliferative effects of 4 and 6 were independent of P-gp status of the cells.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm9016043&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm9016043" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm9016043&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm9016043" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm9016043&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm9016043" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm9016043&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm9016043&amp;href=/doi/10.1021/jm9016043" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm9016043" /></input><a href="/doi/pdf/10.1021/jm9016043" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (3 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm9016043&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm9016043%26sid%3Dliteratum%253Aachs%26pmid%3D20151639%26genre%3Darticle%26aulast%3DLarroque-Lombard%26date%3D2010%26atitle%3DSynthesis%2Band%2BUptake%2Bof%2BFluorescence-Labeled%2BCombi-molecules%2Bby%2BP-Glycoprotein-Proficient%2Band%2B-Deficient%2BUterine%2BSarcoma%2BCells%2BMES-SA%2Band%2BMES-SA%252FDX5%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D53%26issue%3D5%26spage%3D2104%26epage%3D2113%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291428" title="Physiology">Physiology</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=291912" title="Fluorescence">Fluorescence</a>,</li><li><a href="/action/doSearch?ConceptID=290768" title="Antineoplastic agents">Antineoplastic agents</a>,</li><li><a href="/action/doSearch?ConceptID=290896" title="Cells">Cells</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/53/5" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-5/jm9016043/production/images/medium/jm-2009-016043_0008.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-5/jm9016043/production/images/large/jm-2009-016043_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm9016043&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Here, we report on the first synthesis of fluorescent-labeled epidermal growth factor receptor−DNA targeting combi-molecules, and we studied the influence of P-glycoprotein status of human sarcoma MES-SA cells on their growth inhibitory effect and cellular uptake. The results showed that <b>6</b>, bearing a longer spacer between the quinazoline ring and the dansyl group, was more stable and more cytotoxic than <b>4</b>. In contrast to the latter, it induced significant levels of DNA damage in human tumor cells. Moreover, in contrast to doxorubicin, a drug known to be actively effluxed by P-gp, the more stable combi-molecule <b>6</b> induced almost identical levels of drug uptake and DNA damage in P-gp-proficient and -deficient cells. Likewise, in contrast to doxorubicin, <b>4</b> and <b>6</b> exerted equal levels of antiproliferative activity against the two cell types. The results <i>in toto</i> suggest that despite their size, the antiproliferative effects of <b>4</b> and <b>6</b> were independent of P-gp status of the cells.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_54312" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_54312" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">At the advanced stages, solid tumors express a variety of receptors and signaling proteins that not only drive their progression but also render them resistant to tumor drugs. One mechanism of multidrug resistance (MDR)<a class="ref internalNav" href="#fn1" aria-label="a">a</a> is the expression of a reflux pump [e.g., P-glycoprotein (P-gp)] that transports drugs out of the cells,<a onclick="showRef(event, 'ref1 ref2 ref3 ref4 ref5'); return false;" href="javascript:void(0);" class="ref ref1 ref2 ref3 ref4 ref5">(1-5)</a> and this is responsible for drug resistance and treatment failure in approximately 90% of cancer patients.<a onclick="showRef(event, 'ref6 ref7'); return false;" href="javascript:void(0);" class="ref ref6 ref7">(6, 7)</a> Also, some mutations in key signaling proteins are often responsible for chemoresistance. Several attempts to modulate MDR led to a limited degree of success in the clinic, and the design of agents that diffuse into the cells regardless of their P-gp status or that selectively kill P-gp-expressing cells<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> has become a new drug development strategy.</div><div class="NLM_p"><div class="NLM_fn" id="fn1">a<p class="last">Abbreviations: P-gp, P-glycoprotein; EGFR, epidermal growth factor receptor; MDR, multidrug resistance.</p></div></div><div class="NLM_p">Recently, to circumvent problems associated with target heterogeneity in advanced cancers, we developed novel types of drugs capable of inhibiting refractory tumor cell growth by blocking divergent targets such as the epidermal growth factor receptor (EGFR) and genomic DNA. Many prototypes of these agents termed combi-molecules have been shown to block the growth of human cancer cells with disordered signaling.<a onclick="showRef(event, 'ref9 ref10 ref11 ref12 ref13 ref14'); return false;" href="javascript:void(0);" class="ref ref9 ref10 ref11 ref12 ref13 ref14">(9-14)</a> While their ability to concomitantly damage DNA and to induce high levels of apoptosis was demonstrated, the influence of transport pump-mediated MDR on the potency of these multitargeted molecules has yet to be explored. To analyze their intracellular uptake and dependence on MDR status, we designed fluorescence-labeled prototypes <b>4</b> (AL194) and <b>6</b> (AL237)<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> and studied their differential uptake by two human uterine sarcoma cell lines (MES-SA and MES-SA/DX5) that do not express EGFR,<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> the primary target of these combi-molecules. The use of cells deprived of EGFR was to avoid any interference of EGFR or related proteins with the retention or subcellular distribution of the molecules. We have now shown elsewhere that EGFR expression influences their subcellular distribution.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> Importantly, in contrast to the parental MES-SA cell line, the MES-SA/DX5 has been shown to express P-gp and to be resistant to doxorubicin and paclitaxel.<a onclick="showRef(event, 'ref17 ref18 ref19'); return false;" href="javascript:void(0);" class="ref ref17 ref18 ref19">(17-19)</a></div><div class="NLM_p">The new combi-molecules reported herein were designed to degrade into an aminoquinazoline, fluorescing in the blue, and a dansylated DNA-damaging moiety, fluorescing in the green, thereby facilitating the analysis of drug uptake by fluorescence microscopy and flow cytometry. The IC<sub>50</sub> values for EGFR tyrosine kinase inhibition by <b>4</b> and <b>6</b> were 1.4 and 0.6 μM, respectively, and their binary EGFR−DNA targeting properties are extensively discussed in a separate report.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a></div><div class="NLM_p last">Here, we describe the synthesis of the two combi-molecules, one with a short neutral ethano linker and the other with a longer and basic <i>N</i>-methylethanediamine spacer. We compared their differential uptake in MES-SA cells with that of doxorubicin, by fluorescence microscopy and flow cytometry. In contrast to the clinical anticancer drug doxorubicin, the potency of these bulky molecules was independent of the P-gp status of the two cell types. It should be noted that the purpose of this study was not to compare the potency of the fluorescent molecules with that of doxorubicin, a strong DNA intercalator and topoisomerase II inhibitor, but was rather to analyze their differential uptake in comparison with that of doxorubicin, a highly P-gp-dependent drug.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_27487" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_27487" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i3" class="anchor-spacer"></div><h3 class="article-section__title" id="_i3"> Chemistry</h3><div class="NLM_p">The synthesis of compound <b>4</b> and <b>6</b> proceeded according to Schemes <a class="ref internalNav" href="#sch1" aria-label="1">1</a> and <a class="ref internalNav" href="#sch2" aria-label="2">2</a>, respectively. Commercially available 9-fluorenylmethyl <i>N</i>-(2-aminoethyl)carbamate hydrochloride was treated with dansyl chloride in a biphasic ethyl acetate/aqueous potassium carbonate solution to give <b>1</b> (Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>). Compound <b>1</b> was deprotected with morpholine in DMF to give the amino compound <b>2</b>. In parallel, the aminoquinazoline was diazotized in dry acetonitrile with nitrosonium tetrafluoroborate to provide the diazonium salt <b>3</b> as previously described.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> Diazonium salt <b>3</b> was coupled with <b>2</b> in the presence of triethylamine <i>in situ</i> to give the desired compound <b>4</b>. Several attempts to purify <b>4</b> by column chromatography failed due to on-column degradation, which we believe could be due to the conversion of <b>4</b> to a product resulting from loss of nitrogen. Successful purification was achieved by serial trituration of compound <b>4</b> with methylene chloride, ether, and petroleum ether to give a pure red-brown powder. The compound was characterized by NMR and MS, and its purity was confirmed by elemental analysis.</div><figure id="sch1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-5/jm9016043/production/images/medium/jm-2009-016043_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-5/jm9016043/production/images/large/jm-2009-016043_0009.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Compound <b>4</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-5/jm9016043/production/images/large/jm-2009-016043_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm9016043&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) <i>N</i>-Fmoc-ethylenediamine, EtOAc, H<sub>2</sub>O, K<sub>2</sub>CO<sub>3</sub>, 0 °C. (ii) Morpholine, DMF, room temperature. (iii) Diazonium <b>3</b>, Et<sub>3</sub>N, CH<sub>3</sub>CN/Et<sub>2</sub>O, −5 °C.</p></p></figure><div class="NLM_p">The synthesis of compound <b>6</b> proceeded in a similar fashion. An excess of commercially available <i>N</i>-(2-aminoethyl)-<i>N</i>-methylethanediamine was treated with dansyl chloride to give <b>5</b> in ethyl acetate at 0 °C (Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>), and this product was coupled with the diazonium salt of quinazoline <b>3</b> to give <b>6</b>. The purification of <b>6</b> was as difficult as that of <b>4</b>. All attempts to purify this compound by column chromatography failed. Serial trituration provided a pure red-brown powder that was analytically pure. The structure of <b>6</b> was further confirmed by NMR and MS.</div><figure id="sch2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-5/jm9016043/production/images/medium/jm-2009-016043_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-5/jm9016043/production/images/large/jm-2009-016043_0010.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Compound <b>6</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-5/jm9016043/production/images/large/jm-2009-016043_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm9016043&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) <i>N</i>-(2-Aminoethyl)-<i>N</i>-methylethanediamine, EtOAc, 0 °C. (ii) Diazonium <b>3</b>, Et<sub>3</sub>N, CH<sub>3</sub>CN/Et<sub>2</sub>O, −5 °C.</p></p></figure></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i6" class="anchor-spacer"></div><h3 class="article-section__title" id="_i6"> Half-Life in a Serum-Containing Medium</h3><div class="NLM_p">The sole structural difference between <b>4</b> and <b>6</b> is in the nature of the linker. The linker in <b>4</b> is an ethylene group between the sulfonamido moiety of the dansyl and the N3 of the triazene, leaving no possibility for intramolecular hydrogen bonding. By contrast, the dansyl in <b>6</b> is separated by six bond lengths and contains a methylamino group three bond lengths away from the N3 of the triazene, leaving the possibility for intramolecular hydrogen bonding. Interestingly, <b>4</b> was 5-fold less stable than <b>6</b> with a half-life as short as 5 min (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>). Perhaps, the intramolecular interaction between the <i>N</i>-methylamino group and the triazene plays a significant stabilizing role. We have already evoked a similar interaction for explaining the stability of <b>7</b> (Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>), a stable dimethyaminoethyl triazene with a <i>t</i><sub>1/2</sub> = 108 min<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> that showed significant antitumor activity <i>in vivo</i>.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> To further elaborate on the importance of the <i>N</i>-methylamino group on the stability of <b>6</b>, we undertook a molecular modeling study using AM1 semi-empirical calculation.</div><div class="NLM_p">As outlined in Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>, conformer <b>1</b> containing a H-bond is computed to be ∼2 kcal/mol more stable than conformer <b>2</b>, which lacks the H-bond. Conformer <b>1</b> has the proposed H-bond (2.62 Å distance) that stabilizes it. The H-bond is absent in conformer <b>2</b>, as the hydrogen and the amine nitrogen are <i>trans</i> to one another at a distance of 4.08 Å. Compound <b>4</b>, which is not able to adopt H-bond-stabilizing conformations, is less stable. However, in aqueous solution, the superior stability of <b>6</b> is better rationalized in terms of the equilibria depicted in Schemes <a class="ref internalNav" href="#sch3" aria-label="3">3</a> and <a class="ref internalNav" href="#sch4" aria-label="4">4</a>. Because the central nitrogen in <b>6</b> is protonated at physiological pH, the transition state to the formation of the doubly charged species <b>F</b> should have a higher energy when compared with that for <b>C</b> in Scheme <a class="ref internalNav" href="#sch4" aria-label="4">4</a>. This may account for the slower rate of hydrolysis for <b>6</b> when compared with <b>4</b> under physiological conditions.</div><figure id="fig1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-5/jm9016043/production/images/medium/jm-2009-016043_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-5/jm9016043/production/images/large/jm-2009-016043_0003.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Molecular modeling using AM1 semi-empirical calculation of <b>6</b>. The H−N distances are given in Å.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-5/jm9016043/production/images/large/jm-2009-016043_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm9016043&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Half-Lives of Compounds <b>4</b> and <b>6</b> in a Serum-Containing Medium</div></div></div><div class="scrollable-table-wrap"><table class="table single-image" border="0"><colgroup><col /></col></colgroup><tbody><tr valign="top"><td><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-5/jm9016043/production/images/medium/jm-2009-016043_0011.gif" alt="" id="_i8" /></img></td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>*</sup><p class="last">Data are means of three experiments in triplicate.</p></div></div></div><figure id="sch3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-5/jm9016043/production/images/medium/jm-2009-016043_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-5/jm9016043/production/images/large/jm-2009-016043_0001.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Degradation Pathway of Compound <b>6</b> in Physiological Conditions</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-5/jm9016043/production/images/large/jm-2009-016043_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm9016043&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="sch4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-5/jm9016043/production/images/medium/jm-2009-016043_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-5/jm9016043/production/images/large/jm-2009-016043_0002.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Degradation Pathway of Compound <b>4</b> in Physiological Conditions</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-5/jm9016043/production/images/large/jm-2009-016043_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm9016043&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i11" class="anchor-spacer"></div><h3 class="article-section__title" id="_i11"> Differential Growth Inhibitory Activity</h3><div class="NLM_p">The potency of the two dansylated compounds was compared in MES-SA cells that do not express P-gp. MES-SA cells are also deprived of EGFR expression.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> Therefore, the EGFR inhibitory activity of the quinazoline side chain would not influence the growth inhibitory effect of compounds <b>4</b> and <b>6</b>. The results showed that <b>6</b> was 3-fold more potent than <b>4</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>A). Perhaps the rapid decomposition of <b>4</b> compromised its optimal cellular delivery. We also observed a 2-fold stronger potency for <b>6</b> in the MDA-MB-468 breast cancer cells that express EGFR but do not express P-gp,<a onclick="showRef(event, 'ref21 ref22'); return false;" href="javascript:void(0);" class="ref ref21 ref22">(21, 22)</a> indicating that <b>6</b> was more potent than <b>4</b> regardless of the P-gp and the EGFR status of the cells (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>B).</div><figure id="fig2" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-5/jm9016043/production/images/medium/jm-2009-016043_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-5/jm9016043/production/images/large/jm-2009-016043_0004.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Growth inhibition of doxorubicin, <b>4</b>, and <b>6</b> by SRB assay. (A) Comparison of antiproliferative activity of doxorubicin, <b>4</b>, or <b>6</b> in MES-SA and MES-SA/DX5 cells after 96 h. (B) Growth inhibition of <b>4</b> and <b>6</b> in human breast MDA-MB-468 cells. Each point represents an average of two independent experiments performed in triplicate.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-5/jm9016043/production/images/large/jm-2009-016043_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm9016043&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Because our primary goal was to compare the cellular penetration of the two compounds in P-gp-proficient and -deficient cells, we tested their effects on both MES-SA (P-gp-deficient) and its derived MES-SA/DX5 (P-gp-proficient) cells. The latter cell line expresses high levels of P-gp and is resistant to doxorubicin. Using the SRB assay, we showed a 20-fold difference between the sensitivity of MES-SA and MES-SA/DX5 to doxorubicin. In contrast, no significant difference (<i>P</i> > 0.05) was seen for both <b>4</b> and <b>6</b> in their potency against the two cell lines. Combi-molecule <b>6</b> was equally potent in both cell lines, and <b>4</b> was 1.6-fold more potent against MES-SA/DX5 than MES-SA, indicating an even greater potency in the cells that express P-gp.</div></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12"> Cellular Uptake</h3><div class="NLM_p">To verify whether the differential responses correlated with cell penetration, we exploited the fluorescent properties of doxorubicin and those of compounds <b>4</b> and <b>6</b> to analyze their intracellular content by fluorescence microscopy and flow cytometry. We have previously used flow cytometry to analyze doxorubicin and compound <b>6</b> internalization in human breast tumor cells.<a onclick="showRef(event, 'ref15 ref23'); return false;" href="javascript:void(0);" class="ref ref15 ref23">(15, 23)</a></div><div class="NLM_p">Fluorescence microscopy in the parental cell line showed a homogeneous distribution of doxorubicin (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>A, upper panel) throughout the cell population. By contrast, in the MES-SA/DX5 cells (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>A, lower panel), the distribution was heterogeneous with a fraction of the cell population emitting high fluorescence and another with poor to no internalization of doxorubicin. As shown in Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>A, <b>4</b> and <b>6</b> penetrate the cells and decompose inside the cells to generate its bioactive species: EGFR inhibitor, blue fluorescence, and a DNA-damaging species, green fluorescence. The two colors were observed at similar intensity in both cell types. Flow cytometric analysis permitted the quantification of the proportion of cells that did not internalize doxorubicin (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>B) and the combi-molecules (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>B). For the more potent compound <b>6</b>, at a dose range starting with the IC<sub>50</sub> for growth inhibition, no differential internalization between the two cell types was seen. In contrast, 40% of the cell population could not internalize doxorubicin at this dose range.</div><figure id="fig3" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-5/jm9016043/production/images/medium/jm-2009-016043_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-5/jm9016043/production/images/large/jm-2009-016043_0005.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Cellular fluorescence and DNA damage by doxorubicin. (A) Intracellular accumulation of doxorubicin in P-gp-positive and -negative cells was determined by fluorescence microscopy. Cells were incubated with 25 μM doxorubicin for 2 h and washed with PBS, and fluorescence was visualized with a Leica fluorescent microscope (40× magnification). (B) Cellular fluorescence of doxorubicin by FACS. The levels of accumulated fluorescence for doxorubicin (0, 6.25, 12.5, 25, and 50 μM) were quantified in MES-SA and MES-SA/DX5 cells after 2 h. (C) DNA damage induced by doxorubicin in MES-SA (0, 1.5, 6.25, 12.5, 25, and 50 μM) and MES-SA/DX5 (0, 6.25, 12.5, 25, 50, and 100 μM) cells. Cells were exposed for 2 h to doxorubicin, and DNA damage was measured using an alkaline comet assay. Fifty cells were scored from each dose, and the comet tail moment was calculated by comet IV software (Perceptive Instruments). Cells with a comet tail moment greater than that in the control were scored positive and expressed as percent of cells with damaged DNA.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-5/jm9016043/production/images/large/jm-2009-016043_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm9016043&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig4" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-5/jm9016043/production/images/medium/jm-2009-016043_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-5/jm9016043/production/images/large/jm-2009-016043_0006.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. (A) Cellular fluorescence of <b>4</b> and <b>6</b> by fluorescence microscopy. MES-SA and MES-SA/DX5 cells were incubated with <b>4</b> and <b>6</b> for 2 h, and imaging was performed with Leica fluorescent microscope (40× magnification). Visualization of <b>4</b> and <b>6</b> degradation species: Blue aminoquinazoline and green dansylated species were imaged using individual filters. (B) Cellular fluorescence of <b>4</b> and <b>6</b> by FACS. The levels of accumulated fluorescence for <b>4</b> and <b>6</b> (0, 6.25, 12.5, 25, and 50 μM) were quantified in MES-SA and MES-SA/DX5 cells by FACS, and results were analyzed with GraphPad Prism software.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-5/jm9016043/production/images/large/jm-2009-016043_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm9016043&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13"> DNA Damage</h3><div class="NLM_p">The DNA-damaging property of compounds <b>4</b> and <b>6</b> was assessed by alkaline comet assay. The visualization of DNA comet tails in both cell lines using fluorescence microscopy showed that <b>6</b> was a strong DNA-damaging agent, while <b>4</b> was not able to induce DNA damage (Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>). This result is consistent with the stability of the two molecules and also that of the putative dansylated alkyldiazonium released after degradation. The rapid decomposition of <b>4</b> seems again to limit its activity. Moreover, <b>6</b> damaged DNA in both cell lines with the same intensity, independently of P-gp status, which is in agreement with the growth inhibitory results, and also indicated that the combimolecule can penetrate and decompose inside the cells to deliver the DNA-damaging moiety (green fluorescence, Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>A). The levels of DNA damage induced by doxorubicin were also analyzed in the two cell types, and a differential response was seen with doxorubicin inducing a 2-fold greater number of DNA-damaged cells in the MES-SA population when compared with MES-SA/DX5 (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>C). Cells with a higher comet tail moment than the control were scored as damaged, and the data were presented as percent of cells with damaged DNA. This result was consistent with the differential level of doxorubicin uptake observed between these two cell types.</div><figure id="fig5" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-5/jm9016043/production/images/medium/jm-2009-016043_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-5/jm9016043/production/images/large/jm-2009-016043_0007.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. DNA damage induced by <b>4</b> and <b>6</b> at 50 (A) and 100 μM (B). MES-SA and MES-SA/DX5 cells were exposed to each combi-molecule for 2 h followed by assessment of drug-induced DNA damage using an alkaline comet assay. Visualization of DNA comets in both cell lines by fluorescence microscopy (10× magnification) after staining with SYBR Gold. (C) Fifty comets were scored, and the comet tail moment was quantified by comet IV software (Perceptive Instruments). Two independent experiments were averaged for each cell line, and data were analyzed with GraphPad Prism software.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-5/jm9016043/production/images/large/jm-2009-016043_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm9016043&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i14">Conclusion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_13062" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_13062" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">At the advanced stages of many cancers, drug transport is significantly affected by several mechanisms including P-gp-mediated drug efflux.<a onclick="showRef(event, 'ref1 ref2 ref3 ref4 ref5'); return false;" href="javascript:void(0);" class="ref ref1 ref2 ref3 ref4 ref5">(1-5)</a> This presents a daunting challenge to drug development against advanced cancers. The combi-molecules are designed to possess multiple targeting properties with the purpose of simultaneously blocking several signaling networks in the cells. To this end, several pharmacophores must be appended to one single core structure. Therefore, this leads to the branching of pharmacophores through bulky linkers that often affect the size of the resulting molecules and, as a result, their transport into the cells. It is now well-known that the greater the size of an agent is, the more likely that its transport mechanism across the cell membrane will be influenced by efflux proteins. Here, we discovered that at least one mechanism of drug efflux may not prevent cell penetration by two prototypical combi-molecules designed to block EGFR−DNA and carrying a bulky fluorescence-labeled moiety. Although the molecular mechanism of such an important observation requires further elucidation, we believe that the fact that the combi-molecules are designed to decompose inside the cells to generate their bioactive species might be a mean by which the rapid efflux of the intact structure was impeded.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i15">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_80618" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_80618" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> Chemistry</h3><div class="NLM_p"><sup>1</sup>H NMR spectra and <sup>13</sup>C NMR spectra were recorded on a Varian 300 MHz spectrometer. Chemical shifts are given as δ values in parts per million (ppm) and are referenced to the residual solvent proton or carbon peak. Mass spectrometry was performed by the McGill University Mass Spectroscopy Center, and electrospray ionization (ESI) spectra were performed on a Finnigan LC QDUO spectrometer. Data are reported as <i>m</i>/<i>z</i> (intensity relative to base peak = 100). Elemental analyses were carried out by GCL & Chemisar Laboratories (Guelph, Ontario, Canada). The analyses were done two times. All chemicals were purchased from Sigma-Aldrich. Dansyl chloride was purchased from Alfa Aesar, <i>N</i>-(2-aminoethyl)-<i>N</i>-methylethanediamine was from Wako Pure Chemical Industries, Ltd., and mono-Fmoc-ethylenediamine hydrochloride was from Novabiochem. The purities of all compounds tested were >95% as determined by elemental analysis.</div><div id="sec4_1_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i17" class="anchor-spacer"></div><h4 class="article-section__title" id="_i17"> Compound <b>1</b>, 2-Dansyl-9-fluorenylmethyl <i>N</i>-(2-Aminoethyl)carbamate</h4><div class="NLM_p last">9-Fluorenylmethyl <i>N</i>-(2-aminoethyl)carbamate hydrochloride (500 mg, 1.57 mmol) was dissolved in water saturated with potassium carbonate and ethyl acetate (50 mL/50 mL). The mixture was cooled to 0 °C, and a solution of dansyl chloride (3 equiv) in ethyl acetate was added dropwise. The reaction mixture was stirred, and the temperature was raised to room temperature. After 4 h, the organic layer was separated, washed with brine twice and dried with magnesium sulfate, filtered, and evaporated to provide a yellow-green oil, which was purified by trituration in ethyl ether. A white pure solid of compound <b>1</b> was obtained after filtration (742 mg, 92%). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>): δ ppm 2.75 (m, 2H), 2.80 (s, 6H), 2.95 (m, 2H), 4.21 (m, 3H), 7.25 (m, 4H), 7.37 (m, 2H), 7.59 (m, 4H), 7.85 (d, <i>J =</i>7.5 Hz, 1H), 7.99 (m, 1H), 8.08 (d, <i>J =</i>7.5 Hz, 1H), 8.24 (d, <i>J =</i>8.1 Hz, 1H), 8.45 (d, <i>J =</i>8.7 Hz, 1H).</div></div><div id="sec4_1_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i18" class="anchor-spacer"></div><h4 class="article-section__title" id="_i18"> Compound <b>2</b>, Dansyl-<i>N</i>-(2-aminoethyl)amide</h4><div class="NLM_p last">The Fmoc group was removed with morpholine/DMF 1/1 (2 mL) for 30 min at room temperature. The reaction mixture was evaporated, and the crude product was extracted with ethyl acetate and acidic water phase (pH 2). The aqueous phase was alkalinized to pH 5 and extracted with ethyl acetate to eliminate the secondary products from the aqueous layer. The pH was increased to 10, and this aqueous layer was extracted again with ethyl acetate. The organic layer was dried, and the magnesium sulfate was filtered and evaporated to provide pure free amine <b>2</b> (148 mg, 87%). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>): δ ppm 2.45 (m, 2H), 2.75 (m, 2H), 2.81 (s, 6H), 7.24 (d, <i>J =</i>7.2 Hz, 1H), 7.59 (q, <i>J =</i>7.5 Hz, 2H), 8.09 (d, <i>J =</i>7.2 Hz, 1H), 8.28 (d, <i>J =</i>8.4 Hz, 1H), 8.45 (d, <i>J =</i>8.7 Hz, 1H).</div></div><div id="sec4_1_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i19" class="anchor-spacer"></div><h4 class="article-section__title" id="_i19"> Compound <b>5</b>, Dansyl-<i>N</i>-(2-[(2-aminoethyl)-<i>N</i>-methylamino]ethyl)amide</h4><div class="NLM_p last">Dansyl chloride (1 g, 3.71 mmol) was dissolved in 20 mL of ethyl acetate and was added dropwise to a cold solution of <i>N</i>-(2-aminoethyl)-<i>N</i>-methylethanediamine (2.38 mL, 5 equiv) in 80 mL of ethyl acetate. The reaction mixture was stirred at 0 °C under argon. After 2 h, the solution was extracted with neutral water and acidic water (pH 2−3). This acidic water was alkalinized and was extracted with ethyl acetate two times. The organic layer was dried with magnesium sulfate, filtered, and evaporated to provide a yellow oil, which was purified by crystallization in a minimum of ethyl acetate. White pure crystals of compound <b>5</b> were obtained (1.117 g, 86%). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>): δ ppm 1.92 (s, 3H), 2.13 (t, <i>J =</i> 6.3 Hz, 2H), 2.21 (t, <i>J =</i> 6.7 Hz, 2H), 2.40 (t, <i>J =</i> 6.1 Hz, 2H), 2.81 (s, 6H), 2.84 (t, <i>J =</i> 6.9 Hz, 2H), 7.21 (d, <i>J =</i>7.5 Hz, 1H), 7.58 (m, 2H), 8.11 (d, <i>J =</i> 7.2 Hz, 1H), 8.27 (d, <i>J =</i> 8.4 Hz, 1H), 8.43 (d, <i>J =</i> 8.1 Hz, 1H).</div></div><div id="sec4_1_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i20" class="anchor-spacer"></div><h4 class="article-section__title" id="_i20"> Compound <b>4</b></h4><div class="NLM_p last">The diazonium compound <b>3</b> was synthesized as described in ref <a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">14</a>: Amino-anilinoquinazoline (50 mg, 0.184 mmol) was dissolved in dry acetonitrile (5 mL) under argon and cooled to −5 °C. Nitrosonium tetrafluoroborate (2 equiv) in acetonitrile was added directly. After 30 min at −5 °C, the resulting clear orange solution was added dropwise to another solution of compound <b>2</b> (1 equiv) in acetonitrile with triethylamine (2 equiv) at 0 °C, after which the mixture was extracted with ethyl acetate and brine. The organic layer was dried with potassium carbonate and evaporated to provide a brown residue, which was purified by serial trituration: First, the crude product was dissolved in a minimum of methylene chloride and precipitated with petroleum ether and after was triturated in ether/petroleum ether 1/4 to give after filtration a red-brown solid (93 mg, 88%). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>): δ ppm 2.77 (s, 6H), 3.10 (m, 2H), 3.59 (m, 2H), 7.13 (d, <i>J =</i> 8.4 Hz, 1H), 7.22 (d, <i>J =</i> 7.5 Hz, 1H), 7.39 (m, 1H), 7.59 (m, 2H), 7.73 (d, <i>J =</i> 8.7 Hz, 1H), 7.86 (m, 2H), 8.13 (m, 2H), 8.27 (d, <i>J =</i> 8.7 Hz, 1H), 8.35 (s, 1H), 8.43 (d, <i>J =</i> 9.0 Hz, 1H), 8.58 (s, 1H), 9.89 (s, 1H), 10.59 (m, 1H). <sup>13</sup>C NMR (75 MHz, DMSO-<i>d</i><sub>6</sub>): δ ppm 158.13, 153.92, 152.05, 149.23, 148.90, 141.70, 136.29, 133.36, 130.71, 130.23, 129.74, 129.70, 129.50, 129.08, 128.61, 125.68, 124.28, 123.58, 121.89, 120.84, 119.71, 116.28, 115.82, 115.18, 51.72, 46.31, 45.72 (2C). ESI <i>m</i>/<i>z</i> 572.9 (MH<sup>+</sup> with <sup>35</sup>Cl). Anal. (C<sub>28</sub>H<sub>27</sub>ClN<sub>8</sub>O<sub>2</sub>S) C, H, N.</div></div><div id="sec4_1_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i21" class="anchor-spacer"></div><h4 class="article-section__title" id="_i21"> Compound <b>6</b></h4><div class="NLM_p last">The diazonium compound <b>3</b> was still synthesized as previously described.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> Amino-anilinoquinazoline (608 mg, 2.246 mmol) was dissolved in dry acetonitrile (80 mL) under argon and cooled to −5 °C. Nitrosonium tetrafluoroborate (2 equiv) in acetonitrile was added directly. After 30 min at −5 °C, the resulting clear solution was added dropwise to another solution of compound <b>5</b> (1 equiv) in acetonitrile with triethylamine (2 equiv) at 0 °C, after which the mixture was extracted with ethyl acetate and brine. The organic layer was dried with potassium carbonate and evaporated to provide a brown residue, which was purified by serial trituration. The crude product was dissolved in a minimum of methylene chloride and precipitated with petroleum ether, after which it was triturated in ether/petroleum ether 1/4 to give after filtration a red-brown solid (1.2 g, 85%). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>): δ ppm 1.99 (s, 3H), 2.32 (m, 2H), 2.52 (m, 2H), 2.77 (s, 6H), 2.90 (m, 2H), 3.53 (m, 2H), 7.12 to 7.21 (m, 2H), 7.39 (m, 1H), 7.55 (m, 2H), 7.75 to 7.97 (m, 4H), 8.12 (m, 2H), 8.30 (d, <i>J =</i> 8.4 Hz, 1H), 8.40 (m, 1H), 8.43 (s, 1H), 8.60 (s, 1H). <sup>13</sup>C NMR (75 MHz, DMSO-<i>d</i><sub>6</sub>): δ ppm 158.10, 153.83, 152.01, 149.73, 148.78, 141.75, 136.69, 133.37, 130.72, 130.07, 129.76, 129.69, 129.56, 128.92, 128.54, 125.40, 124.25, 123.55, 121.83, 120.79, 119.77, 116.37, 115.76, 115.29, 57.04 (2C), 53.84, 46.40, 45.72 (2C), 41.51. ESI <i>m</i>/<i>z</i> 632.1 (MH<sup>+</sup> with <sup>35</sup>Cl). Anal. (C<sub>31</sub>H<sub>34</sub>ClN<sub>9</sub>O<sub>2</sub>S) C, H, N.</div></div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> Half-Lives</h3><div class="NLM_p last">The half-lives of <b>4</b> and <b>6</b> under physiological conditions were studied by UV spectrophotometer, Farmacia Biotech Ultrospec 2000. The compounds were dissolved in minimum volume of DMSO and diluted with DMEM supplemented with 10% FBS, and the absorbances were read at 335 nm for <b>4</b> and 350 nm for <b>6</b> in a quartz UV cell maintained at 37 °C with a circulating water bath. The experiment was repeated three times for each compound. The half-life was estimated by a one-phase exponential decay curve-fit method using the GraphPad software package (GraphPad software, Inc., San Diego, CA). The thermometer was Traceable VWR digital with ±0.005 °C accuracy.</div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> Molecular Modeling</h3><div class="NLM_p last">Molecular modeling was performed with MOE software (version 2006.08) available from Chemical Computing Group Inc. (Montreal, Quebec, Canada; <a href="http://www.chemcomp.com" class="extLink">www.chemcomp.com</a>).</div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> Biology</h3><div id="sec4_4_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i25" class="anchor-spacer"></div><h4 class="article-section__title" id="_i25"> Cell Culture</h4><div class="NLM_p last">All three cell lines were purchased from the American Type Culture Collection (ATCC, Manassas, VA). Human uterine sarcoma cells, MES-SA, and MES-SA/DX5 (ATCC: CRL-1976 and CRL-1977, respectively) were maintained in McCoy 5A medium, and human breast cancer cells MDA-MB-468 were cultured in DMEM. All media were supplemented with 10% FBS, 1.5 mM <span class="smallcaps smallerCapital">l</span>-glutamine (Wisent Inc., St.-Bruno, Canada), and 100 μg/mL penicillin/streptomycin (GibcoBRL, Gaithersburg, MD). Cells were grown exponentially at 37 °C in a humidified atmosphere of 95% air and 5% carbon dioxide. In all assays, cells were plated 24 h before drug treatment.</div></div><div id="sec4_4_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i26" class="anchor-spacer"></div><h4 class="article-section__title" id="_i26"> Drug Treatment</h4><div class="NLM_p last">Compounds <b>4</b> and <b>6</b> were synthesized in our laboratory, and doxorubicin hydrochloride was purchased from the hospital drug store (Mayne Pharma Inc., Montreal). In all assays, molecules were dissolved in DMSO (50 mM stock solution), and doxorubicin was dissolved in sterile water (2 mg/mL stock solution) and subsequently diluted in McCoy 5A medium before it was added to cells. The concentration of DMSO never exceeded 0.1% (v/v) during treatment.</div></div><div id="sec4_4_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i27" class="anchor-spacer"></div><h4 class="article-section__title" id="_i27"> Growth Inhibition Assay</h4><div class="NLM_p last">MES-SA, MES-SA/DX5, and MDA-MB-468 cells were plated at a density of 5000 cells/well in 96-well flat-bottomed microtiter plates (100 μL of cell/well). Cells were allowed to attach overnight and then were treated with different drug concentrations for 96 h. Thereafter, cells were fixed using 50 μL of 50% trichloroacetic acid for 60 min at 4 °C, washed four times with water, stained with sulforhodamine B (SRB 0.4%) for 2 h at room temperature, rinsed four times with 1% acetic acid, and allowed to dry.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> The resulting colored residue was dissolved in 200 μL of Tris base (10 mM, pH 10.0), and the optical density was recorded at a wavelength of 492 nm using a Bio-Rad microplate reader (model 2550). The results were analyzed by GraphPad Prism (GraphPad Software, Inc.), and the sigmoidal dose−response curve was used to determine 50% cell growth inhibitory concentration (IC<sub>50</sub>). Each point represents the average of at least three independent experiments run in triplicate.</div></div><div id="sec4_4_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i28" class="anchor-spacer"></div><h4 class="article-section__title" id="_i28"> DNA Damage by Alkaline Comet Assay</h4><div class="NLM_p last">The alkaline comet assay was performed as previously described.<a onclick="showRef(event, 'ref25 ref26 ref27'); return false;" href="javascript:void(0);" class="ref ref25 ref26 ref27">(25-27)</a> Briefly, cells were exposed to doxorubicin (0, 1.5, 6.25, 12.5, 25, and 50 μM), <b>4</b>, and <b>6</b> (0, 50, and 100 μM) for 2 h, harvested by trypsinization, collected in ice-cold PBS by centrifugation at 3000 rpm for 5 min, and then resuspended in PBS at 1 × 10<sup>6</sup> cells/mL. Cells were mixed with low melting point agarose (0.7%) in PBS at 37 °C (final dilution 1:10), followed by layering the agarose/cells suspension on GelBond film (Lonza, Rockland, ME). The agarose/cell suspension was allowed to solidify for 10 min and then immediately placed in lysis buffer [2.5 M NaCl, 100 mM tetra-sodium EDTA, 10 mM Tris-base, 1% (w/v) <i>N</i>-lauroyl-sarcosine, 10% (v/v) DMSO, and 1% (v/v) triton X-100, pH 10.0] overnight at 4 °C. Thereafter, the gels were rinsed with distilled water, equilibrated in alkaline electrophoresis buffer [300 mM NaOH, 10 mM tetra-sodium EDTA, 7 mM 8-hydroxyquinoline, 2% (v/v) DMSO, pH 13.0] for 30 min at room temperature, and electrophoresed at 20 V for 25 min in fresh eletrophoresis buffer. The gels were subsequently neutralized in 1 M ammonium acetate and then dehydrated in 100% ethanol overnight. Comets were visualized at 10× magnification using Leica fluorescent microscope after staining with SYBR Gold (1:10000, Molecular Probes, Eugene, OR) for 45 min.</div></div><div id="sec4_4_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i29" class="anchor-spacer"></div><h4 class="article-section__title" id="_i29"> Fluorescence Microscopy</h4><div class="NLM_p last">Fluorescent properties of molecules were used to image drug transport efficiency and intracellular accumulation. MES-SA and MES-SA/DX5 cells were plated at 70% confluence in six-well plates, allowed to adhere overnight, and treated with 0, 25, and 50 μM <b>4</b>, <b>6</b>, or doxorubicin. After 2 h, cells were washed twice with PBS and were directly imaged at 40× using Leica fluorescent microscope (Leica DFC300FX camera) without fixation.</div></div><div id="sec4_4_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i30" class="anchor-spacer"></div><h4 class="article-section__title" id="_i30"> Flow Cytometry Analysis of Intracellular Drug Fluorescence</h4><div class="NLM_p last">MES-SA and MES-SA/DX5 cells were plated at 0.5 × 10<sup>6</sup> cells per well in six-well plates, allowed to adhere overnight, and incubated in the presence of <b>4</b> and <b>6</b> or doxorubicin (0, 1.25, 6.25, 12.5, 25, and 50 μM) for 2 h. Cells were collected by trypsinization, washed twice with PBS, pelleted by centrifugation, and resuspended in 300 μL of PBS supplemented with 1% FBS to prevent cell clumping. Intracellular fluorescence levels were measured using a BD LSR flow cytometer (BD Biosciences, San Jose, CA). For <b>4</b> and <b>6</b>, fluorescence was detected at two wavelengths for the two fluorescent products hydrolyzed in the cell: the aminoquinazoline [excitation at 340 nm and emission at 451 nm (blue)] and the dansylated DNA-damaging species [excitation at 340 nm and emission at 525 nm (green)]. To test the transport efficiency of P-gp-proficient cells (MES-SA/DX5) in comparison with the parental MES-SA P-gp-deficient cells, we quantified the fluorescence levels of doxorubicin [excitation at 480 nm and emission at 560−590 nm (red)] and recorded the percentage of doxorubicin-positive P-pg-expressing cells (MES-SA/DX5). FACS results were analyzed with GraphPad Prism software.</div></div></div></div><div class="NLM_back"><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_25565" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_25565" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Bertrand J. Jean-Claude</span> - <span class="hlFld-Affiliation affiliation">Cancer Drug Research Laboratory, Department of Medicine, Division of Medical Oncology, McGill University Health Center/Royal Victoria Hospital, 687 Pine Avenue West Room M-719, Montreal, Quebec, H3A 1A1 Canada</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#d4beb5b7a5a1b1a7fabeb1b5bab7b8b5a1b0b194a7a0b5b2b2fab9b7b3bdb8b8fab7b5"><span class="__cf_email__" data-cfemail="73191210020616005d1916121d101f120617163300071215155d1e10141a1f1f5d1012">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Anne-Laure Larroque-Lombard</span> - <span class="hlFld-Affiliation affiliation">Cancer Drug Research Laboratory, Department of Medicine, Division of Medical Oncology, McGill University Health Center/Royal Victoria Hospital, 687 Pine Avenue West Room M-719, Montreal, Quebec, H3A 1A1 Canada</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Margarita Todorova</span> - <span class="hlFld-Affiliation affiliation">Cancer Drug Research Laboratory, Department of Medicine, Division of Medical Oncology, McGill University Health Center/Royal Victoria Hospital, 687 Pine Avenue West Room M-719, Montreal, Quebec, H3A 1A1 Canada</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Nahid Golabi</span> - <span class="hlFld-Affiliation affiliation">Cancer Drug Research Laboratory, Department of Medicine, Division of Medical Oncology, McGill University Health Center/Royal Victoria Hospital, 687 Pine Avenue West Room M-719, Montreal, Quebec, H3A 1A1 Canada</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Christopher Williams</span> - <span class="hlFld-Affiliation affiliation">Chemical Computing Group Inc., 1010 Sherbrooke Street West, Suite 910, Montreal, Quebec H3A 2R7, Canada</span></div></li></ul></li><li></li><li></li><li></li></ul></div><div class="testing" data-doi="10.1021/jm9016043" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="ack"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i31">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_04455" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_04455" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We thank the National Cancer Institute of Canada (NCIC Grant 018475), Canadian Institutes of Cancer Research (Grant FRN 49440), and Fonds de la Recherche en Santé du Québec doctoral award (M.T.) for financial support. We gratefully acknowledge Nadim K. Saade from the Department of Chemistry, McGill University, for mass spectra.</p></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i32">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_08715" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_08715" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 27 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Ramachandra, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ambudkar, S. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hrycyna, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dey, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gottesman, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pastan, I.</span><span> </span><span class="NLM_article-title">Human P-Glycoprotein Exhibits Reduced Affinity for Substrates during a Catalytic Transition State</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x">, </span> <span class="NLM_fpage">5010</span><span class="NLM_x">–</span> <span class="NLM_lpage">5019</span></span><div class="citationLinks">[<a href="/doi/10.1021/bi973045u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm9016043&amp;key=1%3ACAS%3A528%3ADyaK1cXitV2jsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=1998&pages=5010-5019&author=M.+Ramachandraauthor=S.+V.+Ambudkarauthor=D.+Chenauthor=C.+A.+Hrycynaauthor=S.+Deyauthor=M.+M.+Gottesmanauthor=I.+Pastan&title=Human+P-Glycoprotein+Exhibits+Reduced+Affinity+for+Substrates+during+a+Catalytic+Transition+State"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Human P-Glycoprotein Exhibits Reduced Affinity for Substrates during a Catalytic Transition State</span></div><div class="casAuthors">Ramachandra, Muralidhara; Ambudkar, Suresh V.; Chen, David; Hrycyna, Christine A.; Dey, Saibal; Gottesman, Michael M.; Pastan, Ira</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">5010-5019</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Human P-glycoprotein (Pgp), a plasma membrane protein that confers multidrug resistance, functions as an ATP-dependent drug efflux pump.  Pgp contains two ATP binding/utilization sites and exhibits ATPase activity that is stimulated in the presence of substrates and modulating agents.  The mechanism of coupling of ATP hydrolysis to drug transport is not known.  To understand the role of ATP hydrolysis in drug binding, it is necessary to develop methods for purifying and reconstituting Pgp that retains properties including stimulation of ATPase activity by known substrates to an extent similar to that in the native membrane.  In this study, (His)6-tagged Pgp was expressed in Trichoplusia ni (High Five) cells using the recombinant baculovirus system and purified by metal affinity chromatog.  Upon reconstitution into phospholipid vesicles, purified Pgp exhibited specific binding to analogs of substrates and ATP in affinity labeling expts. and displayed a high level of drug-stimulated ATPase activity (specific activity ranging from 4.5 to 6.5 μmol min-1 mg-1).  The ATPase activity was inhibited by ADP in a competitive manner, and by vanadate and N-ethylmaleimide at low concns.  Vanadate which is known to inhibit ATPase activity by trapping MgADP at the catalytic site inhibited photoaffinity labeling of Pgp with substrate analogs, [125I]iodoarylazidoprazosin and [3H]azidopine, only under ATP hydrolysis conditions.  Because vanadate-trapped Pgp is known to resemble the ADP and phosphate-bound catalytic transition state, our findings indicate that ATP hydrolysis results in a conformation with reduced affinity for substrates.  A catalytic transition conformation with reduced affinity would essentially result in substrate dissocn. and supports a model for drug transport in which an ATP hydrolysis-induced conformational change leads to drug release toward the extracellular medium.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrD6RihoJf9mbVg90H21EOLACvtfcHk0lgR_I6w3yF3Hw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXitV2jsrk%253D&md5=7841376ab6dd18acb68e44444e98b477</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1021%2Fbi973045u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi973045u%26sid%3Dliteratum%253Aachs%26aulast%3DRamachandra%26aufirst%3DM.%26aulast%3DAmbudkar%26aufirst%3DS.%2BV.%26aulast%3DChen%26aufirst%3DD.%26aulast%3DHrycyna%26aufirst%3DC.%2BA.%26aulast%3DDey%26aufirst%3DS.%26aulast%3DGottesman%26aufirst%3DM.%2BM.%26aulast%3DPastan%26aufirst%3DI.%26atitle%3DHuman%2520P-Glycoprotein%2520Exhibits%2520Reduced%2520Affinity%2520for%2520Substrates%2520during%2520a%2520Catalytic%2520Transition%2520State%26jtitle%3DBiochemistry%26date%3D1998%26volume%3D37%26spage%3D5010%26epage%3D5019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Sharom, F. J.</span><span> </span><span class="NLM_article-title">The P-glycoprotein efflux pump: how does it transport drugs?</span> <span class="citation_source-journal">J. Membr. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">160</span><span class="NLM_x">, </span> <span class="NLM_fpage">161</span><span class="NLM_x">–</span> <span class="NLM_lpage">175</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm9016043&amp;key=10.1007%2Fs002329900305" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Fjm9016043&amp;key=9425600" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm9016043&amp;key=1%3ACAS%3A528%3ADyaK2sXotV2isb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=160&publication_year=1997&pages=161-175&author=F.+J.+Sharom&title=The+P-glycoprotein+efflux+pump%3A+how+does+it+transport+drugs%3F"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">The P-glycoprotein efflux pump: how does it transport drugs?</span></div><div class="casAuthors">Sharom, F. J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Membrane Biology</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">160</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">161-175</span>CODEN:
                <span class="NLM_cas:coden">JMBBBO</span>;
        ISSN:<span class="NLM_cas:issn">0022-2631</span>.
    
            (<span class="NLM_cas:orgname">Springer-Verlag New York Inc.</span>)
        </div><div class="casAbstract">A review, with 118 refs.  P-glycoprotein (Pgp) is an atypical translocating ATPase, with low affinity for ATP and high constitutive ATPase activity.  Pgp also has an unusually broad specificity for hydrophobic substrates, including many chemotherapeutic drugs.  Transport studies in reconstituted systems indicate that drug transport requires ATP hydrolysis and is active, generating a drug concn. gradient.  Binding of drugs and ATP to Pgp induces conformational changes in the protein, and the drug binding site is conformationally coupled to nucleotide-binding domains.  Evidence accumulated to date suggest that the transporter interact directly with nonpolar substrate within the membrane environment, and may act as drug flippase, moving drug from the inner to outer leaflet of the bilayer.  Chemosensitizers that block the action of Pgp are proposed to act as alternative substrates, but their high rate of spontaneous flip-flop across the membrane results in futile cycling of the transporter.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpduTsyKNWuPrVg90H21EOLACvtfcHk0lj9J92Cql5STA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXotV2isb4%253D&md5=52fb1ef5b0a0772eeda2ee1c474ae374</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1007%2Fs002329900305&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs002329900305%26sid%3Dliteratum%253Aachs%26aulast%3DSharom%26aufirst%3DF.%2BJ.%26atitle%3DThe%2520P-glycoprotein%2520efflux%2520pump%253A%2520how%2520does%2520it%2520transport%2520drugs%253F%26jtitle%3DJ.%2520Membr.%2520Biol.%26date%3D1997%26volume%3D160%26spage%3D161%26epage%3D175" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Szakacs, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paterson, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ludwig, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Booth-Genthe, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gottesman, M. M.</span><span> </span><span class="NLM_article-title">Targeting multidrug resistance in cancer</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">219</span><span class="NLM_x">–</span> <span class="NLM_lpage">234</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Fjm9016043&amp;key=10.1038%2Fnrd1984" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Fjm9016043&amp;key=16518375" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm9016043&amp;key=1%3ACAS%3A528%3ADC%252BD28XhvFOlsr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2006&pages=219-234&author=G.+Szakacsauthor=J.+K.+Patersonauthor=J.+A.+Ludwigauthor=C.+Booth-Gentheauthor=M.+M.+Gottesman&title=Targeting+multidrug+resistance+in+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting multidrug resistance in cancer</span></div><div class="casAuthors">Szakacs, Gergely; Paterson, Jill K.; Ludwig, Joseph A.; Booth-Genthe, Catherine; Gottesman, Michael M.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">219-234</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Effective treatment of metastatic cancers usually requires the use of toxic chemotherapy.  In most cases, multiple drugs are used, as resistance to single agents occurs almost universally.  For this reason, elucidation of mechanisms that confer simultaneous resistance to different drugs with different targets and chem. structures - multidrug resistance - has been a major goal of cancer biologists during the past 35 years.  Here, we review the most common of these mechanisms, one that relies on drug efflux from cancer cells mediated by ATP-binding cassette (ABC) transporters.  We describe various approaches to combating multidrug-resistant cancer, including the development of drugs that engage, evade or exploit efflux by ABC transporters.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp7LUp3JikHr7Vg90H21EOLACvtfcHk0lj9J92Cql5STA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhvFOlsr8%253D&md5=67ca376f65aa58a71288167f6815a896</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1038%2Fnrd1984&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd1984%26sid%3Dliteratum%253Aachs%26aulast%3DSzakacs%26aufirst%3DG.%26aulast%3DPaterson%26aufirst%3DJ.%2BK.%26aulast%3DLudwig%26aufirst%3DJ.%2BA.%26aulast%3DBooth-Genthe%26aufirst%3DC.%26aulast%3DGottesman%26aufirst%3DM.%2BM.%26atitle%3DTargeting%2520multidrug%2520resistance%2520in%2520cancer%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2006%26volume%3D5%26spage%3D219%26epage%3D234" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Longley, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnston, P. G.</span><span> </span><span class="NLM_article-title">Molecular mechanisms of drug resistance</span> <span class="citation_source-journal">J. Pathol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">205</span><span class="NLM_x">, </span> <span class="NLM_fpage">275</span><span class="NLM_x">–</span> <span class="NLM_lpage">292</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm9016043&amp;key=10.1002%2Fpath.1706" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm9016043&amp;key=15641020" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm9016043&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhsFOgsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=205&publication_year=2005&pages=275-292&author=D.+B.+Longleyauthor=P.+G.+Johnston&title=Molecular+mechanisms+of+drug+resistance"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular mechanisms of drug resistance</span></div><div class="casAuthors">Longley, D. B.; Johnston, P. G.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pathology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">205</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">275-292</span>CODEN:
                <span class="NLM_cas:coden">JPTLAS</span>;
        ISSN:<span class="NLM_cas:issn">0022-3417</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons Ltd.</span>)
        </div><div class="casAbstract">A review.  Resistance to chemotherapy limits the effectiveness of anti-cancer drug treatment.  Tumors may be intrinsically drug-resistant or develop resistance to chemotherapy during treatment.  Acquired resistance is a particular problem, as tumors not only become resistant to the drugs originally used to treat them, but may also become cross-resistant to other drugs with different mechanisms of action.  Resistance to chemotherapy is believed to cause treatment failure in over 90% of patients with metastatic cancer, and resistant micrometastic tumor cells may also reduce the effectiveness of chemotherapy in the adjuvant setting.  Clearly, if drug resistance could be overcome, the impact on survival would be highly significant.  This review focuses on mol. mechanisms of drug resistance that operate to reduce drug sensitivity in cancer cells.  Drug resistance can occur at many levels, including increased drug efflux, drug inactivation, alterations in drug target, processing of drug-induced damage, and evasion of apoptosis.  Advances in DNA microarray and proteomic technol., and the ongoing development of new targeted therapies have opened up new opportunities to combat drug resistance.  We are now able to characterize the signalling pathways involved in regulating tumor cell response to chemotherapy more completely than ever before.  This will facilitate the future development of rational combined chemotherapy regimens, in which the newer targeted therapies are used in combination with cytotoxic drugs to ehnance chemotherapy activity.  The ability to predict response to chemotherapy and to modulate this response with targeted therapies will permit selection of the best treatment for individual patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoOyHxwyfZgyrVg90H21EOLACvtfcHk0lj9J92Cql5STA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhsFOgsrk%253D&md5=956919d3f59f9deff581b62c43a9b7bc</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1002%2Fpath.1706&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fpath.1706%26sid%3Dliteratum%253Aachs%26aulast%3DLongley%26aufirst%3DD.%2BB.%26aulast%3DJohnston%26aufirst%3DP.%2BG.%26atitle%3DMolecular%2520mechanisms%2520of%2520drug%2520resistance%26jtitle%3DJ.%2520Pathol.%26date%3D2005%26volume%3D205%26spage%3D275%26epage%3D292" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Loo, T. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clarke, D. M.</span><span> </span><span class="NLM_article-title">Recent progress in understanding the mechanism of P-glycoprotein-mediated drug efflux</span> <span class="citation_source-journal">J. Membr. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">206</span><span class="NLM_x">, </span> <span class="NLM_fpage">173</span><span class="NLM_x">–</span> <span class="NLM_lpage">185</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Fjm9016043&amp;key=10.1007%2Fs00232-005-0792-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Fjm9016043&amp;key=16456713" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm9016043&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtFWmsbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=206&publication_year=2005&pages=173-185&author=T.+W.+Looauthor=D.+M.+Clarke&title=Recent+progress+in+understanding+the+mechanism+of+P-glycoprotein-mediated+drug+efflux"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Recent progress in understanding the mechanism of P-glycoprotein-mediated drug efflux</span></div><div class="casAuthors">Loo, T. W.; Clarke, D. M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Membrane Biology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">206</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">173-185</span>CODEN:
                <span class="NLM_cas:coden">JMBBBO</span>;
        ISSN:<span class="NLM_cas:issn">0022-2631</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  P-glycoprotein (P-gp) is an ATP-dependent drug pump that can transport a broad range of hydrophobic compds. out of the cell.  The protein is clin. important because of its contribution to the phenomenon of multidrug resistance during AIDS/HIV and cancer chemotherapy.  P-gp is a member of the ATP-binding cassette (ABC) family of proteins.  It is a single polypeptide that contains two repeats joined by a linker region.  Each repeat has a transmembrane domain consisting of six transmembrane segments followed by a hydrophilic domain contg. the nucleotide-binding domain.  In this mini-review, we discuss recent progress in detg. the structure and mechanism of human P-glycoprotein.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqCpkkw_pMyQrVg90H21EOLACvtfcHk0lhAH__m09hJEg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtFWmsbk%253D&md5=db47870508882bd90f8618577797a98b</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1007%2Fs00232-005-0792-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00232-005-0792-1%26sid%3Dliteratum%253Aachs%26aulast%3DLoo%26aufirst%3DT.%2BW.%26aulast%3DClarke%26aufirst%3DD.%2BM.%26atitle%3DRecent%2520progress%2520in%2520understanding%2520the%2520mechanism%2520of%2520P-glycoprotein-mediated%2520drug%2520efflux%26jtitle%3DJ.%2520Membr.%2520Biol.%26date%3D2005%26volume%3D206%26spage%3D173%26epage%3D185" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Aller, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ward, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weng, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chittaboina, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhuo, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harrell, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trinh, Y. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Urbatsch, I. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, G.</span><span> </span><span class="NLM_article-title">Structure of P-Glycoprotein Reveals a Molecular Basis for Poly-Specific Drug Binding</span> <span class="citation_source-journal">Science (Washington, DC, U. S.)</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">323</span><span class="NLM_x">, </span> <span class="NLM_fpage">1718</span><span class="NLM_x">–</span> <span class="NLM_lpage">1722</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm9016043&amp;key=10.1126%2Fscience.1168750" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm9016043&amp;key=19325113" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm9016043&amp;key=1%3ACAS%3A528%3ADC%252BD1MXjs1Kgtro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=323&publication_year=2009&pages=1718-1722&author=S.+G.+Allerauthor=J.+Yuauthor=A.+Wardauthor=Y.+Wengauthor=S.+Chittaboinaauthor=R.+Zhuoauthor=P.+M.+Harrellauthor=Y.+T.+Trinhauthor=Q.+Zhangauthor=I.+L.+Urbatschauthor=G.+Chang&title=Structure+of+P-Glycoprotein+Reveals+a+Molecular+Basis+for+Poly-Specific+Drug+Binding"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Structure of P-Glycoprotein Reveals a Molecular Basis for Poly-Specific Drug Binding</span></div><div class="casAuthors">Aller, Stephen G.; Yu, Jodie; Ward, Andrew; Weng, Yue; Chittaboina, Srinivas; Zhuo, Rupeng; Harrell, Patina M.; Trinh, Yenphuong T.; Zhang, Qinghai; Urbatsch, Ina L.; Chang, Geoffrey</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">323</span>
        (<span class="NLM_cas:issue">5922</span>),
    <span class="NLM_cas:pages">1718-1722</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">P-glycoprotein (P-gp) detoxifies cells by exporting hundreds of chem. unrelated toxins but has been implicated in multidrug resistance (MDR) in the treatment of cancers.  Substrate promiscuity is a hallmark of P-gp activity, thus a structural description of poly-specific drug-binding is important for the rational design of anticancer drugs and MDR inhibitors.  The x-ray structure of apo P-gp at 3.8 angstroms reveals an internal cavity of ~6000 angstroms cubed with a 30 angstrom sepn. of the two nucleotide-binding domains.  Two addnl. P-gp structures with cyclic peptide inhibitors demonstrate distinct drug-binding sites in the internal cavity capable of stereoselectivity that is based on hydrophobic and arom. interactions.  Apo and drug-bound P-gp structures have portals open to the cytoplasm and the inner leaflet of the lipid bilayer for drug entry.  The inward-facing conformation represents an initial stage of the transport cycle that is competent for drug binding.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq2EUmR-iQyaLVg90H21EOLACvtfcHk0lhAH__m09hJEg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXjs1Kgtro%253D&md5=66c7398b0257e6c05161a1afbecdafb1</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1126%2Fscience.1168750&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1168750%26sid%3Dliteratum%253Aachs%26aulast%3DAller%26aufirst%3DS.%2BG.%26aulast%3DYu%26aufirst%3DJ.%26aulast%3DWard%26aufirst%3DA.%26aulast%3DWeng%26aufirst%3DY.%26aulast%3DChittaboina%26aufirst%3DS.%26aulast%3DZhuo%26aufirst%3DR.%26aulast%3DHarrell%26aufirst%3DP.%2BM.%26aulast%3DTrinh%26aufirst%3DY.%2BT.%26aulast%3DZhang%26aufirst%3DQ.%26aulast%3DUrbatsch%26aufirst%3DI.%2BL.%26aulast%3DChang%26aufirst%3DG.%26atitle%3DStructure%2520of%2520P-Glycoprotein%2520Reveals%2520a%2520Molecular%2520Basis%2520for%2520Poly-Specific%2520Drug%2520Binding%26jtitle%3DScience%2520%2528Washington%252C%2520DC%252C%2520U.%2520S.%2529%26date%3D2009%26volume%3D323%26spage%3D1718%26epage%3D1722" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Perez, R. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamilton, T. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ozols, R. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, R. C.</span><span> </span><span class="NLM_article-title">Mechanisms and modulation of resistance to chemotherapy in ovarian cancer</span> <span class="citation_source-journal">Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">71</span><span class="NLM_x">, </span> <span class="NLM_fpage">1571</span><span class="NLM_x">–</span> <span class="NLM_lpage">80</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=1993&pages=1571-80&author=R.+P.+Perezauthor=T.+C.+Hamiltonauthor=R.+F.+Ozolsauthor=R.+C.+Young&title=Mechanisms+and+modulation+of+resistance+to+chemotherapy+in+ovarian+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPerez%26aufirst%3DR.%2BP.%26aulast%3DHamilton%26aufirst%3DT.%2BC.%26aulast%3DOzols%26aufirst%3DR.%2BF.%26aulast%3DYoung%26aufirst%3DR.%2BC.%26atitle%3DMechanisms%2520and%2520modulation%2520of%2520resistance%2520to%2520chemotherapy%2520in%2520ovarian%2520cancer%26jtitle%3DCancer%26date%3D1993%26volume%3D71%26spage%3D1571%26epage%3D80" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Turk, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hall, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chu, B. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ludwig, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fales, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gottesman, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Szakacs, G.</span><span> </span><span class="NLM_article-title">Identification of Compounds Selectively Killing Multidrug-Resistant Cancer Cells</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">69</span><span class="NLM_x">, </span> <span class="NLM_fpage">8293</span><span class="NLM_x">–</span> <span class="NLM_lpage">8301</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2009&pages=8293-8301&author=D.+Turkauthor=M.+D.+Hallauthor=B.+F.+Chuauthor=J.+A.+Ludwigauthor=H.+M.+Falesauthor=M.+M.+Gottesmanauthor=G.+Szakacs&title=Identification+of+Compounds+Selectively+Killing+Multidrug-Resistant+Cancer+Cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTurk%26aufirst%3DD.%26aulast%3DHall%26aufirst%3DM.%2BD.%26aulast%3DChu%26aufirst%3DB.%2BF.%26aulast%3DLudwig%26aufirst%3DJ.%2BA.%26aulast%3DFales%26aufirst%3DH.%2BM.%26aulast%3DGottesman%26aufirst%3DM.%2BM.%26aulast%3DSzakacs%26aufirst%3DG.%26atitle%3DIdentification%2520of%2520Compounds%2520Selectively%2520Killing%2520Multidrug-Resistant%2520Cancer%2520Cells%26jtitle%3DCancer%2520Res.%26date%3D2009%26volume%3D69%26spage%3D8293%26epage%3D8301" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Brahimi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matheson, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dudouit, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McNamee, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tari, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jean-Claude, B. J.</span><span> </span><span class="NLM_article-title">Inhibition of epidermal growth factor receptor-mediated signaling by “Combi-Triazene” BJ2000, a new probe for Combi-Targeting postulates</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">303</span><span class="NLM_x">, </span> <span class="NLM_fpage">238</span><span class="NLM_x">–</span> <span class="NLM_lpage">246</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Fjm9016043&amp;key=10.1124%2Fjpet.102.039099" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Fjm9016043&amp;key=12235257" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Fjm9016043&amp;key=1%3ACAS%3A528%3ADC%252BD38XnsV2qsLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=303&publication_year=2002&pages=238-246&author=F.+Brahimiauthor=S.+L.+Mathesonauthor=F.+Dudouitauthor=J.+P.+McNameeauthor=A.+M.+Tariauthor=B.+J.+Jean-Claude&title=Inhibition+of+epidermal+growth+factor+receptor-mediated+signaling+by+%E2%80%9CCombi-Triazene%E2%80%9D+BJ2000%2C+a+new+probe+for+Combi-Targeting+postulates"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of epidermal growth factor receptor-mediated signaling by "Combi-Triazene" BJ2000, a new probe for Combi-Targeting postulates</span></div><div class="casAuthors">Brahimi, Fouad; Matheson, Stephanie L.; Dudouit, Fabienne; McNamee, James P.; Tari, Ana M.; Jean-Claude, Bertrand J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">303</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">238-246</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The Combi-Targeting concept postulates that a mol. termed combi-mol. (C-mol.) with binary epidermal growth factor receptor (EGFR) targeting/DNA-damaging properties and with the ability to be hydrolyzed to another EGFR inhibitor should induce sustained antiproliferative activity in cells overexpressing EGFR.  Because we postulate that the EGFR affinity of the C-mol. and that of its hydrolytic metabolites are crit. parameters for sustained potency against EGFR-overexpressing cells, we synthesized BJ2000 (IC50 = 0.1 μM, competitive binding at ATP site), a novel C-mol. that can decomp. into a 6-amino-4-anilinoquinazoline FD105 (IC50 = 0.2 μM).  Studies using the EGFR-overexpressing A431 cells revealed that BJ2000 could damage DNA and block epidermal growth factor-stimulated EGFR autophosphorylation by a partially irreversible mechanism.  Blockade of EGFR autophosphorylation subsequently induced inhibition of mitogen-activated protein kinase activation and c-fos gene expression.  ELISA and growth factor-mediated stimulation of proliferation assays in the EGFR-expressing NIH3T3HER14 demonstrated the preferential EGFR-targeting properties of BJ2000, and more importantly suggest that blockade of EGFR phosphorylation by this drug translate into significant growth inhibitory effects.  These properties culminated into irreversible antiproliferative effects as confirmed by a sulforhodamine B assay.  Five days after a 2-h treatment, BJ2000 retained significant antiproliferative effect in A431 cells, whereas its reversible metabolite FD105 almost completely lost its activity.  This result in toto lend support to the Combi-Targeting concept according to which a mol. conjugate kept small enough to interact with EGFR and designed to degrade into another inhibitor of the same target plus a DNA-damaging species may induce sustained growth inhibitory effect in EGFR-overexpressing cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrbJ9ASdjBjlLVg90H21EOLACvtfcHk0ljjh8z1zh8nHw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XnsV2qsLY%253D&md5=c10a7f1cc231cbf64fbe468e89df26d7</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1124%2Fjpet.102.039099&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.102.039099%26sid%3Dliteratum%253Aachs%26aulast%3DBrahimi%26aufirst%3DF.%26aulast%3DMatheson%26aufirst%3DS.%2BL.%26aulast%3DDudouit%26aufirst%3DF.%26aulast%3DMcNamee%26aufirst%3DJ.%2BP.%26aulast%3DTari%26aufirst%3DA.%2BM.%26aulast%3DJean-Claude%26aufirst%3DB.%2BJ.%26atitle%3DInhibition%2520of%2520epidermal%2520growth%2520factor%2520receptor-mediated%2520signaling%2520by%2520%25E2%2580%259CCombi-Triazene%25E2%2580%259D%2520BJ2000%252C%2520a%2520new%2520probe%2520for%2520Combi-Targeting%2520postulates%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2002%26volume%3D303%26spage%3D238%26epage%3D246" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Brahimi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rachid, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McNamee, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alaoui-Jamali, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tari, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jean-Claude, B. J.</span><span> </span><span class="NLM_article-title">Mechanism of action of a novel “combi-triazene” engineered to possess a polar functional group on the alkylating moiety: Evidence for enhancement of potency</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">70</span><span class="NLM_x">, </span> <span class="NLM_fpage">511</span><span class="NLM_x">–</span> <span class="NLM_lpage">519</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2005&pages=511-519&author=F.+Brahimiauthor=Z.+Rachidauthor=J.+P.+McNameeauthor=M.+A.+Alaoui-Jamaliauthor=A.+M.+Tariauthor=B.+J.+Jean-Claude&title=Mechanism+of+action+of+a+novel+%E2%80%9Ccombi-triazene%E2%80%9D+engineered+to+possess+a+polar+functional+group+on+the+alkylating+moiety%3A+Evidence+for+enhancement+of+potency"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBrahimi%26aufirst%3DF.%26aulast%3DRachid%26aufirst%3DZ.%26aulast%3DMcNamee%26aufirst%3DJ.%2BP.%26aulast%3DAlaoui-Jamali%26aufirst%3DM.%2BA.%26aulast%3DTari%26aufirst%3DA.%2BM.%26aulast%3DJean-Claude%26aufirst%3DB.%2BJ.%26atitle%3DMechanism%2520of%2520action%2520of%2520a%2520novel%2520%25E2%2580%259Ccombi-triazene%25E2%2580%259D%2520engineered%2520to%2520possess%2520a%2520polar%2520functional%2520group%2520on%2520the%2520alkylating%2520moiety%253A%2520Evidence%2520for%2520enhancement%2520of%2520potency%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2005%26volume%3D70%26spage%3D511%26epage%3D519" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Brahimi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rachid, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qiu, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McNamee, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Y.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tari, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jean-Claude, B. J.</span><span> </span><span class="NLM_article-title">Multiple mechanisms of action of ZR2002 in human breast cancer cells: A novel combi-molecule designed to block signaling mediated by the ERB family of oncogenes and to damage genomic DNA</span> <span class="citation_source-journal">Int. J. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">112</span><span class="NLM_x">, </span> <span class="NLM_fpage">484</span><span class="NLM_x">–</span> <span class="NLM_lpage">491</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Fjm9016043&amp;key=10.1002%2Fijc.20383" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Fjm9016043&amp;key=15382076" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Fjm9016043&amp;key=1%3ACAS%3A528%3ADC%252BD2cXovVels7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=112&publication_year=2004&pages=484-491&author=F.+Brahimiauthor=Z.+Rachidauthor=Q.+Qiuauthor=J.+P.+McNameeauthor=Y.-J.+Liauthor=A.+M.+Tariauthor=B.+J.+Jean-Claude&title=Multiple+mechanisms+of+action+of+ZR2002+in+human+breast+cancer+cells%3A+A+novel+combi-molecule+designed+to+block+signaling+mediated+by+the+ERB+family+of+oncogenes+and+to+damage+genomic+DNA"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Multiple mechanisms of action of ZR2002 in human breast cancer cells: A novel combi-molecule designed to block signaling mediated by the ERB family of oncogenes and to damage genomic DNA</span></div><div class="casAuthors">Brahimi, Fouad; Rachid, Zakaria; Qiu, Qiyu; McNamee, James P.; Li, Yu-Jiang; Tari, Ana M.; Jean-Claude, Bertrand J.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Cancer</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">112</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">484-491</span>CODEN:
                <span class="NLM_cas:coden">IJCNAW</span>;
        ISSN:<span class="NLM_cas:issn">0020-7136</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">The mechanism of action of ZR2002, a chimeric amino quinazoline designed to possess mixed EGFR tyrosine kinase (TK) inhibitory and DNA targeting properties, was compared to those of ZR01, a reversible inhibitor of the same class and PD168393, a known irreversible inhibitor of EGFR.  ZR2002 exhibited 4-fold stronger EGFR TK inhibitory activity than its structural homolog ZR01 but was approx. 3-fold less active than the 6-acrylamidoquinazoline PD168393.  It preferentially blocked EGF and TGFα-induced cell growth over PDGF and serum.  It also inhibited signal transduction in heregulin-stimulated breast tumor cells, indicating that it does not only block EGFR but also its closely related erbB2 gene product.  In contrast to its structural homologs, ZR2002 was capable of inducing significant levels of DNA strand breaks in MDA-MB-468 cells after a short 2 h drug exposure at a concn. as low as 10 μM.  Reversibility studies using whole cell autophosphorylation and growth assays in human breast cell lines showed that in contrast to its reversible inhibitor counterpart ZR01, ZR2002 induced irreversible inhibition of EGF-stimulated autophosphorylation in MDA-MB-468 cells and irreversible inhibition of cell growth.  Moreover despite possessing a weaker binding affinity than PD168393, it induced a significantly more sustained antiproliferative effect than the latter after a pulse 2 h exposure.  More importantly, in contrast to ZR01 and PD168393, ZR2002 was capable of inducing significant levels of cell death by apoptosis in MDA-MB-468 cells.  The results in toto suggest that the superior antiproliferative potency of ZR2002 may be due to its ability to induce a protracted blockade of receptor tyrosine kinase-mediated signaling while damaging cellular DNA, a combination of events that may trigger cell-killing by apoptosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqQRc4i0h34A7Vg90H21EOLACvtfcHk0ljjh8z1zh8nHw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXovVels7Y%253D&md5=6f00657f83f73adb48f5a3e89b3c58e4</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1002%2Fijc.20383&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fijc.20383%26sid%3Dliteratum%253Aachs%26aulast%3DBrahimi%26aufirst%3DF.%26aulast%3DRachid%26aufirst%3DZ.%26aulast%3DQiu%26aufirst%3DQ.%26aulast%3DMcNamee%26aufirst%3DJ.%2BP.%26aulast%3DLi%26aufirst%3DY.-J.%26aulast%3DTari%26aufirst%3DA.%2BM.%26aulast%3DJean-Claude%26aufirst%3DB.%2BJ.%26atitle%3DMultiple%2520mechanisms%2520of%2520action%2520of%2520ZR2002%2520in%2520human%2520breast%2520cancer%2520cells%253A%2520A%2520novel%2520combi-molecule%2520designed%2520to%2520block%2520signaling%2520mediated%2520by%2520the%2520ERB%2520family%2520of%2520oncogenes%2520and%2520to%2520damage%2520genomic%2520DNA%26jtitle%3DInt.%2520J.%2520Cancer%26date%3D2004%26volume%3D112%26spage%3D484%26epage%3D491" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Domarkas, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dudouit, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qiyu, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Banerjee, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brahimi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jean-Claude, B. J.</span><span> </span><span class="NLM_article-title">The Combi-Targeting Concept: Synthesis of Stable Nitrosoureas Designed to Inhibit the Epidermal Growth Factor Receptor (EGFR)</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">3544</span><span class="NLM_x">–</span> <span class="NLM_lpage">3552</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0600390" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Fjm9016043&amp;key=1%3ACAS%3A528%3ADC%252BD28XkslKht7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=3544-3552&author=J.+Domarkasauthor=F.+Dudouitauthor=C.+Williamsauthor=Q.+Qiyuauthor=R.+Banerjeeauthor=F.+Brahimiauthor=B.+J.+Jean-Claude&title=The+Combi-Targeting+Concept%3A+Synthesis+of+Stable+Nitrosoureas+Designed+to+Inhibit+the+Epidermal+Growth+Factor+Receptor+%28EGFR%29"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">The Combi-Targeting Concept: Synthesis of Stable Nitrosoureas Designed to Inhibit the Epidermal Growth Factor Receptor (EGFR)</span></div><div class="casAuthors">Domarkas, Juozas; Dudouit, Fabienne; Williams, Christopher; Qiu, Qiyu; Banerjee, Ranjita; Brahimi, Fouad; Bertrand, Jacques Jean-Claude</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">3544-3552</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">According to the "combi-targeting" concept, the EGFR tyrosine kinase (TK) inhibitory potency of compds. termed "combi-mols." is crit. for selective growth inhibition of tumor cells with disordered expression of EGFR or its closest family member erbB2.  Here a report is presented on the optimization of the EGFR TK inhibitory potency of the combi-mols. of the (nitroso)urea class by comparison with their aminoquinazoline and (ureido)quinazoline precursors.  This led to the discovery of a new structural parameter that influences their EGFR TK inhibitory potency, i.e., the torsion angle between the plane of the quinazoline ring and the ureido or the (nitroso)ureido moiety of the synthesized drugs.  Chloro and bromo compds. with small angles (0.5-3°) were generally stronger EGFR TK inhibitors than those with large angles (18-21°).  This was further corroborated by ligand-receptor van der Waals interaction calcns. that showed significant binding hindrance imposed by large torsion angles in the narrow ATP cleft of EGFR.  Selective antiproliferative studies in a pair of mouse fibroblast NIH3T3 cells, one of which NIH3T3/neu being transfected with the erbB2 oncogene, showed that IC50 values for inhibition of EGFR TK could be good predictors of their selective potency against the serum-stimulated growth of the erbB2-transfected cell line (Pearson r = 0.8).  On the basis of stability (t1/2), EGFR TK inhibitory potency (IC50), and selective erbB2 targeting, N-(2-chloroethyl)-N'-methyl-N'-[4-[(3-chlorophenyl)amino]-6-quinazolinyl]-N-nitrosourea, a stable (nitroso)urea, was considered to have the structural requirements for further development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrxsPsnA7Mo27Vg90H21EOLACvtfcHk0ljjh8z1zh8nHw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XkslKht7c%253D&md5=8467f8ee9d926318324ee4856c88b2aa</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1021%2Fjm0600390&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0600390%26sid%3Dliteratum%253Aachs%26aulast%3DDomarkas%26aufirst%3DJ.%26aulast%3DDudouit%26aufirst%3DF.%26aulast%3DWilliams%26aufirst%3DC.%26aulast%3DQiyu%26aufirst%3DQ.%26aulast%3DBanerjee%26aufirst%3DR.%26aulast%3DBrahimi%26aufirst%3DF.%26aulast%3DJean-Claude%26aufirst%3DB.%2BJ.%26atitle%3DThe%2520Combi-Targeting%2520Concept%253A%2520Synthesis%2520of%2520Stable%2520Nitrosoureas%2520Designed%2520to%2520Inhibit%2520the%2520Epidermal%2520Growth%2520Factor%2520Receptor%2520%2528EGFR%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D3544%26epage%3D3552" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Banerjee, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rachid, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McNamee, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jean-Claude, B. J.</span><span> </span><span class="NLM_article-title">Synthesis of a Prodrug Designed To Release Multiple Inhibitors of the Epidermal Growth Factor Receptor Tyrosine Kinase and an Alkylating Agent: A Novel Tumor Targeting Concept</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">5546</span><span class="NLM_x">–</span> <span class="NLM_lpage">5551</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm030423m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2003&pages=5546-5551&author=R.+Banerjeeauthor=Z.+Rachidauthor=J.+McNameeauthor=B.+J.+Jean-Claude&title=Synthesis+of+a+Prodrug+Designed+To+Release+Multiple+Inhibitors+of+the+Epidermal+Growth+Factor+Receptor+Tyrosine+Kinase+and+an+Alkylating+Agent%3A+A+Novel+Tumor+Targeting+Concept"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1021%2Fjm030423m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm030423m%26sid%3Dliteratum%253Aachs%26aulast%3DBanerjee%26aufirst%3DR.%26aulast%3DRachid%26aufirst%3DZ.%26aulast%3DMcNamee%26aufirst%3DJ.%26aulast%3DJean-Claude%26aufirst%3DB.%2BJ.%26atitle%3DSynthesis%2520of%2520a%2520Prodrug%2520Designed%2520To%2520Release%2520Multiple%2520Inhibitors%2520of%2520the%2520Epidermal%2520Growth%2520Factor%2520Receptor%2520Tyrosine%2520Kinase%2520and%2520an%2520Alkylating%2520Agent%253A%2520A%2520Novel%2520Tumor%2520Targeting%2520Concept%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2003%26volume%3D46%26spage%3D5546%26epage%3D5551" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Rachid, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brahimi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Katsoulas, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Teoh, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jean-Claude, B. J.</span><span> </span><span class="NLM_article-title">The Combi-Targeting Concept: Chemical Dissection of the Dual Targeting Properties of a Series of “Combi-Triazenes</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">4313</span><span class="NLM_x">–</span> <span class="NLM_lpage">4321</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm030142e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2003&pages=4313-4321&author=Z.+Rachidauthor=F.+Brahimiauthor=A.+Katsoulasauthor=N.+Teohauthor=B.+J.+Jean-Claude&title=The+Combi-Targeting+Concept%3A+Chemical+Dissection+of+the+Dual+Targeting+Properties+of+a+Series+of+%E2%80%9CCombi-Triazenes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1021%2Fjm030142e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm030142e%26sid%3Dliteratum%253Aachs%26aulast%3DRachid%26aufirst%3DZ.%26aulast%3DBrahimi%26aufirst%3DF.%26aulast%3DKatsoulas%26aufirst%3DA.%26aulast%3DTeoh%26aufirst%3DN.%26aulast%3DJean-Claude%26aufirst%3DB.%2BJ.%26atitle%3DThe%2520Combi-Targeting%2520Concept%253A%2520Chemical%2520Dissection%2520of%2520the%2520Dual%2520Targeting%2520Properties%2520of%2520a%2520Series%2520of%2520%25E2%2580%259CCombi-Triazenes%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2003%26volume%3D46%26spage%3D4313%26epage%3D4321" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Todorova, M.; Larroque, A.-L.; Dauphin-Pierre, S.; Fang, Y. Q.; Jean-Claude, B. J.</span><span> </span><span class="NLM_article-title">Cellular imaging and signaling to AL237, a fluorescent-labeled probe for the combi-targeting approach to tumor targeting</span>.  <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span>accepted for publication.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&author=M.+Todorova&author=A.-L.+Larroque&author=S.+Dauphin-Pierre&author=Y.+Q.+Fang&author=B.+J.+Jean-Claude&title=Cellular+imaging+and+signaling+to+AL237%2C+a+fluorescent-labeled+probe+for+the+combi-targeting+approach+to+tumor+targeting"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTodorova%26aufirst%3DM.%26atitle%3DCellular%2520imaging%2520and%2520signaling%2520to%2520AL237%252C%2520a%2520fluorescent-labeled%2520probe%2520for%2520the%2520combi-targeting%2520approach%2520to%2520tumor%2520targeting%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Yip, W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weyergang, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berg, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tonnesen, H. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Selbo, P. K.</span><span> </span><span class="NLM_article-title">Targeted delivery and enhanced cytotoxicity of cetuximab-saporin by photochemical internalization in EGFR-positive cancer cells</span> <span class="citation_source-journal">Mol. Pharmaceutics</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">241</span><span class="NLM_x">–</span> <span class="NLM_lpage">451</span></span><div class="citationLinks">[<a href="/doi/10.1021/mp060105u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Fjm9016043&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtVOmtLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2007&pages=241-451&author=W.+L.+Yipauthor=A.+Weyergangauthor=K.+Bergauthor=H.+H.+Tonnesenauthor=P.+K.+Selbo&title=Targeted+delivery+and+enhanced+cytotoxicity+of+cetuximab-saporin+by+photochemical+internalization+in+EGFR-positive+cancer+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Targeted Delivery and Enhanced Cytotoxicity of Cetuximab-Saporin by Photochemical Internalization in EGFR-Positive Cancer Cells</span></div><div class="casAuthors">Yip, Wai Lam; Weyergang, Anette; Berg, Kristian; Tonnesen, Hanne H.; Selbo, Pl K.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmaceutics</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">241-251</span>CODEN:
                <span class="NLM_cas:coden">MPOHBP</span>;
        ISSN:<span class="NLM_cas:issn">1543-8384</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Photochem. internalization (PCI) is a novel technol. of macromol. delivery.  By PCI, endocytosed membrane-impermeable therapeutic drugs are photochem. released from entrapment in endo-lysosomal compartments to the cytosol of target cells.  In the present report, we describe the in vitro proof-of-concept for PCI of cetuximab-saporin, an immunotoxin targeting EGFR-expressing cells.  This immunotoxin consists of the chimeric murine-human IgG1 monoclonal antibody cetuximab (C225 or Erbitux) bound to the type I ribosome-inactivating protein toxin saporin by a biotin-streptavidin linkage.  The photochem. treatment enhanced the cytotoxicity of the immunotoxin in a synergistic manner in three different EGFR-expressing carcinoma cell lines derived from different tumor tissues (colorectal, HCT-116; prostate, DU-145; and epidermis, A-431).  Both cytotoxicity of cetuximab-saporin and epifluorescence of Alexa488-cetuximab were evaluated by competition with cetuximab demonstrating specific binding and uptake of cetuximab-saporin in EGFR pos. cells.  In the EGFR-neg. uterine sarcoma cell line MES-SA, neither binding nor preferential accumulation of Alexa488-cetuximab was detected.  In addn., PCI enhanced the cytotoxicity of cetuximab-saporin to the same extent as streptavidin-saporin in the MES-SA cells.  In conclusion, PCI enhances selectivity of the cytotoxicity of the immunotoxin cetuximab-saporin in EGFR-expressing cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrxr4SzMv6tJLVg90H21EOLACvtfcHk0li4dBHiGcAXmw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtVOmtLw%253D&md5=8b86555133b3155645ce4e746506815f</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1021%2Fmp060105u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fmp060105u%26sid%3Dliteratum%253Aachs%26aulast%3DYip%26aufirst%3DW.%2BL.%26aulast%3DWeyergang%26aufirst%3DA.%26aulast%3DBerg%26aufirst%3DK.%26aulast%3DTonnesen%26aufirst%3DH.%2BH.%26aulast%3DSelbo%26aufirst%3DP.%2BK.%26atitle%3DTargeted%2520delivery%2520and%2520enhanced%2520cytotoxicity%2520of%2520cetuximab-saporin%2520by%2520photochemical%2520internalization%2520in%2520EGFR-positive%2520cancer%2520cells%26jtitle%3DMol.%2520Pharmaceutics%26date%3D2007%26volume%3D4%26spage%3D241%26epage%3D451" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Harker, W. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MacKintosh, F. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sikic, B. I.</span><span> </span><span class="NLM_article-title">Development and characterization of a human sarcoma cell line, MES-SA, sensitive to multiple drugs</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1983</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">4943</span><span class="NLM_x">–</span> <span class="NLM_lpage">4950</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Fjm9016043&amp;key=6883344" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Fjm9016043&amp;key=1%3ACAS%3A528%3ADyaL2cXhtFykuro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=1983&pages=4943-4950&author=W.+G.+Harkerauthor=F.+R.+MacKintoshauthor=B.+I.+Sikic&title=Development+and+characterization+of+a+human+sarcoma+cell+line%2C+MES-SA%2C+sensitive+to+multiple+drugs"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Development and characterization of a human sarcoma cell line, MES-SA, sensitive to multiple drugs</span></div><div class="casAuthors">Harker, W. Graydon; MacKintosh, F. Roy; Sikic, Branimir Ivan</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">1983</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">4943-50</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    </div><div class="casAbstract">A cell line designated MES-SA has been developed from a human uterine sarcoma.  Histol., the surgical specimen and tumors developing after MES-SA inoculation into nude mice were identical, consisting of sheets of anaplastic sarcoma cells amid scant hyalinized stroma.  The nonepithelial origin of this line was supported by ultrastructural anal. and neg. mucin staining.  The MES-SA line readily forms colonies in soft agar with plating efficiencies ranging from 10 to 20%.  MES-SA has a modal chromosome no. of 45.  Karyotypic abnormalities include: monosomic forms of chromosomes 5, 6, and 7; a 5q, 6p translocation; and one marker chromosome.  In vitro sensitivities to doxorubicin, dactinomycin, mitomycin C, and bleomycin have been demonstrated.  These drug sensitivities remain stable over long periods of monolayer growth and after passage in nude mice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoCYEB4uZReg7Vg90H21EOLACvtfcHk0liRsvaBoF8BGw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2cXhtFykuro%253D&md5=0109270f55e1ed4aa7d87f75009a4331</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHarker%26aufirst%3DW.%2BG.%26aulast%3DMacKintosh%26aufirst%3DF.%2BR.%26aulast%3DSikic%26aufirst%3DB.%2BI.%26atitle%3DDevelopment%2520and%2520characterization%2520of%2520a%2520human%2520sarcoma%2520cell%2520line%252C%2520MES-SA%252C%2520sensitive%2520to%2520multiple%2520drugs%26jtitle%3DCancer%2520Res.%26date%3D1983%26volume%3D43%26spage%3D4943%26epage%3D4950" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Harker, W. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sikic, B. I.</span><span> </span><span class="NLM_article-title">Multidrug (pleiotropic) resistance in doxorubicin-selected variants of the human sarcoma cell line MES-SA</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1985</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">4091</span><span class="NLM_x">–</span> <span class="NLM_lpage">4096</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Fjm9016043&amp;key=4028002" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Fjm9016043&amp;key=1%3ACAS%3A528%3ADyaL2MXlslWmtLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=1985&pages=4091-4096&author=W.+G.+Harkerauthor=B.+I.+Sikic&title=Multidrug+%28pleiotropic%29+resistance+in+doxorubicin-selected+variants+of+the+human+sarcoma+cell+line+MES-SA"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Multidrug (pleiotropic) resistance in doxorubicin-selected variants of the human sarcoma cell line MES-SA</span></div><div class="casAuthors">Harker, W. Graydon; Sikic, Branimir Ivan</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">1985</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">4091-6</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    </div><div class="casAbstract">Doxorubicin (DOX)  [23214-92-8]-resistant sublines of the human sarcoma cell line MES-SA were selected by continuous in vitro exposure to DOX; stepwise increases in DOX concn. produced variants which were 25- and 100-fold resistant to DOX.  These sublines displayed marked cross-resistant to daunorubicin  [20830-81-3], dactinomycin  [50-76-0], mitoxantrone  [65271-80-9], colchicine  [64-86-8], vincristine  [57-22-7], vinblastine  [865-21-4], and etoposide  [33419-42-0] and moderate resistance to mitomycin C  [50-07-7] and melphalan  [148-82-3].  Cross-resistance was not obsd., however, to methotrexate  [59-05-2], 5-fluorouracil  [51-21-8], bleomycin  [11056-06-7], carmustine  [154-93-8], or cisplatin  [15663-27-1].  DOX resistance in these cell lines appeared to be stable despite long periods of growth in drug-free medium.  Two addnl. marker chromosomes were identified in the 100-fold resistant variant, which indicated clonal selection during drug exposure, but no double minute chromosomes or homogeneously staining regions were noted.  Doxorubicin accumulation in the DOX-resistant cells was reduced by approx. 50% compared to that of the sensitive MES-SA cells, as a result of enhanced efflux of DOX from the resistant cells.  There was no evidence of appreciable DOX metab. by either the sensitive or resistant cells.  These studies demonstrate marked DOX resistance and multidrug resistance arising in a human sarcoma line during exposure to DOX.  The pleiotropic nature of this resistance is similar to that described in other models.  Decreased drug accumulation due to enhanced drug efflux is identified as a major mechanism of resistance in these cells, although other factors may also be involved.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpJX9_zdf-RX7Vg90H21EOLACvtfcHk0liRsvaBoF8BGw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2MXlslWmtLY%253D&md5=d08d715f84eccd8fa0a3638a5c0e4a9a</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHarker%26aufirst%3DW.%2BG.%26aulast%3DSikic%26aufirst%3DB.%2BI.%26atitle%3DMultidrug%2520%2528pleiotropic%2529%2520resistance%2520in%2520doxorubicin-selected%2520variants%2520of%2520the%2520human%2520sarcoma%2520cell%2520line%2520MES-SA%26jtitle%3DCancer%2520Res.%26date%3D1985%26volume%3D45%26spage%3D4091%26epage%3D4096" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Koo, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rhee, Y. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, E. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahn, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bae, H. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahn, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kang, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, S. U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, M. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, S. H.</span><span> </span><span class="NLM_article-title">Quinoline derivative KB3−1 potentiates paclitaxel induced cytotoxicity and cycle arrest via multidrug resistance reversal in MES-SA/DX5 cancer cells</span> <span class="citation_source-journal">Life Sci</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">83</span><span class="NLM_x">, </span> <span class="NLM_fpage">700</span><span class="NLM_x">–</span> <span class="NLM_lpage">708</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=83&publication_year=2008&pages=700-708&author=J.+S.+Kooauthor=W.+C.+Choiauthor=Y.+H.+Rheeauthor=H.+J.+Leeauthor=E.+O.+Leeauthor=K.+S.+Ahnauthor=H.+S.+Baeauthor=K.+S.+Ahnauthor=J.+M.+Kangauthor=S.+U.+Choiauthor=M.+O.+Kimauthor=J.+Luauthor=S.+H.+Kim&title=Quinoline+derivative+KB3%E2%88%921+potentiates+paclitaxel+induced+cytotoxicity+and+cycle+arrest+via+multidrug+resistance+reversal+in+MES-SA%2FDX5+cancer+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKoo%26aufirst%3DJ.%2BS.%26aulast%3DChoi%26aufirst%3DW.%2BC.%26aulast%3DRhee%26aufirst%3DY.%2BH.%26aulast%3DLee%26aufirst%3DH.%2BJ.%26aulast%3DLee%26aufirst%3DE.%2BO.%26aulast%3DAhn%26aufirst%3DK.%2BS.%26aulast%3DBae%26aufirst%3DH.%2BS.%26aulast%3DAhn%26aufirst%3DK.%2BS.%26aulast%3DKang%26aufirst%3DJ.%2BM.%26aulast%3DChoi%26aufirst%3DS.%2BU.%26aulast%3DKim%26aufirst%3DM.%2BO.%26aulast%3DLu%26aufirst%3DJ.%26aulast%3DKim%26aufirst%3DS.%2BH.%26atitle%3DQuinoline%2520derivative%2520KB3%25E2%2588%25921%2520potentiates%2520paclitaxel%2520induced%2520cytotoxicity%2520and%2520cycle%2520arrest%2520via%2520multidrug%2520resistance%2520reversal%2520in%2520MES-SA%252FDX5%2520cancer%2520cells%26jtitle%3DLife%2520Sci%26date%3D2008%26volume%3D83%26spage%3D700%26epage%3D708" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Merayo, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rachid, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qiu, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brahimi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jean-Claude, B. J.</span><span> </span><span class="NLM_article-title">The combi-targeting concept: Evidence for the formation of a novel inhibitor in vivo</span> <span class="citation_source-journal">Anti-Cancer Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">165</span><span class="NLM_x">–</span> <span class="NLM_lpage">171</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2006&pages=165-171&author=N.+Merayoauthor=Z.+Rachidauthor=Q.+Qiuauthor=F.+Brahimiauthor=B.+J.+Jean-Claude&title=The+combi-targeting+concept%3A+Evidence+for+the+formation+of+a+novel+inhibitor+in+vivo"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMerayo%26aufirst%3DN.%26aulast%3DRachid%26aufirst%3DZ.%26aulast%3DQiu%26aufirst%3DQ.%26aulast%3DBrahimi%26aufirst%3DF.%26aulast%3DJean-Claude%26aufirst%3DB.%2BJ.%26atitle%3DThe%2520combi-targeting%2520concept%253A%2520Evidence%2520for%2520the%2520formation%2520of%2520a%2520novel%2520inhibitor%2520in%2520vivo%26jtitle%3DAnti-Cancer%2520Drugs%26date%3D2006%26volume%3D17%26spage%3D165%26epage%3D171" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Wang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giuliano, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cabot, M. C.</span><span> </span><span class="NLM_article-title">Enhanced de novo ceramide generation through activation of serine palmitoyltransferase by the P-glycoprotein antagonist SDZ PSC 833 in breast cancer cells</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">719</span><span class="NLM_x">–</span> <span class="NLM_lpage">726</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Fjm9016043&amp;key=12479368" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Fjm9016043&amp;key=1%3ACAS%3A528%3ADC%252BD38XlsFSmtLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2002&pages=719-726&author=H.+Wangauthor=A.+E.+Giulianoauthor=M.+C.+Cabot&title=Enhanced+de+novo+ceramide+generation+through+activation+of+serine+palmitoyltransferase+by+the+P-glycoprotein+antagonist+SDZ+PSC+833+in+breast+cancer+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Enhanced de novo ceramide generation through activation of serine palmitoyltransferase by the P-glycoprotein antagonist SDZ PSC 833 in breast cancer cells</span></div><div class="casAuthors">Wang, Hongtao; Giuliano, Armando E.; Cabot, Myles C.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">719-726</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">SDZ PSC 833 (PSC 833), a P-glycoprotein-targeted multidrug resistance modulator, sensitizes cancer cells to chemotherapy.  Here we show that PSC 833 also potentiates the formation of ceramide.  Because ceramide is a second messenger in chemotherapy-induced apoptosis, knowledge of the lipid pathways influenced by PSC 833 is of relevance.  In intact MDA-MB 468 breast cancer cells, ceramide generation increased 3-fold 1 h after PSC 833 addn. (5.0 μM).  Cyclosporine A, a structural analog, failed to impact ceramide metab.  Sphinganine, the upstream precursor of ceramide, also increased in response to PSC 833, and this could be blocked by adding L-cycloserine, a serine palmitoyltransferase (SPT) inhibitor.  Exposure of cultured cells to PSC 833 (30 min to 4 h; 1-10 μM), followed by isolation of microsomes for in vitro assay, increased SPT activity 60%, whereas palmitoyl CoA synthetase and ceramide synthase activities were not altered.  SPT activity was also heightened by pretreating cells with either paclitaxel, N-(4-hydroxyphenyl)retinamide, etoposide, or daunorubicin; however, activation was half that attained by PSC 833.  PSC 833 stimulated ceramide generation in other breast cancer cell lines as well, including BT-20, MDA-MB 231, Hs 578T, T-47D, and MCF-7.  In summary, several types of anticancer agents and the P-glycoprotein modulator PSC 833 share the ability to increase cellular ceramide levels by activation of SPT, the rate-limiting enzyme in the de novo pathway of ceramide synthesis.  These data provide novel insight in the area of lipid-mediated cell death.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo-crAhxvKrOLVg90H21EOLACvtfcHk0liRsvaBoF8BGw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XlsFSmtLY%253D&md5=79a21f193577eb2783fa96c6f4dd37bc</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DH.%26aulast%3DGiuliano%26aufirst%3DA.%2BE.%26aulast%3DCabot%26aufirst%3DM.%2BC.%26atitle%3DEnhanced%2520de%2520novo%2520ceramide%2520generation%2520through%2520activation%2520of%2520serine%2520palmitoyltransferase%2520by%2520the%2520P-glycoprotein%2520antagonist%2520SDZ%2520PSC%2520833%2520in%2520breast%2520cancer%2520cells%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2002%26volume%3D1%26spage%3D719%26epage%3D726" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Liem, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Appleyard, M. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O'Neill, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hupp, T. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chamberlain, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, A. M.</span><span> </span><span class="NLM_article-title">Doxorubicin and vinorelbine act independently via p53 expression and p38 activation respectively in breast cancer cell lines</span> <span class="citation_source-journal">Br. J. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">88</span><span class="NLM_x">, </span> <span class="NLM_fpage">1281</span><span class="NLM_x">–</span> <span class="NLM_lpage">1284</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Fjm9016043&amp;key=10.1038%2Fsj.bjc.6600898" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Fjm9016043&amp;key=12698197" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Fjm9016043&amp;key=1%3ACAS%3A528%3ADC%252BD3sXivFShsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=88&publication_year=2003&pages=1281-1284&author=A.+A.+Liemauthor=M.+V.+Appleyardauthor=M.+A.+O%27Neillauthor=T.+R.+Huppauthor=M.+P.+Chamberlainauthor=A.+M.+Thompson&title=Doxorubicin+and+vinorelbine+act+independently+via+p53+expression+and+p38+activation+respectively+in+breast+cancer+cell+lines"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Doxorubicin and vinorelbine act independently via p53 expression and p38 activation respectively in breast cancer cell lines</span></div><div class="casAuthors">Liem, A. A.; Appleyard, M. V. C. L.; O'Neill, M. A.; Hupp, T. R.; Chamberlain, M. P.; Thompson, A. M.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Cancer</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">88</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1281-1284</span>CODEN:
                <span class="NLM_cas:coden">BJCAAI</span>;
        ISSN:<span class="NLM_cas:issn">0007-0920</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">In the treatment of breast cancer, combination chemotherapy is used to overcome drug resistance.  Combining doxorubicin and vinorelbine in the treatment of patients with metastatic breast cancer has shown high response rates; even single-agent vinorelbine in patients previously exposed to anthracyclines results in significant remission.  Alterations in protein kinase-mediated signal transduction and p53 mutations may play a role in drug resistance with cross-talk between signal transduction and p53 pathways.  The aim of this study was to establish the effects of doxorubicin and vinorelbine, as single agents, in combination, and as sequential treatments, on signal transduction and p53 in the breast cancer cell lines MCF-7 and MDA-MB-468.  In both cell lines, increased p38 activity was demonstrated following vinorelbine but not doxorubicin treatment, whether vinorelbine was given prior to or simultaneously with doxorubicin.  Mitogen-activated protein kinase (MAPK) activity and p53 expression remained unchanged following vinorelbine treatment.  Doxorubicin treatment resulted in increased p53 expression, without changes in MAPK or p38 activity.  These findings suggest that the effect of doxorubicin and vinorelbine used in combination may be achieved at least in part through distinct mechanisms.  This additivism, where doxorubicin acts via p53 expression and vinorelbine through p38 activation, may contribute to the high clin. response rate when the two drugs are used together in the treatment of breast cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq_WmjPER-yT7Vg90H21EOLACvtfcHk0lhbSMHrpEsLTg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXivFShsLw%253D&md5=dbbee6a8319118d2e33f84cef3a79ddc</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjc.6600898&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjc.6600898%26sid%3Dliteratum%253Aachs%26aulast%3DLiem%26aufirst%3DA.%2BA.%26aulast%3DAppleyard%26aufirst%3DM.%2BV.%26aulast%3DO%2527Neill%26aufirst%3DM.%2BA.%26aulast%3DHupp%26aufirst%3DT.%2BR.%26aulast%3DChamberlain%26aufirst%3DM.%2BP.%26aulast%3DThompson%26aufirst%3DA.%2BM.%26atitle%3DDoxorubicin%2520and%2520vinorelbine%2520act%2520independently%2520via%2520p53%2520expression%2520and%2520p38%2520activation%2520respectively%2520in%2520breast%2520cancer%2520cell%2520lines%26jtitle%3DBr.%2520J.%2520Cancer%26date%3D2003%26volume%3D88%26spage%3D1281%26epage%3D1284" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Panasci, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jean-Claude, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vasilescu, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mustafa, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Damian, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Damian, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Georges, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Batist, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leyland-Jones, B.</span><span> </span><span class="NLM_article-title">Sensitization to doxorubicin resistance in breast cancer cell lines by tamoxifen and megestrol acetate</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">1097</span><span class="NLM_x">–</span> <span class="NLM_lpage">1102</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=1996&pages=1097-1102&author=L.+Panasciauthor=B.+J.+Jean-Claudeauthor=D.+Vasilescuauthor=A.+Mustafaauthor=S.+Damianauthor=Z.+Damianauthor=E.+Georgesauthor=Z.+Liuauthor=G.+Batistauthor=B.+Leyland-Jones&title=Sensitization+to+doxorubicin+resistance+in+breast+cancer+cell+lines+by+tamoxifen+and+megestrol+acetate"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPanasci%26aufirst%3DL.%26aulast%3DJean-Claude%26aufirst%3DB.%2BJ.%26aulast%3DVasilescu%26aufirst%3DD.%26aulast%3DMustafa%26aufirst%3DA.%26aulast%3DDamian%26aufirst%3DS.%26aulast%3DDamian%26aufirst%3DZ.%26aulast%3DGeorges%26aufirst%3DE.%26aulast%3DLiu%26aufirst%3DZ.%26aulast%3DBatist%26aufirst%3DG.%26aulast%3DLeyland-Jones%26aufirst%3DB.%26atitle%3DSensitization%2520to%2520doxorubicin%2520resistance%2520in%2520breast%2520cancer%2520cell%2520lines%2520by%2520tamoxifen%2520and%2520megestrol%2520acetate%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D1996%26volume%3D52%26spage%3D1097%26epage%3D1102" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Skehan, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Storeng, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scudiero, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monks, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McMahon, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vistica, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Warren, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bokesch, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kenney, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boyd, M. R.</span><span> </span><span class="NLM_article-title">New colorimetric cytotoxicity assay for anticancer-drug screening</span> <span class="citation_source-journal">J. Natl. Cancer Inst.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1990</span><span class="NLM_x">, </span> <span class="NLM_volume">82</span><span class="NLM_x">, </span> <span class="NLM_fpage">1107</span><span class="NLM_x">–</span> <span class="NLM_lpage">1112</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Fjm9016043&amp;key=10.1093%2Fjnci%2F82.13.1107" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Fjm9016043&amp;key=2359136" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Fjm9016043&amp;key=1%3ACAS%3A528%3ADyaK3cXltVylsL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=82&publication_year=1990&pages=1107-1112&author=P.+Skehanauthor=R.+Storengauthor=D.+Scudieroauthor=A.+Monksauthor=J.+McMahonauthor=D.+Visticaauthor=J.+T.+Warrenauthor=H.+Bokeschauthor=S.+Kenneyauthor=M.+R.+Boyd&title=New+colorimetric+cytotoxicity+assay+for+anticancer-drug+screening"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">New colorimetric cytotoxicity assay for anticancer-drug screening</span></div><div class="casAuthors">Skehan, Philip; Storeng, Ritsa; Scudiero, Dominic; Monks, Anne; McMahon, James; Vistica, David; Warren, Jonathan T.; Bokesch, Heidi; Kenney, Susan; Boyd, Michael R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the National Cancer Institute</span>
        (<span class="NLM_cas:date">1990</span>),
    <span class="NLM_cas:volume">82</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">1107-12</span>CODEN:
                <span class="NLM_cas:coden">JNCIEQ</span>;
        ISSN:<span class="NLM_cas:issn">0027-8874</span>.
    </div><div class="casAbstract">A rapid, sensitive, and inexpensive method was developed for measuring the cellular protein content of adherent and suspension cultures in 96-well microtiter plates.  The method is suitable for ordinary lab. purposes and for very large-scale applications, such as the National Cancer Institute's disease-oriented in vitro anticancer-drug discovery screen, which requires the use of several million culture wells per yr.  Cultures fixed with trichloroacetic acid were stained for 30 min with 0.4% (wt/vol) sulforhodamine B (SRB) dissolved in 1% acetic acid.  Unbound dye was removed by four washes with 1% acetic acid, and protein-bound dye was extd. with 10 mM unbuffered Tris base [tris(hydroxymethyl)aminomethane] for detn. of optical d. in a computer-interfaced, 96-well microtiter plate reader.  The SRB assay results were linear with the no. of cells and with values for cellular protein measured by both the Lowry and Bradford assays at densities ranging from sparse subconfluence to multilayered supraconfluence.  The signal-to-noise ratio at 564 nm was approx. 1.5 with 1,000 cells per well.  The sensitivity of the SRB assay compared favorably with sensitivities of several fluorescence assays and was superior to those of both the Lowry and Bradford assays and to those of 20 other visible dyes.  The SRB assay provides a colorimetric end point that is nondestructive, indefinitely stable, and visible to the naked eye.  It provides a sensitive measure of drug-induced cytotoxicity, is useful in quantitating clonogenicity, and is well suited to high-vol., automated drug screening.  SRB fluoresces strongly with laser excitation at 488 nm and can be measured quant. at the single-cell level by static fluorescence cytometry.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrA1MIZ3rkcqLVg90H21EOLACvtfcHk0lhbSMHrpEsLTg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3cXltVylsL8%253D&md5=d7bc1784a1f181842d2999efa7fa870c</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1093%2Fjnci%2F82.13.1107&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjnci%252F82.13.1107%26sid%3Dliteratum%253Aachs%26aulast%3DSkehan%26aufirst%3DP.%26aulast%3DStoreng%26aufirst%3DR.%26aulast%3DScudiero%26aufirst%3DD.%26aulast%3DMonks%26aufirst%3DA.%26aulast%3DMcMahon%26aufirst%3DJ.%26aulast%3DVistica%26aufirst%3DD.%26aulast%3DWarren%26aufirst%3DJ.%2BT.%26aulast%3DBokesch%26aufirst%3DH.%26aulast%3DKenney%26aufirst%3DS.%26aulast%3DBoyd%26aufirst%3DM.%2BR.%26atitle%3DNew%2520colorimetric%2520cytotoxicity%2520assay%2520for%2520anticancer-drug%2520screening%26jtitle%3DJ.%2520Natl.%2520Cancer%2520Inst.%26date%3D1990%26volume%3D82%26spage%3D1107%26epage%3D1112" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Matheson, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McNamee, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alaoui-Jamali, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tari, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jean-Claude, B. J.</span><span> </span><span class="NLM_article-title">The combi-targeting concept: Dissection of the binary mechanism of action of the combi-triazene SMA41 in vitro and antitumor activity in vivo</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">311</span><span class="NLM_x">, </span> <span class="NLM_fpage">1163</span><span class="NLM_x">–</span> <span class="NLM_lpage">1170</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Fjm9016043&amp;key=10.1124%2Fjpet.104.071977" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Fjm9016043&amp;key=15358812" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Fjm9016043&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtVKmtLjF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=311&publication_year=2004&pages=1163-1170&author=S.+L.+Mathesonauthor=J.+P.+McNameeauthor=T.+Wangauthor=M.+A.+Alaoui-Jamaliauthor=A.+M.+Tariauthor=B.+J.+Jean-Claude&title=The+combi-targeting+concept%3A+Dissection+of+the+binary+mechanism+of+action+of+the+combi-triazene+SMA41+in+vitro+and+antitumor+activity+in+vivo"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">The combi-targeting concept: Dissection of the binary mechanism of action of the combi-triazene SMA41 in vitro and antitumor activity in vivo</span></div><div class="casAuthors">Matheson, Stephanie L.; McNamee, James P.; Wang, Taiqui; Alaoui-Jamali, Moulay A.; Tari, Ana M.; Jean-Claude, Bertrand J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">311</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1163-1170</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">We have previously reported the synthesis of SMA41, a unimol. combination of an epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI) of the quinazoline class and a DNA-damaging monomethyltriazene termed "combimol.".  Hydrolysis of 1-[4-(m-tolylamino)-6-quinazolinyl]-3-methyltriazene (SMA41) gives rise to an intact TKI [6-amino-4-(3-methylanilino)quinazoline; SMA52] capable of inhibiting epidermal growth factor (EGF)-induced EGFR autophosphorylation and a DNA-targeting methyldiazonium species.  Herein, we showed that SMA41 blocked EGF-induced EGFR autophosphorylation by an irreversible mechanism, suggesting that it may covalently damage the receptor in these cells.  More importantly, this was assocd. with significant inhibition of mitogen-activated protein kinase activation in A431 cells.  In cells treated with [14C]SMA41, radio-high-performance liq. chromatog. detection of both N7- and O6-methylguanine revealed an almost complete repair of the O6-methylguanine lesions and a greater tolerance of the N7-methylguanine adducts 24 h post-treatment.  In contrast to temozolomide (a cyclic triazene used in the clinic) and the reversible inhibitor SMA52, SMA41 induced significant cell cycle arrest in S, G2, and M phases 24 h after a 2-h drug exposure.  Furthermore, in vivo studies demonstrated that SMA41 was well tolerated.  At 200 mg/kg, it showed approx. 2-fold greater antiproliferative activity than SMA52 in A431 cells implanted in immunocompromised SCID mice.  These results suggest that the binary targeting properties of SMA41 are assocd. with a binary cascade of events in the cells that seem to culminate into significant growth inhibition in vitro and in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqkhi3W-ADWZLVg90H21EOLACvtfcHk0lhbSMHrpEsLTg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtVKmtLjF&md5=e4d1a0bfe3202e961e7e2a1f2ecb8d21</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1124%2Fjpet.104.071977&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.104.071977%26sid%3Dliteratum%253Aachs%26aulast%3DMatheson%26aufirst%3DS.%2BL.%26aulast%3DMcNamee%26aufirst%3DJ.%2BP.%26aulast%3DWang%26aufirst%3DT.%26aulast%3DAlaoui-Jamali%26aufirst%3DM.%2BA.%26aulast%3DTari%26aufirst%3DA.%2BM.%26aulast%3DJean-Claude%26aufirst%3DB.%2BJ.%26atitle%3DThe%2520combi-targeting%2520concept%253A%2520Dissection%2520of%2520the%2520binary%2520mechanism%2520of%2520action%2520of%2520the%2520combi-triazene%2520SMA41%2520in%2520vitro%2520and%2520antitumor%2520activity%2520in%2520vivo%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2004%26volume%3D311%26spage%3D1163%26epage%3D1170" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Olive, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Banath, J. P.</span><span> </span><span class="NLM_article-title">The comet assay: A method to measure DNA damage in individual cells</span> <span class="citation_source-journal">Nat. Protoc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">23</span><span class="NLM_x">–</span> <span class="NLM_lpage">29</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2006&pages=23-29&author=P.+L.+Oliveauthor=J.+P.+Banath&title=The+comet+assay%3A+A+method+to+measure+DNA+damage+in+individual+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DOlive%26aufirst%3DP.%2BL.%26aulast%3DBanath%26aufirst%3DJ.%2BP.%26atitle%3DThe%2520comet%2520assay%253A%2520A%2520method%2520to%2520measure%2520DNA%2520damage%2520in%2520individual%2520cells%26jtitle%3DNat.%2520Protoc.%26date%3D2006%26volume%3D1%26spage%3D23%26epage%3D29" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">McNamee, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McLean, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferrarotto, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bellier, P. V.</span><span> </span><span class="NLM_article-title">Comet assay: Rapid processing of multiple samples</span> <span class="citation_source-journal">Mutat. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">466</span><span class="NLM_x">, </span> <span class="NLM_fpage">63</span><span class="NLM_x">–</span> <span class="NLM_lpage">69</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Fjm9016043&amp;key=10.1016%2FS1383-5718%2800%2900004-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Fjm9016043&amp;key=10751727" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Fjm9016043&amp;key=1%3ACAS%3A528%3ADC%252BD3cXitFKqu70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=466&publication_year=2000&pages=63-69&author=J.+P.+McNameeauthor=J.+R.+McLeanauthor=C.+L.+Ferrarottoauthor=P.+V.+Bellier&title=Comet+assay%3A+Rapid+processing+of+multiple+samples"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Comet assay: rapid processing of multiple samples</span></div><div class="casAuthors">McNamee, J. P.; McLean, J. R. N.; Ferrarotto, C. L.; Bellier, P. V.</div><div class="citationInfo"><span class="NLM_cas:title">Mutation Research, Genetic Toxicology and Environmental Mutagenesis</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">466</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">63-69</span>CODEN:
                <span class="NLM_cas:coden">MRGMFI</span>;
        ISSN:<span class="NLM_cas:issn">1383-5718</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The present study describes modifications to the basic comet protocol that increase productivity and efficiency without sacrificing assay reliability.  A simple technique is described for rapidly prepg. up to 96 comet assay samples simultaneously.  The sample prepn. technique allows thin layers of agarose-embedded cells to be prepd. in multiple wells attached to a flexible film of Gelbond, which improves the ease of manipulating and processing samples.  To evaluate the effect of these modifications on assay sensitivity, dose-response curves are presented for DNA damage induced by exposure of TK6 cells to low concns. of hydrogen peroxide (0-10 μM) and for exposure of human lymphocytes to x-irradn. (0-100 cGy).  The limit of detection of DNA damage induced by hydrogen peroxide in TK6 cells was obsd. to be 1 uM for all parameters (tail ratio, tail moment, tail length and comet length) while the limit of detection of DNA damage in human lymphocytes was 10 cGy for tail and comet length parameters, but 50 cGy for tail ratio and tail moment parameters.  These results are similar to those previously reported using the conventional alk. comet assay.  The application of SYBR Gold for detection of DNA damage was compared to that of propidium iodide.  Measurements of matching samples for tail length and comet length were similar using both stains.  However, comets stained with SYBR Gold persisted longer and were much brighter than those obtained with propidium iodide.  SYBR Gold was found to be ideal for measuring tail length and comet length but, under present assay conditions, impractical for measuring tail ratio or tail moment due to satn. of staining in the head region of the comets.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqPRF1MTuXqFLVg90H21EOLACvtfcHk0lj_yzD-trZlSg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXitFKqu70%253D&md5=042f68b9d8f97b3601719e7aec2fd782</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1016%2FS1383-5718%2800%2900004-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1383-5718%252800%252900004-8%26sid%3Dliteratum%253Aachs%26aulast%3DMcNamee%26aufirst%3DJ.%2BP.%26aulast%3DMcLean%26aufirst%3DJ.%2BR.%26aulast%3DFerrarotto%26aufirst%3DC.%2BL.%26aulast%3DBellier%26aufirst%3DP.%2BV.%26atitle%3DComet%2520assay%253A%2520Rapid%2520processing%2520of%2520multiple%2520samples%26jtitle%3DMutat.%2520Res.%26date%3D2000%26volume%3D466%26spage%3D63%26epage%3D69" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 10 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jinjing  Qin</span>, <span class="hlFld-ContribAuthor ">Zhenhua  Li</span>, <span class="hlFld-ContribAuthor ">Shengzhe  Ma</span>, <span class="hlFld-ContribAuthor ">Lixian  Ye</span>, <span class="hlFld-ContribAuthor ">Guoqiang  Jin</span>, <span class="hlFld-ContribAuthor ">Weike  Su</span>. </span><span class="cited-content_cbyCitation_article-title">One-pot cascade ring enlargement of isatin-3-oximes to 2,4-dichloroquinazolines mediated by bis(trichloromethyl)carbonate and triarylphosphine oxide. </span><span class="cited-content_cbyCitation_journal-name">Phosphorus, Sulfur, and Silicon and the Related Elements</span><span> <strong>2020,</strong> <em>195 </em>
                                    (12)
                                     , 1007-1012. <a href="https://doi.org/10.1080/10426507.2020.1782910" title="DOI URL">https://doi.org/10.1080/10426507.2020.1782910</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/10426507.2020.1782910&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F10426507.2020.1782910%26sid%3Dliteratum%253Aachs%26jtitle%3DPhosphorus%252C%2520Sulfur%252C%2520and%2520Silicon%2520and%2520the%2520Related%2520Elements%26atitle%3DOne-pot%252Bcascade%252Bring%252Benlargement%252Bof%252Bisatin-3-oximes%252Bto%252B2%25252C4-dichloroquinazolines%252Bmediated%252Bby%252Bbis%252528trichloromethyl%252529carbonate%252Band%252Btriarylphosphine%252Boxide%26aulast%3DQin%26aufirst%3DJinjing%26date%3D2020%26date%3D2020%26volume%3D195%26issue%3D12%26spage%3D1007%26epage%3D1012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yaling  Zhang</span>, <span class="hlFld-ContribAuthor ">Qiaoli  Hou</span>, <span class="hlFld-ContribAuthor ">Xiabing  Li</span>, <span class="hlFld-ContribAuthor ">Jiuling  Zhu</span>, <span class="hlFld-ContribAuthor ">Wei  Wang</span>, <span class="hlFld-ContribAuthor ">Baolin  Li</span>, <span class="hlFld-ContribAuthor ">Lijun  Zhao</span>, <span class="hlFld-ContribAuthor ">Haibin  Xia</span>. </span><span class="cited-content_cbyCitation_article-title">Enrichment of novel quinazoline derivatives with high antitumor activity in mitochondria tracked by its self-fluorescence. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>178 </em>, 417-432. <a href="https://doi.org/10.1016/j.ejmech.2019.06.015" title="DOI URL">https://doi.org/10.1016/j.ejmech.2019.06.015</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2019.06.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2019.06.015%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DEnrichment%252Bof%252Bnovel%252Bquinazoline%252Bderivatives%252Bwith%252Bhigh%252Bantitumor%252Bactivity%252Bin%252Bmitochondria%252Btracked%252Bby%252Bits%252Bself-fluorescence%26aulast%3DZhang%26aufirst%3DYaling%26date%3D2019%26volume%3D178%26spage%3D417%26epage%3D432" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nathália F.B.  Azeredo</span>, <span class="hlFld-ContribAuthor ">Fabrícia P.  Souza</span>, <span class="hlFld-ContribAuthor ">Felipe C.  Demidoff</span>, <span class="hlFld-ContribAuthor ">Chaquip D.  Netto</span>, <span class="hlFld-ContribAuthor ">Jackson A.L.C.  Resende</span>, <span class="hlFld-ContribAuthor ">Roberto W.A.  Franco</span>, <span class="hlFld-ContribAuthor ">Pio  Colepicolo</span>, <span class="hlFld-ContribAuthor ">Ana M.C.  Ferreira</span>, <span class="hlFld-ContribAuthor ">Christiane  Fernandes</span>. </span><span class="cited-content_cbyCitation_article-title">New strategies for the synthesis of naphthoquinones employing Cu(II) complexes: Crystal structures and cytotoxicity. </span><span class="cited-content_cbyCitation_journal-name">Journal of Molecular Structure</span><span> <strong>2018,</strong> <em>1152 </em>, 11-20. <a href="https://doi.org/10.1016/j.molstruc.2017.08.066" title="DOI URL">https://doi.org/10.1016/j.molstruc.2017.08.066</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.molstruc.2017.08.066&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.molstruc.2017.08.066%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Molecular%2520Structure%26atitle%3DNew%252Bstrategies%252Bfor%252Bthe%252Bsynthesis%252Bof%252Bnaphthoquinones%252Bemploying%252BCu%252528II%252529%252Bcomplexes%25253A%252BCrystal%252Bstructures%252Band%252Bcytotoxicity%26aulast%3DAzeredo%26aufirst%3DNath%25C3%25A1lia%2BF.B.%26date%3D2018%26volume%3D1152%26spage%3D11%26epage%3D20" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Adriana Pires  Vieira</span>, <span class="hlFld-ContribAuthor ">Erika Mattos  Stein</span>, <span class="hlFld-ContribAuthor ">Daniel Xavier  Andreguetti</span>, <span class="hlFld-ContribAuthor ">Pio  Colepicolo</span>, <span class="hlFld-ContribAuthor ">Ana Maria  da Costa Ferreira</span>. </span><span class="cited-content_cbyCitation_article-title">Preparation of silver nanoparticles using aqueous extracts of the red algae Laurencia aldingensis and Laurenciella sp. and their cytotoxic activities. </span><span class="cited-content_cbyCitation_journal-name">Journal of Applied Phycology</span><span> <strong>2016,</strong> <em>28 </em>
                                    (4)
                                     , 2615-2622. <a href="https://doi.org/10.1007/s10811-015-0757-4" title="DOI URL">https://doi.org/10.1007/s10811-015-0757-4</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s10811-015-0757-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs10811-015-0757-4%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Applied%2520Phycology%26atitle%3DPreparation%252Bof%252Bsilver%252Bnanoparticles%252Busing%252Baqueous%252Bextracts%252Bof%252Bthe%252Bred%252Balgae%252BLaurencia%252Baldingensis%252Band%252BLaurenciella%252Bsp.%252Band%252Btheir%252Bcytotoxic%252Bactivities%26aulast%3DVieira%26aufirst%3DAdriana%2BPires%26date%3D2016%26date%3D2015%26volume%3D28%26issue%3D4%26spage%3D2615%26epage%3D2622" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Suman  Rao</span>, <span class="hlFld-ContribAuthor ">Anne-Laure  Larroque-Lombard</span>, <span class="hlFld-ContribAuthor ">Lisa  Peyrard</span>, <span class="hlFld-ContribAuthor ">Cédric  Thauvin</span>, <span class="hlFld-ContribAuthor ">Zakaria  Rachid</span>, <span class="hlFld-ContribAuthor ">Christopher  Williams</span>, <span class="hlFld-ContribAuthor ">Bertrand J.  Jean-Claude</span>, . </span><span class="cited-content_cbyCitation_article-title">Target Modulation by a Kinase Inhibitor Engineered to Induce a Tandem Blockade of the Epidermal Growth Factor Receptor (EGFR) and c-Src: The Concept of Type III Combi-Targeting. </span><span class="cited-content_cbyCitation_journal-name">PLOS ONE</span><span> <strong>2015,</strong> <em>10 </em>
                                    (2)
                                     , e0117215. <a href="https://doi.org/10.1371/journal.pone.0117215" title="DOI URL">https://doi.org/10.1371/journal.pone.0117215</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1371/journal.pone.0117215&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1371%2Fjournal.pone.0117215%26sid%3Dliteratum%253Aachs%26jtitle%3DPLOS%2520ONE%26atitle%3DTarget%252BModulation%252Bby%252Ba%252BKinase%252BInhibitor%252BEngineered%252Bto%252BInduce%252Ba%252BTandem%252BBlockade%252Bof%252Bthe%252BEpidermal%252BGrowth%252BFactor%252BReceptor%252B%252528EGFR%252529%252Band%252Bc-Src%25253A%252BThe%252BConcept%252Bof%252BType%252BIII%252BCombi-Targeting%26aulast%3DRao%26aufirst%3DSuman%26date%3D2015%26date%3D2015%26volume%3D10%26issue%3D2%26spage%3De0117215" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lin-Chiang Sherlock  Huang</span>, <span class="hlFld-ContribAuthor ">Hong  Chuang</span>, <span class="hlFld-ContribAuthor ">Mohit  Kapoor</span>, <span class="hlFld-ContribAuthor ">Cheng-Ying  Hsieh</span>, <span class="hlFld-ContribAuthor ">Shih-Ching  Chou</span>, <span class="hlFld-ContribAuthor ">Hui-Hsien  Lin</span>, <span class="hlFld-ContribAuthor ">Yi-Wei  Chen</span>, <span class="hlFld-ContribAuthor ">Chia-Ching  Chang</span>, <span class="hlFld-ContribAuthor ">Jih-Ru  Hwu</span>, <span class="hlFld-ContribAuthor ">Yu-Chuan  Liang</span>, <span class="hlFld-ContribAuthor ">Ming-Hua  Hsu</span>. </span><span class="cited-content_cbyCitation_article-title">Development of nordihydroguaiaretic acid derivatives as potential multidrug-resistant selective agents for cancer treatment. </span><span class="cited-content_cbyCitation_journal-name">RSC Advances</span><span> <strong>2015,</strong> <em>5 </em>
                                    (130)
                                     , 107833-107838. <a href="https://doi.org/10.1039/C5RA18827J" title="DOI URL">https://doi.org/10.1039/C5RA18827J</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C5RA18827J&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC5RA18827J%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Advances%26atitle%3DDevelopment%252Bof%252Bnordihydroguaiaretic%252Bacid%252Bderivatives%252Bas%252Bpotential%252Bmultidrug-resistant%252Bselective%252Bagents%252Bfor%252Bcancer%252Btreatment%26aulast%3DHuang%26aufirst%3DLin-Chiang%2BSherlock%26date%3D2015%26date%3D2015%26volume%3D5%26issue%3D130%26spage%3D107833%26epage%3D107838" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Bernardo A.  Iglesias</span>, <span class="hlFld-ContribAuthor ">Manfredo  Hörner</span>, <span class="hlFld-ContribAuthor ">Henrique E.  Toma</span>, <span class="hlFld-ContribAuthor ">Koiti  Araki</span>. </span><span class="cited-content_cbyCitation_article-title">5-(1-(4-phenyl)-3-(4-nitrophenyl)triazene)-10,15,20-triphenylporphyrin: a new triazene-porphyrin dye and its spectroelectrochemical properties. </span><span class="cited-content_cbyCitation_journal-name">Journal of Porphyrins and Phthalocyanines</span><span> <strong>2012,</strong> <em>16 </em>
                                    (02)
                                     , 200-209. <a href="https://doi.org/10.1142/S1088424612004501" title="DOI URL">https://doi.org/10.1142/S1088424612004501</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1142/S1088424612004501&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1142%2FS1088424612004501%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Porphyrins%2520and%2520Phthalocyanines%26atitle%3D5-%2525281-%2525284-phenyl%252529-3-%2525284-nitrophenyl%252529triazene%252529-10%25252C15%25252C20-triphenylporphyrin%25253A%252Ba%252Bnew%252Btriazene-porphyrin%252Bdye%252Band%252Bits%252Bspectroelectrochemical%252Bproperties%26aulast%3DIglesias%26aufirst%3DBernardo%2BA.%26date%3D2012%26date%3D2012%26volume%3D16%26issue%3D02%26spage%3D200%26epage%3D209" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Anne-Laure  Larroque-Lombard</span>, <span class="hlFld-ContribAuthor ">Margarita  Todorova</span>, <span class="hlFld-ContribAuthor ">Qiu  Qiyu</span>, <span class="hlFld-ContribAuthor ">Bertrand  Jean-Claude</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and Studies on Three-Compartment Flavone-Containing Combi-Molecules Designed to Target EGFR, DNA, and MEK. </span><span class="cited-content_cbyCitation_journal-name">Chemical Biology & Drug Design</span><span> <strong>2011,</strong> <em>77 </em>
                                    (5)
                                     , 309-318. <a href="https://doi.org/10.1111/j.1747-0285.2011.01098.x" title="DOI URL">https://doi.org/10.1111/j.1747-0285.2011.01098.x</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/j.1747-0285.2011.01098.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fj.1747-0285.2011.01098.x%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Biology%2520%2526%2520Drug%2520Design%26atitle%3DSynthesis%252Band%252BStudies%252Bon%252BThree-Compartment%252BFlavone-Containing%252BCombi-Molecules%252BDesigned%252Bto%252BTarget%252BEGFR%25252C%252BDNA%25252C%252Band%252BMEK%26aulast%3DLarroque-Lombard%26aufirst%3DAnne-Laure%26date%3D2011%26date%3D2011%26volume%3D77%26issue%3D5%26spage%3D309%26epage%3D318" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Michael M.  Miller</span>, <span class="hlFld-ContribAuthor ">Albert J.  DelMonte</span>. </span><span class="cited-content_cbyCitation_article-title">Six-Membered Ring Systems. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2011,</strong>,, 371-402. <a href="https://doi.org/10.1016/B978-0-08-096805-6.00013-9" title="DOI URL">https://doi.org/10.1016/B978-0-08-096805-6.00013-9</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-08-096805-6.00013-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-08-096805-6.00013-9%26sid%3Dliteratum%253Aachs%26atitle%3DSix-Membered%252BRing%252BSystems%26aulast%3DMiller%26aufirst%3DMichael%2BM.%26date%3D2011%26spage%3D371%26epage%3D402%26pub%3DElsevier%26date%3D2011%26volume%3D23" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Margarita I.  Todorova</span>, <span class="hlFld-ContribAuthor ">Anne-Laure  Larroque</span>, <span class="hlFld-ContribAuthor ">Sabine  Dauphin-Pierre</span>, <span class="hlFld-ContribAuthor ">You-Qiang  Fang</span>, <span class="hlFld-ContribAuthor ">Bertrand J.  Jean-Claude</span>. </span><span class="cited-content_cbyCitation_article-title">Subcellular Distribution of a Fluorescence-Labeled Combi-Molecule Designed to Block Epidermal Growth Factor Receptor Tyrosine Kinase and Damage DNA with a Green Fluorescent Species. </span><span class="cited-content_cbyCitation_journal-name">Molecular Cancer Therapeutics</span><span> <strong>2010,</strong> <em>9 </em>
                                    (4)
                                     , 869-882. <a href="https://doi.org/10.1158/1535-7163.MCT-09-0673" title="DOI URL">https://doi.org/10.1158/1535-7163.MCT-09-0673</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1158/1535-7163.MCT-09-0673&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1158%2F1535-7163.MCT-09-0673%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Cancer%2520Therapeutics%26atitle%3DSubcellular%252BDistribution%252Bof%252Ba%252BFluorescence-Labeled%252BCombi-Molecule%252BDesigned%252Bto%252BBlock%252BEpidermal%252BGrowth%252BFactor%252BReceptor%252BTyrosine%252BKinase%252Band%252BDamage%252BDNA%252Bwith%252Ba%252BGreen%252BFluorescent%252BSpecies%26aulast%3DTodorova%26aufirst%3DMargarita%2BI.%26date%3D2010%26date%3D2010%26volume%3D9%26issue%3D4%26spage%3D869%26epage%3D882" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-5/jm9016043/production/images/medium/jm-2009-016043_0008.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-5/jm9016043/production/images/large/jm-2009-016043_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm9016043&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-5/jm9016043/production/images/medium/jm-2009-016043_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-5/jm9016043/production/images/large/jm-2009-016043_0009.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Compound <b>4</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-5/jm9016043/production/images/large/jm-2009-016043_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm9016043&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) <i>N</i>-Fmoc-ethylenediamine, EtOAc, H<sub>2</sub>O, K<sub>2</sub>CO<sub>3</sub>, 0 °C. (ii) Morpholine, DMF, room temperature. (iii) Diazonium <b>3</b>, Et<sub>3</sub>N, CH<sub>3</sub>CN/Et<sub>2</sub>O, −5 °C.</p></p></figure><figure data-id="sch2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-5/jm9016043/production/images/medium/jm-2009-016043_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-5/jm9016043/production/images/large/jm-2009-016043_0010.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Compound <b>6</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-5/jm9016043/production/images/large/jm-2009-016043_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm9016043&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) <i>N</i>-(2-Aminoethyl)-<i>N</i>-methylethanediamine, EtOAc, 0 °C. (ii) Diazonium <b>3</b>, Et<sub>3</sub>N, CH<sub>3</sub>CN/Et<sub>2</sub>O, −5 °C.</p></p></figure><figure data-id="fig1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-5/jm9016043/production/images/medium/jm-2009-016043_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-5/jm9016043/production/images/large/jm-2009-016043_0003.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Molecular modeling using AM1 semi-empirical calculation of <b>6</b>. The H−N distances are given in Å.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-5/jm9016043/production/images/large/jm-2009-016043_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm9016043&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-5/jm9016043/production/images/medium/jm-2009-016043_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-5/jm9016043/production/images/large/jm-2009-016043_0001.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Degradation Pathway of Compound <b>6</b> in Physiological Conditions</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-5/jm9016043/production/images/large/jm-2009-016043_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm9016043&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-5/jm9016043/production/images/medium/jm-2009-016043_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-5/jm9016043/production/images/large/jm-2009-016043_0002.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Degradation Pathway of Compound <b>4</b> in Physiological Conditions</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-5/jm9016043/production/images/large/jm-2009-016043_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm9016043&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-5/jm9016043/production/images/medium/jm-2009-016043_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-5/jm9016043/production/images/large/jm-2009-016043_0004.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Growth inhibition of doxorubicin, <b>4</b>, and <b>6</b> by SRB assay. (A) Comparison of antiproliferative activity of doxorubicin, <b>4</b>, or <b>6</b> in MES-SA and MES-SA/DX5 cells after 96 h. (B) Growth inhibition of <b>4</b> and <b>6</b> in human breast MDA-MB-468 cells. Each point represents an average of two independent experiments performed in triplicate.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-5/jm9016043/production/images/large/jm-2009-016043_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm9016043&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-5/jm9016043/production/images/medium/jm-2009-016043_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-5/jm9016043/production/images/large/jm-2009-016043_0005.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Cellular fluorescence and DNA damage by doxorubicin. (A) Intracellular accumulation of doxorubicin in P-gp-positive and -negative cells was determined by fluorescence microscopy. Cells were incubated with 25 μM doxorubicin for 2 h and washed with PBS, and fluorescence was visualized with a Leica fluorescent microscope (40× magnification). (B) Cellular fluorescence of doxorubicin by FACS. The levels of accumulated fluorescence for doxorubicin (0, 6.25, 12.5, 25, and 50 μM) were quantified in MES-SA and MES-SA/DX5 cells after 2 h. (C) DNA damage induced by doxorubicin in MES-SA (0, 1.5, 6.25, 12.5, 25, and 50 μM) and MES-SA/DX5 (0, 6.25, 12.5, 25, 50, and 100 μM) cells. Cells were exposed for 2 h to doxorubicin, and DNA damage was measured using an alkaline comet assay. Fifty cells were scored from each dose, and the comet tail moment was calculated by comet IV software (Perceptive Instruments). Cells with a comet tail moment greater than that in the control were scored positive and expressed as percent of cells with damaged DNA.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-5/jm9016043/production/images/large/jm-2009-016043_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm9016043&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-5/jm9016043/production/images/medium/jm-2009-016043_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-5/jm9016043/production/images/large/jm-2009-016043_0006.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. (A) Cellular fluorescence of <b>4</b> and <b>6</b> by fluorescence microscopy. MES-SA and MES-SA/DX5 cells were incubated with <b>4</b> and <b>6</b> for 2 h, and imaging was performed with Leica fluorescent microscope (40× magnification). Visualization of <b>4</b> and <b>6</b> degradation species: Blue aminoquinazoline and green dansylated species were imaged using individual filters. (B) Cellular fluorescence of <b>4</b> and <b>6</b> by FACS. The levels of accumulated fluorescence for <b>4</b> and <b>6</b> (0, 6.25, 12.5, 25, and 50 μM) were quantified in MES-SA and MES-SA/DX5 cells by FACS, and results were analyzed with GraphPad Prism software.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-5/jm9016043/production/images/large/jm-2009-016043_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm9016043&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-5/jm9016043/production/images/medium/jm-2009-016043_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-5/jm9016043/production/images/large/jm-2009-016043_0007.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. DNA damage induced by <b>4</b> and <b>6</b> at 50 (A) and 100 μM (B). MES-SA and MES-SA/DX5 cells were exposed to each combi-molecule for 2 h followed by assessment of drug-induced DNA damage using an alkaline comet assay. Visualization of DNA comets in both cell lines by fluorescence microscopy (10× magnification) after staining with SYBR Gold. (C) Fifty comets were scored, and the comet tail moment was quantified by comet IV software (Perceptive Instruments). Two independent experiments were averaged for each cell line, and data were analyzed with GraphPad Prism software.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-5/jm9016043/production/images/large/jm-2009-016043_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm9016043&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i32">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_44023" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_44023" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 27 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Ramachandra, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ambudkar, S. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hrycyna, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dey, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gottesman, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pastan, I.</span><span> </span><span class="NLM_article-title">Human P-Glycoprotein Exhibits Reduced Affinity for Substrates during a Catalytic Transition State</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x">, </span> <span class="NLM_fpage">5010</span><span class="NLM_x">–</span> <span class="NLM_lpage">5019</span></span><div class="citationLinks">[<a href="/doi/10.1021/bi973045u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm9016043&amp;key=1%3ACAS%3A528%3ADyaK1cXitV2jsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=1998&pages=5010-5019&author=M.+Ramachandraauthor=S.+V.+Ambudkarauthor=D.+Chenauthor=C.+A.+Hrycynaauthor=S.+Deyauthor=M.+M.+Gottesmanauthor=I.+Pastan&title=Human+P-Glycoprotein+Exhibits+Reduced+Affinity+for+Substrates+during+a+Catalytic+Transition+State"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Human P-Glycoprotein Exhibits Reduced Affinity for Substrates during a Catalytic Transition State</span></div><div class="casAuthors">Ramachandra, Muralidhara; Ambudkar, Suresh V.; Chen, David; Hrycyna, Christine A.; Dey, Saibal; Gottesman, Michael M.; Pastan, Ira</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">5010-5019</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Human P-glycoprotein (Pgp), a plasma membrane protein that confers multidrug resistance, functions as an ATP-dependent drug efflux pump.  Pgp contains two ATP binding/utilization sites and exhibits ATPase activity that is stimulated in the presence of substrates and modulating agents.  The mechanism of coupling of ATP hydrolysis to drug transport is not known.  To understand the role of ATP hydrolysis in drug binding, it is necessary to develop methods for purifying and reconstituting Pgp that retains properties including stimulation of ATPase activity by known substrates to an extent similar to that in the native membrane.  In this study, (His)6-tagged Pgp was expressed in Trichoplusia ni (High Five) cells using the recombinant baculovirus system and purified by metal affinity chromatog.  Upon reconstitution into phospholipid vesicles, purified Pgp exhibited specific binding to analogs of substrates and ATP in affinity labeling expts. and displayed a high level of drug-stimulated ATPase activity (specific activity ranging from 4.5 to 6.5 μmol min-1 mg-1).  The ATPase activity was inhibited by ADP in a competitive manner, and by vanadate and N-ethylmaleimide at low concns.  Vanadate which is known to inhibit ATPase activity by trapping MgADP at the catalytic site inhibited photoaffinity labeling of Pgp with substrate analogs, [125I]iodoarylazidoprazosin and [3H]azidopine, only under ATP hydrolysis conditions.  Because vanadate-trapped Pgp is known to resemble the ADP and phosphate-bound catalytic transition state, our findings indicate that ATP hydrolysis results in a conformation with reduced affinity for substrates.  A catalytic transition conformation with reduced affinity would essentially result in substrate dissocn. and supports a model for drug transport in which an ATP hydrolysis-induced conformational change leads to drug release toward the extracellular medium.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrD6RihoJf9mbVg90H21EOLACvtfcHk0lhho19Q2HCXlw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXitV2jsrk%253D&md5=7841376ab6dd18acb68e44444e98b477</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1021%2Fbi973045u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi973045u%26sid%3Dliteratum%253Aachs%26aulast%3DRamachandra%26aufirst%3DM.%26aulast%3DAmbudkar%26aufirst%3DS.%2BV.%26aulast%3DChen%26aufirst%3DD.%26aulast%3DHrycyna%26aufirst%3DC.%2BA.%26aulast%3DDey%26aufirst%3DS.%26aulast%3DGottesman%26aufirst%3DM.%2BM.%26aulast%3DPastan%26aufirst%3DI.%26atitle%3DHuman%2520P-Glycoprotein%2520Exhibits%2520Reduced%2520Affinity%2520for%2520Substrates%2520during%2520a%2520Catalytic%2520Transition%2520State%26jtitle%3DBiochemistry%26date%3D1998%26volume%3D37%26spage%3D5010%26epage%3D5019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Sharom, F. J.</span><span> </span><span class="NLM_article-title">The P-glycoprotein efflux pump: how does it transport drugs?</span> <span class="citation_source-journal">J. Membr. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">160</span><span class="NLM_x">, </span> <span class="NLM_fpage">161</span><span class="NLM_x">–</span> <span class="NLM_lpage">175</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm9016043&amp;key=10.1007%2Fs002329900305" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Fjm9016043&amp;key=9425600" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm9016043&amp;key=1%3ACAS%3A528%3ADyaK2sXotV2isb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=160&publication_year=1997&pages=161-175&author=F.+J.+Sharom&title=The+P-glycoprotein+efflux+pump%3A+how+does+it+transport+drugs%3F"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">The P-glycoprotein efflux pump: how does it transport drugs?</span></div><div class="casAuthors">Sharom, F. J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Membrane Biology</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">160</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">161-175</span>CODEN:
                <span class="NLM_cas:coden">JMBBBO</span>;
        ISSN:<span class="NLM_cas:issn">0022-2631</span>.
    
            (<span class="NLM_cas:orgname">Springer-Verlag New York Inc.</span>)
        </div><div class="casAbstract">A review, with 118 refs.  P-glycoprotein (Pgp) is an atypical translocating ATPase, with low affinity for ATP and high constitutive ATPase activity.  Pgp also has an unusually broad specificity for hydrophobic substrates, including many chemotherapeutic drugs.  Transport studies in reconstituted systems indicate that drug transport requires ATP hydrolysis and is active, generating a drug concn. gradient.  Binding of drugs and ATP to Pgp induces conformational changes in the protein, and the drug binding site is conformationally coupled to nucleotide-binding domains.  Evidence accumulated to date suggest that the transporter interact directly with nonpolar substrate within the membrane environment, and may act as drug flippase, moving drug from the inner to outer leaflet of the bilayer.  Chemosensitizers that block the action of Pgp are proposed to act as alternative substrates, but their high rate of spontaneous flip-flop across the membrane results in futile cycling of the transporter.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpduTsyKNWuPrVg90H21EOLACvtfcHk0lhho19Q2HCXlw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXotV2isb4%253D&md5=52fb1ef5b0a0772eeda2ee1c474ae374</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1007%2Fs002329900305&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs002329900305%26sid%3Dliteratum%253Aachs%26aulast%3DSharom%26aufirst%3DF.%2BJ.%26atitle%3DThe%2520P-glycoprotein%2520efflux%2520pump%253A%2520how%2520does%2520it%2520transport%2520drugs%253F%26jtitle%3DJ.%2520Membr.%2520Biol.%26date%3D1997%26volume%3D160%26spage%3D161%26epage%3D175" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Szakacs, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paterson, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ludwig, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Booth-Genthe, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gottesman, M. M.</span><span> </span><span class="NLM_article-title">Targeting multidrug resistance in cancer</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">219</span><span class="NLM_x">–</span> <span class="NLM_lpage">234</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Fjm9016043&amp;key=10.1038%2Fnrd1984" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Fjm9016043&amp;key=16518375" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm9016043&amp;key=1%3ACAS%3A528%3ADC%252BD28XhvFOlsr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2006&pages=219-234&author=G.+Szakacsauthor=J.+K.+Patersonauthor=J.+A.+Ludwigauthor=C.+Booth-Gentheauthor=M.+M.+Gottesman&title=Targeting+multidrug+resistance+in+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting multidrug resistance in cancer</span></div><div class="casAuthors">Szakacs, Gergely; Paterson, Jill K.; Ludwig, Joseph A.; Booth-Genthe, Catherine; Gottesman, Michael M.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">219-234</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Effective treatment of metastatic cancers usually requires the use of toxic chemotherapy.  In most cases, multiple drugs are used, as resistance to single agents occurs almost universally.  For this reason, elucidation of mechanisms that confer simultaneous resistance to different drugs with different targets and chem. structures - multidrug resistance - has been a major goal of cancer biologists during the past 35 years.  Here, we review the most common of these mechanisms, one that relies on drug efflux from cancer cells mediated by ATP-binding cassette (ABC) transporters.  We describe various approaches to combating multidrug-resistant cancer, including the development of drugs that engage, evade or exploit efflux by ABC transporters.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp7LUp3JikHr7Vg90H21EOLACvtfcHk0ljzWZpKQ7XbKA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhvFOlsr8%253D&md5=67ca376f65aa58a71288167f6815a896</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1038%2Fnrd1984&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd1984%26sid%3Dliteratum%253Aachs%26aulast%3DSzakacs%26aufirst%3DG.%26aulast%3DPaterson%26aufirst%3DJ.%2BK.%26aulast%3DLudwig%26aufirst%3DJ.%2BA.%26aulast%3DBooth-Genthe%26aufirst%3DC.%26aulast%3DGottesman%26aufirst%3DM.%2BM.%26atitle%3DTargeting%2520multidrug%2520resistance%2520in%2520cancer%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2006%26volume%3D5%26spage%3D219%26epage%3D234" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Longley, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnston, P. G.</span><span> </span><span class="NLM_article-title">Molecular mechanisms of drug resistance</span> <span class="citation_source-journal">J. Pathol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">205</span><span class="NLM_x">, </span> <span class="NLM_fpage">275</span><span class="NLM_x">–</span> <span class="NLM_lpage">292</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm9016043&amp;key=10.1002%2Fpath.1706" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm9016043&amp;key=15641020" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm9016043&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhsFOgsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=205&publication_year=2005&pages=275-292&author=D.+B.+Longleyauthor=P.+G.+Johnston&title=Molecular+mechanisms+of+drug+resistance"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular mechanisms of drug resistance</span></div><div class="casAuthors">Longley, D. B.; Johnston, P. G.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pathology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">205</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">275-292</span>CODEN:
                <span class="NLM_cas:coden">JPTLAS</span>;
        ISSN:<span class="NLM_cas:issn">0022-3417</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons Ltd.</span>)
        </div><div class="casAbstract">A review.  Resistance to chemotherapy limits the effectiveness of anti-cancer drug treatment.  Tumors may be intrinsically drug-resistant or develop resistance to chemotherapy during treatment.  Acquired resistance is a particular problem, as tumors not only become resistant to the drugs originally used to treat them, but may also become cross-resistant to other drugs with different mechanisms of action.  Resistance to chemotherapy is believed to cause treatment failure in over 90% of patients with metastatic cancer, and resistant micrometastic tumor cells may also reduce the effectiveness of chemotherapy in the adjuvant setting.  Clearly, if drug resistance could be overcome, the impact on survival would be highly significant.  This review focuses on mol. mechanisms of drug resistance that operate to reduce drug sensitivity in cancer cells.  Drug resistance can occur at many levels, including increased drug efflux, drug inactivation, alterations in drug target, processing of drug-induced damage, and evasion of apoptosis.  Advances in DNA microarray and proteomic technol., and the ongoing development of new targeted therapies have opened up new opportunities to combat drug resistance.  We are now able to characterize the signalling pathways involved in regulating tumor cell response to chemotherapy more completely than ever before.  This will facilitate the future development of rational combined chemotherapy regimens, in which the newer targeted therapies are used in combination with cytotoxic drugs to ehnance chemotherapy activity.  The ability to predict response to chemotherapy and to modulate this response with targeted therapies will permit selection of the best treatment for individual patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoOyHxwyfZgyrVg90H21EOLACvtfcHk0ljzWZpKQ7XbKA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhsFOgsrk%253D&md5=956919d3f59f9deff581b62c43a9b7bc</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1002%2Fpath.1706&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fpath.1706%26sid%3Dliteratum%253Aachs%26aulast%3DLongley%26aufirst%3DD.%2BB.%26aulast%3DJohnston%26aufirst%3DP.%2BG.%26atitle%3DMolecular%2520mechanisms%2520of%2520drug%2520resistance%26jtitle%3DJ.%2520Pathol.%26date%3D2005%26volume%3D205%26spage%3D275%26epage%3D292" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Loo, T. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clarke, D. M.</span><span> </span><span class="NLM_article-title">Recent progress in understanding the mechanism of P-glycoprotein-mediated drug efflux</span> <span class="citation_source-journal">J. Membr. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">206</span><span class="NLM_x">, </span> <span class="NLM_fpage">173</span><span class="NLM_x">–</span> <span class="NLM_lpage">185</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Fjm9016043&amp;key=10.1007%2Fs00232-005-0792-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Fjm9016043&amp;key=16456713" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm9016043&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtFWmsbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=206&publication_year=2005&pages=173-185&author=T.+W.+Looauthor=D.+M.+Clarke&title=Recent+progress+in+understanding+the+mechanism+of+P-glycoprotein-mediated+drug+efflux"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Recent progress in understanding the mechanism of P-glycoprotein-mediated drug efflux</span></div><div class="casAuthors">Loo, T. W.; Clarke, D. M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Membrane Biology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">206</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">173-185</span>CODEN:
                <span class="NLM_cas:coden">JMBBBO</span>;
        ISSN:<span class="NLM_cas:issn">0022-2631</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  P-glycoprotein (P-gp) is an ATP-dependent drug pump that can transport a broad range of hydrophobic compds. out of the cell.  The protein is clin. important because of its contribution to the phenomenon of multidrug resistance during AIDS/HIV and cancer chemotherapy.  P-gp is a member of the ATP-binding cassette (ABC) family of proteins.  It is a single polypeptide that contains two repeats joined by a linker region.  Each repeat has a transmembrane domain consisting of six transmembrane segments followed by a hydrophilic domain contg. the nucleotide-binding domain.  In this mini-review, we discuss recent progress in detg. the structure and mechanism of human P-glycoprotein.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqCpkkw_pMyQrVg90H21EOLACvtfcHk0ljzWZpKQ7XbKA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtFWmsbk%253D&md5=db47870508882bd90f8618577797a98b</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1007%2Fs00232-005-0792-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00232-005-0792-1%26sid%3Dliteratum%253Aachs%26aulast%3DLoo%26aufirst%3DT.%2BW.%26aulast%3DClarke%26aufirst%3DD.%2BM.%26atitle%3DRecent%2520progress%2520in%2520understanding%2520the%2520mechanism%2520of%2520P-glycoprotein-mediated%2520drug%2520efflux%26jtitle%3DJ.%2520Membr.%2520Biol.%26date%3D2005%26volume%3D206%26spage%3D173%26epage%3D185" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Aller, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ward, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weng, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chittaboina, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhuo, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harrell, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trinh, Y. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Urbatsch, I. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, G.</span><span> </span><span class="NLM_article-title">Structure of P-Glycoprotein Reveals a Molecular Basis for Poly-Specific Drug Binding</span> <span class="citation_source-journal">Science (Washington, DC, U. S.)</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">323</span><span class="NLM_x">, </span> <span class="NLM_fpage">1718</span><span class="NLM_x">–</span> <span class="NLM_lpage">1722</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm9016043&amp;key=10.1126%2Fscience.1168750" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm9016043&amp;key=19325113" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm9016043&amp;key=1%3ACAS%3A528%3ADC%252BD1MXjs1Kgtro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=323&publication_year=2009&pages=1718-1722&author=S.+G.+Allerauthor=J.+Yuauthor=A.+Wardauthor=Y.+Wengauthor=S.+Chittaboinaauthor=R.+Zhuoauthor=P.+M.+Harrellauthor=Y.+T.+Trinhauthor=Q.+Zhangauthor=I.+L.+Urbatschauthor=G.+Chang&title=Structure+of+P-Glycoprotein+Reveals+a+Molecular+Basis+for+Poly-Specific+Drug+Binding"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Structure of P-Glycoprotein Reveals a Molecular Basis for Poly-Specific Drug Binding</span></div><div class="casAuthors">Aller, Stephen G.; Yu, Jodie; Ward, Andrew; Weng, Yue; Chittaboina, Srinivas; Zhuo, Rupeng; Harrell, Patina M.; Trinh, Yenphuong T.; Zhang, Qinghai; Urbatsch, Ina L.; Chang, Geoffrey</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">323</span>
        (<span class="NLM_cas:issue">5922</span>),
    <span class="NLM_cas:pages">1718-1722</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">P-glycoprotein (P-gp) detoxifies cells by exporting hundreds of chem. unrelated toxins but has been implicated in multidrug resistance (MDR) in the treatment of cancers.  Substrate promiscuity is a hallmark of P-gp activity, thus a structural description of poly-specific drug-binding is important for the rational design of anticancer drugs and MDR inhibitors.  The x-ray structure of apo P-gp at 3.8 angstroms reveals an internal cavity of ~6000 angstroms cubed with a 30 angstrom sepn. of the two nucleotide-binding domains.  Two addnl. P-gp structures with cyclic peptide inhibitors demonstrate distinct drug-binding sites in the internal cavity capable of stereoselectivity that is based on hydrophobic and arom. interactions.  Apo and drug-bound P-gp structures have portals open to the cytoplasm and the inner leaflet of the lipid bilayer for drug entry.  The inward-facing conformation represents an initial stage of the transport cycle that is competent for drug binding.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq2EUmR-iQyaLVg90H21EOLACvtfcHk0lgcoDID4wwWlw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXjs1Kgtro%253D&md5=66c7398b0257e6c05161a1afbecdafb1</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1126%2Fscience.1168750&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1168750%26sid%3Dliteratum%253Aachs%26aulast%3DAller%26aufirst%3DS.%2BG.%26aulast%3DYu%26aufirst%3DJ.%26aulast%3DWard%26aufirst%3DA.%26aulast%3DWeng%26aufirst%3DY.%26aulast%3DChittaboina%26aufirst%3DS.%26aulast%3DZhuo%26aufirst%3DR.%26aulast%3DHarrell%26aufirst%3DP.%2BM.%26aulast%3DTrinh%26aufirst%3DY.%2BT.%26aulast%3DZhang%26aufirst%3DQ.%26aulast%3DUrbatsch%26aufirst%3DI.%2BL.%26aulast%3DChang%26aufirst%3DG.%26atitle%3DStructure%2520of%2520P-Glycoprotein%2520Reveals%2520a%2520Molecular%2520Basis%2520for%2520Poly-Specific%2520Drug%2520Binding%26jtitle%3DScience%2520%2528Washington%252C%2520DC%252C%2520U.%2520S.%2529%26date%3D2009%26volume%3D323%26spage%3D1718%26epage%3D1722" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Perez, R. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamilton, T. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ozols, R. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, R. C.</span><span> </span><span class="NLM_article-title">Mechanisms and modulation of resistance to chemotherapy in ovarian cancer</span> <span class="citation_source-journal">Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">71</span><span class="NLM_x">, </span> <span class="NLM_fpage">1571</span><span class="NLM_x">–</span> <span class="NLM_lpage">80</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=1993&pages=1571-80&author=R.+P.+Perezauthor=T.+C.+Hamiltonauthor=R.+F.+Ozolsauthor=R.+C.+Young&title=Mechanisms+and+modulation+of+resistance+to+chemotherapy+in+ovarian+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPerez%26aufirst%3DR.%2BP.%26aulast%3DHamilton%26aufirst%3DT.%2BC.%26aulast%3DOzols%26aufirst%3DR.%2BF.%26aulast%3DYoung%26aufirst%3DR.%2BC.%26atitle%3DMechanisms%2520and%2520modulation%2520of%2520resistance%2520to%2520chemotherapy%2520in%2520ovarian%2520cancer%26jtitle%3DCancer%26date%3D1993%26volume%3D71%26spage%3D1571%26epage%3D80" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Turk, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hall, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chu, B. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ludwig, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fales, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gottesman, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Szakacs, G.</span><span> </span><span class="NLM_article-title">Identification of Compounds Selectively Killing Multidrug-Resistant Cancer Cells</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">69</span><span class="NLM_x">, </span> <span class="NLM_fpage">8293</span><span class="NLM_x">–</span> <span class="NLM_lpage">8301</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2009&pages=8293-8301&author=D.+Turkauthor=M.+D.+Hallauthor=B.+F.+Chuauthor=J.+A.+Ludwigauthor=H.+M.+Falesauthor=M.+M.+Gottesmanauthor=G.+Szakacs&title=Identification+of+Compounds+Selectively+Killing+Multidrug-Resistant+Cancer+Cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTurk%26aufirst%3DD.%26aulast%3DHall%26aufirst%3DM.%2BD.%26aulast%3DChu%26aufirst%3DB.%2BF.%26aulast%3DLudwig%26aufirst%3DJ.%2BA.%26aulast%3DFales%26aufirst%3DH.%2BM.%26aulast%3DGottesman%26aufirst%3DM.%2BM.%26aulast%3DSzakacs%26aufirst%3DG.%26atitle%3DIdentification%2520of%2520Compounds%2520Selectively%2520Killing%2520Multidrug-Resistant%2520Cancer%2520Cells%26jtitle%3DCancer%2520Res.%26date%3D2009%26volume%3D69%26spage%3D8293%26epage%3D8301" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Brahimi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matheson, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dudouit, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McNamee, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tari, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jean-Claude, B. J.</span><span> </span><span class="NLM_article-title">Inhibition of epidermal growth factor receptor-mediated signaling by “Combi-Triazene” BJ2000, a new probe for Combi-Targeting postulates</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">303</span><span class="NLM_x">, </span> <span class="NLM_fpage">238</span><span class="NLM_x">–</span> <span class="NLM_lpage">246</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Fjm9016043&amp;key=10.1124%2Fjpet.102.039099" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Fjm9016043&amp;key=12235257" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Fjm9016043&amp;key=1%3ACAS%3A528%3ADC%252BD38XnsV2qsLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=303&publication_year=2002&pages=238-246&author=F.+Brahimiauthor=S.+L.+Mathesonauthor=F.+Dudouitauthor=J.+P.+McNameeauthor=A.+M.+Tariauthor=B.+J.+Jean-Claude&title=Inhibition+of+epidermal+growth+factor+receptor-mediated+signaling+by+%E2%80%9CCombi-Triazene%E2%80%9D+BJ2000%2C+a+new+probe+for+Combi-Targeting+postulates"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of epidermal growth factor receptor-mediated signaling by "Combi-Triazene" BJ2000, a new probe for Combi-Targeting postulates</span></div><div class="casAuthors">Brahimi, Fouad; Matheson, Stephanie L.; Dudouit, Fabienne; McNamee, James P.; Tari, Ana M.; Jean-Claude, Bertrand J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">303</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">238-246</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The Combi-Targeting concept postulates that a mol. termed combi-mol. (C-mol.) with binary epidermal growth factor receptor (EGFR) targeting/DNA-damaging properties and with the ability to be hydrolyzed to another EGFR inhibitor should induce sustained antiproliferative activity in cells overexpressing EGFR.  Because we postulate that the EGFR affinity of the C-mol. and that of its hydrolytic metabolites are crit. parameters for sustained potency against EGFR-overexpressing cells, we synthesized BJ2000 (IC50 = 0.1 μM, competitive binding at ATP site), a novel C-mol. that can decomp. into a 6-amino-4-anilinoquinazoline FD105 (IC50 = 0.2 μM).  Studies using the EGFR-overexpressing A431 cells revealed that BJ2000 could damage DNA and block epidermal growth factor-stimulated EGFR autophosphorylation by a partially irreversible mechanism.  Blockade of EGFR autophosphorylation subsequently induced inhibition of mitogen-activated protein kinase activation and c-fos gene expression.  ELISA and growth factor-mediated stimulation of proliferation assays in the EGFR-expressing NIH3T3HER14 demonstrated the preferential EGFR-targeting properties of BJ2000, and more importantly suggest that blockade of EGFR phosphorylation by this drug translate into significant growth inhibitory effects.  These properties culminated into irreversible antiproliferative effects as confirmed by a sulforhodamine B assay.  Five days after a 2-h treatment, BJ2000 retained significant antiproliferative effect in A431 cells, whereas its reversible metabolite FD105 almost completely lost its activity.  This result in toto lend support to the Combi-Targeting concept according to which a mol. conjugate kept small enough to interact with EGFR and designed to degrade into another inhibitor of the same target plus a DNA-damaging species may induce sustained growth inhibitory effect in EGFR-overexpressing cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrbJ9ASdjBjlLVg90H21EOLACvtfcHk0lgcoDID4wwWlw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XnsV2qsLY%253D&md5=c10a7f1cc231cbf64fbe468e89df26d7</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1124%2Fjpet.102.039099&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.102.039099%26sid%3Dliteratum%253Aachs%26aulast%3DBrahimi%26aufirst%3DF.%26aulast%3DMatheson%26aufirst%3DS.%2BL.%26aulast%3DDudouit%26aufirst%3DF.%26aulast%3DMcNamee%26aufirst%3DJ.%2BP.%26aulast%3DTari%26aufirst%3DA.%2BM.%26aulast%3DJean-Claude%26aufirst%3DB.%2BJ.%26atitle%3DInhibition%2520of%2520epidermal%2520growth%2520factor%2520receptor-mediated%2520signaling%2520by%2520%25E2%2580%259CCombi-Triazene%25E2%2580%259D%2520BJ2000%252C%2520a%2520new%2520probe%2520for%2520Combi-Targeting%2520postulates%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2002%26volume%3D303%26spage%3D238%26epage%3D246" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Brahimi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rachid, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McNamee, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alaoui-Jamali, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tari, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jean-Claude, B. J.</span><span> </span><span class="NLM_article-title">Mechanism of action of a novel “combi-triazene” engineered to possess a polar functional group on the alkylating moiety: Evidence for enhancement of potency</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">70</span><span class="NLM_x">, </span> <span class="NLM_fpage">511</span><span class="NLM_x">–</span> <span class="NLM_lpage">519</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2005&pages=511-519&author=F.+Brahimiauthor=Z.+Rachidauthor=J.+P.+McNameeauthor=M.+A.+Alaoui-Jamaliauthor=A.+M.+Tariauthor=B.+J.+Jean-Claude&title=Mechanism+of+action+of+a+novel+%E2%80%9Ccombi-triazene%E2%80%9D+engineered+to+possess+a+polar+functional+group+on+the+alkylating+moiety%3A+Evidence+for+enhancement+of+potency"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBrahimi%26aufirst%3DF.%26aulast%3DRachid%26aufirst%3DZ.%26aulast%3DMcNamee%26aufirst%3DJ.%2BP.%26aulast%3DAlaoui-Jamali%26aufirst%3DM.%2BA.%26aulast%3DTari%26aufirst%3DA.%2BM.%26aulast%3DJean-Claude%26aufirst%3DB.%2BJ.%26atitle%3DMechanism%2520of%2520action%2520of%2520a%2520novel%2520%25E2%2580%259Ccombi-triazene%25E2%2580%259D%2520engineered%2520to%2520possess%2520a%2520polar%2520functional%2520group%2520on%2520the%2520alkylating%2520moiety%253A%2520Evidence%2520for%2520enhancement%2520of%2520potency%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2005%26volume%3D70%26spage%3D511%26epage%3D519" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Brahimi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rachid, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qiu, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McNamee, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Y.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tari, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jean-Claude, B. J.</span><span> </span><span class="NLM_article-title">Multiple mechanisms of action of ZR2002 in human breast cancer cells: A novel combi-molecule designed to block signaling mediated by the ERB family of oncogenes and to damage genomic DNA</span> <span class="citation_source-journal">Int. J. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">112</span><span class="NLM_x">, </span> <span class="NLM_fpage">484</span><span class="NLM_x">–</span> <span class="NLM_lpage">491</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Fjm9016043&amp;key=10.1002%2Fijc.20383" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Fjm9016043&amp;key=15382076" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Fjm9016043&amp;key=1%3ACAS%3A528%3ADC%252BD2cXovVels7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=112&publication_year=2004&pages=484-491&author=F.+Brahimiauthor=Z.+Rachidauthor=Q.+Qiuauthor=J.+P.+McNameeauthor=Y.-J.+Liauthor=A.+M.+Tariauthor=B.+J.+Jean-Claude&title=Multiple+mechanisms+of+action+of+ZR2002+in+human+breast+cancer+cells%3A+A+novel+combi-molecule+designed+to+block+signaling+mediated+by+the+ERB+family+of+oncogenes+and+to+damage+genomic+DNA"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Multiple mechanisms of action of ZR2002 in human breast cancer cells: A novel combi-molecule designed to block signaling mediated by the ERB family of oncogenes and to damage genomic DNA</span></div><div class="casAuthors">Brahimi, Fouad; Rachid, Zakaria; Qiu, Qiyu; McNamee, James P.; Li, Yu-Jiang; Tari, Ana M.; Jean-Claude, Bertrand J.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Cancer</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">112</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">484-491</span>CODEN:
                <span class="NLM_cas:coden">IJCNAW</span>;
        ISSN:<span class="NLM_cas:issn">0020-7136</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">The mechanism of action of ZR2002, a chimeric amino quinazoline designed to possess mixed EGFR tyrosine kinase (TK) inhibitory and DNA targeting properties, was compared to those of ZR01, a reversible inhibitor of the same class and PD168393, a known irreversible inhibitor of EGFR.  ZR2002 exhibited 4-fold stronger EGFR TK inhibitory activity than its structural homolog ZR01 but was approx. 3-fold less active than the 6-acrylamidoquinazoline PD168393.  It preferentially blocked EGF and TGFα-induced cell growth over PDGF and serum.  It also inhibited signal transduction in heregulin-stimulated breast tumor cells, indicating that it does not only block EGFR but also its closely related erbB2 gene product.  In contrast to its structural homologs, ZR2002 was capable of inducing significant levels of DNA strand breaks in MDA-MB-468 cells after a short 2 h drug exposure at a concn. as low as 10 μM.  Reversibility studies using whole cell autophosphorylation and growth assays in human breast cell lines showed that in contrast to its reversible inhibitor counterpart ZR01, ZR2002 induced irreversible inhibition of EGF-stimulated autophosphorylation in MDA-MB-468 cells and irreversible inhibition of cell growth.  Moreover despite possessing a weaker binding affinity than PD168393, it induced a significantly more sustained antiproliferative effect than the latter after a pulse 2 h exposure.  More importantly, in contrast to ZR01 and PD168393, ZR2002 was capable of inducing significant levels of cell death by apoptosis in MDA-MB-468 cells.  The results in toto suggest that the superior antiproliferative potency of ZR2002 may be due to its ability to induce a protracted blockade of receptor tyrosine kinase-mediated signaling while damaging cellular DNA, a combination of events that may trigger cell-killing by apoptosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqQRc4i0h34A7Vg90H21EOLACvtfcHk0lgozfNUkGiuGg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXovVels7Y%253D&md5=6f00657f83f73adb48f5a3e89b3c58e4</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1002%2Fijc.20383&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fijc.20383%26sid%3Dliteratum%253Aachs%26aulast%3DBrahimi%26aufirst%3DF.%26aulast%3DRachid%26aufirst%3DZ.%26aulast%3DQiu%26aufirst%3DQ.%26aulast%3DMcNamee%26aufirst%3DJ.%2BP.%26aulast%3DLi%26aufirst%3DY.-J.%26aulast%3DTari%26aufirst%3DA.%2BM.%26aulast%3DJean-Claude%26aufirst%3DB.%2BJ.%26atitle%3DMultiple%2520mechanisms%2520of%2520action%2520of%2520ZR2002%2520in%2520human%2520breast%2520cancer%2520cells%253A%2520A%2520novel%2520combi-molecule%2520designed%2520to%2520block%2520signaling%2520mediated%2520by%2520the%2520ERB%2520family%2520of%2520oncogenes%2520and%2520to%2520damage%2520genomic%2520DNA%26jtitle%3DInt.%2520J.%2520Cancer%26date%3D2004%26volume%3D112%26spage%3D484%26epage%3D491" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Domarkas, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dudouit, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qiyu, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Banerjee, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brahimi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jean-Claude, B. J.</span><span> </span><span class="NLM_article-title">The Combi-Targeting Concept: Synthesis of Stable Nitrosoureas Designed to Inhibit the Epidermal Growth Factor Receptor (EGFR)</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">3544</span><span class="NLM_x">–</span> <span class="NLM_lpage">3552</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0600390" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Fjm9016043&amp;key=1%3ACAS%3A528%3ADC%252BD28XkslKht7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=3544-3552&author=J.+Domarkasauthor=F.+Dudouitauthor=C.+Williamsauthor=Q.+Qiyuauthor=R.+Banerjeeauthor=F.+Brahimiauthor=B.+J.+Jean-Claude&title=The+Combi-Targeting+Concept%3A+Synthesis+of+Stable+Nitrosoureas+Designed+to+Inhibit+the+Epidermal+Growth+Factor+Receptor+%28EGFR%29"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">The Combi-Targeting Concept: Synthesis of Stable Nitrosoureas Designed to Inhibit the Epidermal Growth Factor Receptor (EGFR)</span></div><div class="casAuthors">Domarkas, Juozas; Dudouit, Fabienne; Williams, Christopher; Qiu, Qiyu; Banerjee, Ranjita; Brahimi, Fouad; Bertrand, Jacques Jean-Claude</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">3544-3552</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">According to the "combi-targeting" concept, the EGFR tyrosine kinase (TK) inhibitory potency of compds. termed "combi-mols." is crit. for selective growth inhibition of tumor cells with disordered expression of EGFR or its closest family member erbB2.  Here a report is presented on the optimization of the EGFR TK inhibitory potency of the combi-mols. of the (nitroso)urea class by comparison with their aminoquinazoline and (ureido)quinazoline precursors.  This led to the discovery of a new structural parameter that influences their EGFR TK inhibitory potency, i.e., the torsion angle between the plane of the quinazoline ring and the ureido or the (nitroso)ureido moiety of the synthesized drugs.  Chloro and bromo compds. with small angles (0.5-3°) were generally stronger EGFR TK inhibitors than those with large angles (18-21°).  This was further corroborated by ligand-receptor van der Waals interaction calcns. that showed significant binding hindrance imposed by large torsion angles in the narrow ATP cleft of EGFR.  Selective antiproliferative studies in a pair of mouse fibroblast NIH3T3 cells, one of which NIH3T3/neu being transfected with the erbB2 oncogene, showed that IC50 values for inhibition of EGFR TK could be good predictors of their selective potency against the serum-stimulated growth of the erbB2-transfected cell line (Pearson r = 0.8).  On the basis of stability (t1/2), EGFR TK inhibitory potency (IC50), and selective erbB2 targeting, N-(2-chloroethyl)-N'-methyl-N'-[4-[(3-chlorophenyl)amino]-6-quinazolinyl]-N-nitrosourea, a stable (nitroso)urea, was considered to have the structural requirements for further development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrxsPsnA7Mo27Vg90H21EOLACvtfcHk0lgozfNUkGiuGg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XkslKht7c%253D&md5=8467f8ee9d926318324ee4856c88b2aa</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1021%2Fjm0600390&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0600390%26sid%3Dliteratum%253Aachs%26aulast%3DDomarkas%26aufirst%3DJ.%26aulast%3DDudouit%26aufirst%3DF.%26aulast%3DWilliams%26aufirst%3DC.%26aulast%3DQiyu%26aufirst%3DQ.%26aulast%3DBanerjee%26aufirst%3DR.%26aulast%3DBrahimi%26aufirst%3DF.%26aulast%3DJean-Claude%26aufirst%3DB.%2BJ.%26atitle%3DThe%2520Combi-Targeting%2520Concept%253A%2520Synthesis%2520of%2520Stable%2520Nitrosoureas%2520Designed%2520to%2520Inhibit%2520the%2520Epidermal%2520Growth%2520Factor%2520Receptor%2520%2528EGFR%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D3544%26epage%3D3552" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Banerjee, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rachid, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McNamee, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jean-Claude, B. J.</span><span> </span><span class="NLM_article-title">Synthesis of a Prodrug Designed To Release Multiple Inhibitors of the Epidermal Growth Factor Receptor Tyrosine Kinase and an Alkylating Agent: A Novel Tumor Targeting Concept</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">5546</span><span class="NLM_x">–</span> <span class="NLM_lpage">5551</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm030423m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2003&pages=5546-5551&author=R.+Banerjeeauthor=Z.+Rachidauthor=J.+McNameeauthor=B.+J.+Jean-Claude&title=Synthesis+of+a+Prodrug+Designed+To+Release+Multiple+Inhibitors+of+the+Epidermal+Growth+Factor+Receptor+Tyrosine+Kinase+and+an+Alkylating+Agent%3A+A+Novel+Tumor+Targeting+Concept"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1021%2Fjm030423m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm030423m%26sid%3Dliteratum%253Aachs%26aulast%3DBanerjee%26aufirst%3DR.%26aulast%3DRachid%26aufirst%3DZ.%26aulast%3DMcNamee%26aufirst%3DJ.%26aulast%3DJean-Claude%26aufirst%3DB.%2BJ.%26atitle%3DSynthesis%2520of%2520a%2520Prodrug%2520Designed%2520To%2520Release%2520Multiple%2520Inhibitors%2520of%2520the%2520Epidermal%2520Growth%2520Factor%2520Receptor%2520Tyrosine%2520Kinase%2520and%2520an%2520Alkylating%2520Agent%253A%2520A%2520Novel%2520Tumor%2520Targeting%2520Concept%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2003%26volume%3D46%26spage%3D5546%26epage%3D5551" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Rachid, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brahimi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Katsoulas, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Teoh, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jean-Claude, B. J.</span><span> </span><span class="NLM_article-title">The Combi-Targeting Concept: Chemical Dissection of the Dual Targeting Properties of a Series of “Combi-Triazenes</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">4313</span><span class="NLM_x">–</span> <span class="NLM_lpage">4321</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm030142e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2003&pages=4313-4321&author=Z.+Rachidauthor=F.+Brahimiauthor=A.+Katsoulasauthor=N.+Teohauthor=B.+J.+Jean-Claude&title=The+Combi-Targeting+Concept%3A+Chemical+Dissection+of+the+Dual+Targeting+Properties+of+a+Series+of+%E2%80%9CCombi-Triazenes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1021%2Fjm030142e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm030142e%26sid%3Dliteratum%253Aachs%26aulast%3DRachid%26aufirst%3DZ.%26aulast%3DBrahimi%26aufirst%3DF.%26aulast%3DKatsoulas%26aufirst%3DA.%26aulast%3DTeoh%26aufirst%3DN.%26aulast%3DJean-Claude%26aufirst%3DB.%2BJ.%26atitle%3DThe%2520Combi-Targeting%2520Concept%253A%2520Chemical%2520Dissection%2520of%2520the%2520Dual%2520Targeting%2520Properties%2520of%2520a%2520Series%2520of%2520%25E2%2580%259CCombi-Triazenes%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2003%26volume%3D46%26spage%3D4313%26epage%3D4321" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Todorova, M.; Larroque, A.-L.; Dauphin-Pierre, S.; Fang, Y. Q.; Jean-Claude, B. J.</span><span> </span><span class="NLM_article-title">Cellular imaging and signaling to AL237, a fluorescent-labeled probe for the combi-targeting approach to tumor targeting</span>.  <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span>accepted for publication.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&author=M.+Todorova&author=A.-L.+Larroque&author=S.+Dauphin-Pierre&author=Y.+Q.+Fang&author=B.+J.+Jean-Claude&title=Cellular+imaging+and+signaling+to+AL237%2C+a+fluorescent-labeled+probe+for+the+combi-targeting+approach+to+tumor+targeting"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTodorova%26aufirst%3DM.%26atitle%3DCellular%2520imaging%2520and%2520signaling%2520to%2520AL237%252C%2520a%2520fluorescent-labeled%2520probe%2520for%2520the%2520combi-targeting%2520approach%2520to%2520tumor%2520targeting%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Yip, W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weyergang, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berg, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tonnesen, H. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Selbo, P. K.</span><span> </span><span class="NLM_article-title">Targeted delivery and enhanced cytotoxicity of cetuximab-saporin by photochemical internalization in EGFR-positive cancer cells</span> <span class="citation_source-journal">Mol. Pharmaceutics</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">241</span><span class="NLM_x">–</span> <span class="NLM_lpage">451</span></span><div class="citationLinks">[<a href="/doi/10.1021/mp060105u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Fjm9016043&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtVOmtLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2007&pages=241-451&author=W.+L.+Yipauthor=A.+Weyergangauthor=K.+Bergauthor=H.+H.+Tonnesenauthor=P.+K.+Selbo&title=Targeted+delivery+and+enhanced+cytotoxicity+of+cetuximab-saporin+by+photochemical+internalization+in+EGFR-positive+cancer+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Targeted Delivery and Enhanced Cytotoxicity of Cetuximab-Saporin by Photochemical Internalization in EGFR-Positive Cancer Cells</span></div><div class="casAuthors">Yip, Wai Lam; Weyergang, Anette; Berg, Kristian; Tonnesen, Hanne H.; Selbo, Pl K.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmaceutics</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">241-251</span>CODEN:
                <span class="NLM_cas:coden">MPOHBP</span>;
        ISSN:<span class="NLM_cas:issn">1543-8384</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Photochem. internalization (PCI) is a novel technol. of macromol. delivery.  By PCI, endocytosed membrane-impermeable therapeutic drugs are photochem. released from entrapment in endo-lysosomal compartments to the cytosol of target cells.  In the present report, we describe the in vitro proof-of-concept for PCI of cetuximab-saporin, an immunotoxin targeting EGFR-expressing cells.  This immunotoxin consists of the chimeric murine-human IgG1 monoclonal antibody cetuximab (C225 or Erbitux) bound to the type I ribosome-inactivating protein toxin saporin by a biotin-streptavidin linkage.  The photochem. treatment enhanced the cytotoxicity of the immunotoxin in a synergistic manner in three different EGFR-expressing carcinoma cell lines derived from different tumor tissues (colorectal, HCT-116; prostate, DU-145; and epidermis, A-431).  Both cytotoxicity of cetuximab-saporin and epifluorescence of Alexa488-cetuximab were evaluated by competition with cetuximab demonstrating specific binding and uptake of cetuximab-saporin in EGFR pos. cells.  In the EGFR-neg. uterine sarcoma cell line MES-SA, neither binding nor preferential accumulation of Alexa488-cetuximab was detected.  In addn., PCI enhanced the cytotoxicity of cetuximab-saporin to the same extent as streptavidin-saporin in the MES-SA cells.  In conclusion, PCI enhances selectivity of the cytotoxicity of the immunotoxin cetuximab-saporin in EGFR-expressing cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrxr4SzMv6tJLVg90H21EOLACvtfcHk0lhICpdlfYN1eQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtVOmtLw%253D&md5=8b86555133b3155645ce4e746506815f</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1021%2Fmp060105u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fmp060105u%26sid%3Dliteratum%253Aachs%26aulast%3DYip%26aufirst%3DW.%2BL.%26aulast%3DWeyergang%26aufirst%3DA.%26aulast%3DBerg%26aufirst%3DK.%26aulast%3DTonnesen%26aufirst%3DH.%2BH.%26aulast%3DSelbo%26aufirst%3DP.%2BK.%26atitle%3DTargeted%2520delivery%2520and%2520enhanced%2520cytotoxicity%2520of%2520cetuximab-saporin%2520by%2520photochemical%2520internalization%2520in%2520EGFR-positive%2520cancer%2520cells%26jtitle%3DMol.%2520Pharmaceutics%26date%3D2007%26volume%3D4%26spage%3D241%26epage%3D451" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Harker, W. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MacKintosh, F. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sikic, B. I.</span><span> </span><span class="NLM_article-title">Development and characterization of a human sarcoma cell line, MES-SA, sensitive to multiple drugs</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1983</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">4943</span><span class="NLM_x">–</span> <span class="NLM_lpage">4950</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Fjm9016043&amp;key=6883344" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Fjm9016043&amp;key=1%3ACAS%3A528%3ADyaL2cXhtFykuro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=1983&pages=4943-4950&author=W.+G.+Harkerauthor=F.+R.+MacKintoshauthor=B.+I.+Sikic&title=Development+and+characterization+of+a+human+sarcoma+cell+line%2C+MES-SA%2C+sensitive+to+multiple+drugs"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Development and characterization of a human sarcoma cell line, MES-SA, sensitive to multiple drugs</span></div><div class="casAuthors">Harker, W. Graydon; MacKintosh, F. Roy; Sikic, Branimir Ivan</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">1983</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">4943-50</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    </div><div class="casAbstract">A cell line designated MES-SA has been developed from a human uterine sarcoma.  Histol., the surgical specimen and tumors developing after MES-SA inoculation into nude mice were identical, consisting of sheets of anaplastic sarcoma cells amid scant hyalinized stroma.  The nonepithelial origin of this line was supported by ultrastructural anal. and neg. mucin staining.  The MES-SA line readily forms colonies in soft agar with plating efficiencies ranging from 10 to 20%.  MES-SA has a modal chromosome no. of 45.  Karyotypic abnormalities include: monosomic forms of chromosomes 5, 6, and 7; a 5q, 6p translocation; and one marker chromosome.  In vitro sensitivities to doxorubicin, dactinomycin, mitomycin C, and bleomycin have been demonstrated.  These drug sensitivities remain stable over long periods of monolayer growth and after passage in nude mice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoCYEB4uZReg7Vg90H21EOLACvtfcHk0liM_44YccO_ww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2cXhtFykuro%253D&md5=0109270f55e1ed4aa7d87f75009a4331</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHarker%26aufirst%3DW.%2BG.%26aulast%3DMacKintosh%26aufirst%3DF.%2BR.%26aulast%3DSikic%26aufirst%3DB.%2BI.%26atitle%3DDevelopment%2520and%2520characterization%2520of%2520a%2520human%2520sarcoma%2520cell%2520line%252C%2520MES-SA%252C%2520sensitive%2520to%2520multiple%2520drugs%26jtitle%3DCancer%2520Res.%26date%3D1983%26volume%3D43%26spage%3D4943%26epage%3D4950" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Harker, W. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sikic, B. I.</span><span> </span><span class="NLM_article-title">Multidrug (pleiotropic) resistance in doxorubicin-selected variants of the human sarcoma cell line MES-SA</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1985</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">4091</span><span class="NLM_x">–</span> <span class="NLM_lpage">4096</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Fjm9016043&amp;key=4028002" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Fjm9016043&amp;key=1%3ACAS%3A528%3ADyaL2MXlslWmtLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=1985&pages=4091-4096&author=W.+G.+Harkerauthor=B.+I.+Sikic&title=Multidrug+%28pleiotropic%29+resistance+in+doxorubicin-selected+variants+of+the+human+sarcoma+cell+line+MES-SA"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Multidrug (pleiotropic) resistance in doxorubicin-selected variants of the human sarcoma cell line MES-SA</span></div><div class="casAuthors">Harker, W. Graydon; Sikic, Branimir Ivan</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">1985</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">4091-6</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    </div><div class="casAbstract">Doxorubicin (DOX)  [23214-92-8]-resistant sublines of the human sarcoma cell line MES-SA were selected by continuous in vitro exposure to DOX; stepwise increases in DOX concn. produced variants which were 25- and 100-fold resistant to DOX.  These sublines displayed marked cross-resistant to daunorubicin  [20830-81-3], dactinomycin  [50-76-0], mitoxantrone  [65271-80-9], colchicine  [64-86-8], vincristine  [57-22-7], vinblastine  [865-21-4], and etoposide  [33419-42-0] and moderate resistance to mitomycin C  [50-07-7] and melphalan  [148-82-3].  Cross-resistance was not obsd., however, to methotrexate  [59-05-2], 5-fluorouracil  [51-21-8], bleomycin  [11056-06-7], carmustine  [154-93-8], or cisplatin  [15663-27-1].  DOX resistance in these cell lines appeared to be stable despite long periods of growth in drug-free medium.  Two addnl. marker chromosomes were identified in the 100-fold resistant variant, which indicated clonal selection during drug exposure, but no double minute chromosomes or homogeneously staining regions were noted.  Doxorubicin accumulation in the DOX-resistant cells was reduced by approx. 50% compared to that of the sensitive MES-SA cells, as a result of enhanced efflux of DOX from the resistant cells.  There was no evidence of appreciable DOX metab. by either the sensitive or resistant cells.  These studies demonstrate marked DOX resistance and multidrug resistance arising in a human sarcoma line during exposure to DOX.  The pleiotropic nature of this resistance is similar to that described in other models.  Decreased drug accumulation due to enhanced drug efflux is identified as a major mechanism of resistance in these cells, although other factors may also be involved.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpJX9_zdf-RX7Vg90H21EOLACvtfcHk0liM_44YccO_ww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2MXlslWmtLY%253D&md5=d08d715f84eccd8fa0a3638a5c0e4a9a</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHarker%26aufirst%3DW.%2BG.%26aulast%3DSikic%26aufirst%3DB.%2BI.%26atitle%3DMultidrug%2520%2528pleiotropic%2529%2520resistance%2520in%2520doxorubicin-selected%2520variants%2520of%2520the%2520human%2520sarcoma%2520cell%2520line%2520MES-SA%26jtitle%3DCancer%2520Res.%26date%3D1985%26volume%3D45%26spage%3D4091%26epage%3D4096" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Koo, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rhee, Y. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, E. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahn, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bae, H. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahn, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kang, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, S. U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, M. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, S. H.</span><span> </span><span class="NLM_article-title">Quinoline derivative KB3−1 potentiates paclitaxel induced cytotoxicity and cycle arrest via multidrug resistance reversal in MES-SA/DX5 cancer cells</span> <span class="citation_source-journal">Life Sci</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">83</span><span class="NLM_x">, </span> <span class="NLM_fpage">700</span><span class="NLM_x">–</span> <span class="NLM_lpage">708</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=83&publication_year=2008&pages=700-708&author=J.+S.+Kooauthor=W.+C.+Choiauthor=Y.+H.+Rheeauthor=H.+J.+Leeauthor=E.+O.+Leeauthor=K.+S.+Ahnauthor=H.+S.+Baeauthor=K.+S.+Ahnauthor=J.+M.+Kangauthor=S.+U.+Choiauthor=M.+O.+Kimauthor=J.+Luauthor=S.+H.+Kim&title=Quinoline+derivative+KB3%E2%88%921+potentiates+paclitaxel+induced+cytotoxicity+and+cycle+arrest+via+multidrug+resistance+reversal+in+MES-SA%2FDX5+cancer+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKoo%26aufirst%3DJ.%2BS.%26aulast%3DChoi%26aufirst%3DW.%2BC.%26aulast%3DRhee%26aufirst%3DY.%2BH.%26aulast%3DLee%26aufirst%3DH.%2BJ.%26aulast%3DLee%26aufirst%3DE.%2BO.%26aulast%3DAhn%26aufirst%3DK.%2BS.%26aulast%3DBae%26aufirst%3DH.%2BS.%26aulast%3DAhn%26aufirst%3DK.%2BS.%26aulast%3DKang%26aufirst%3DJ.%2BM.%26aulast%3DChoi%26aufirst%3DS.%2BU.%26aulast%3DKim%26aufirst%3DM.%2BO.%26aulast%3DLu%26aufirst%3DJ.%26aulast%3DKim%26aufirst%3DS.%2BH.%26atitle%3DQuinoline%2520derivative%2520KB3%25E2%2588%25921%2520potentiates%2520paclitaxel%2520induced%2520cytotoxicity%2520and%2520cycle%2520arrest%2520via%2520multidrug%2520resistance%2520reversal%2520in%2520MES-SA%252FDX5%2520cancer%2520cells%26jtitle%3DLife%2520Sci%26date%3D2008%26volume%3D83%26spage%3D700%26epage%3D708" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Merayo, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rachid, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qiu, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brahimi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jean-Claude, B. J.</span><span> </span><span class="NLM_article-title">The combi-targeting concept: Evidence for the formation of a novel inhibitor in vivo</span> <span class="citation_source-journal">Anti-Cancer Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">165</span><span class="NLM_x">–</span> <span class="NLM_lpage">171</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2006&pages=165-171&author=N.+Merayoauthor=Z.+Rachidauthor=Q.+Qiuauthor=F.+Brahimiauthor=B.+J.+Jean-Claude&title=The+combi-targeting+concept%3A+Evidence+for+the+formation+of+a+novel+inhibitor+in+vivo"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMerayo%26aufirst%3DN.%26aulast%3DRachid%26aufirst%3DZ.%26aulast%3DQiu%26aufirst%3DQ.%26aulast%3DBrahimi%26aufirst%3DF.%26aulast%3DJean-Claude%26aufirst%3DB.%2BJ.%26atitle%3DThe%2520combi-targeting%2520concept%253A%2520Evidence%2520for%2520the%2520formation%2520of%2520a%2520novel%2520inhibitor%2520in%2520vivo%26jtitle%3DAnti-Cancer%2520Drugs%26date%3D2006%26volume%3D17%26spage%3D165%26epage%3D171" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Wang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giuliano, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cabot, M. C.</span><span> </span><span class="NLM_article-title">Enhanced de novo ceramide generation through activation of serine palmitoyltransferase by the P-glycoprotein antagonist SDZ PSC 833 in breast cancer cells</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">719</span><span class="NLM_x">–</span> <span class="NLM_lpage">726</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Fjm9016043&amp;key=12479368" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Fjm9016043&amp;key=1%3ACAS%3A528%3ADC%252BD38XlsFSmtLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2002&pages=719-726&author=H.+Wangauthor=A.+E.+Giulianoauthor=M.+C.+Cabot&title=Enhanced+de+novo+ceramide+generation+through+activation+of+serine+palmitoyltransferase+by+the+P-glycoprotein+antagonist+SDZ+PSC+833+in+breast+cancer+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Enhanced de novo ceramide generation through activation of serine palmitoyltransferase by the P-glycoprotein antagonist SDZ PSC 833 in breast cancer cells</span></div><div class="casAuthors">Wang, Hongtao; Giuliano, Armando E.; Cabot, Myles C.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">719-726</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">SDZ PSC 833 (PSC 833), a P-glycoprotein-targeted multidrug resistance modulator, sensitizes cancer cells to chemotherapy.  Here we show that PSC 833 also potentiates the formation of ceramide.  Because ceramide is a second messenger in chemotherapy-induced apoptosis, knowledge of the lipid pathways influenced by PSC 833 is of relevance.  In intact MDA-MB 468 breast cancer cells, ceramide generation increased 3-fold 1 h after PSC 833 addn. (5.0 μM).  Cyclosporine A, a structural analog, failed to impact ceramide metab.  Sphinganine, the upstream precursor of ceramide, also increased in response to PSC 833, and this could be blocked by adding L-cycloserine, a serine palmitoyltransferase (SPT) inhibitor.  Exposure of cultured cells to PSC 833 (30 min to 4 h; 1-10 μM), followed by isolation of microsomes for in vitro assay, increased SPT activity 60%, whereas palmitoyl CoA synthetase and ceramide synthase activities were not altered.  SPT activity was also heightened by pretreating cells with either paclitaxel, N-(4-hydroxyphenyl)retinamide, etoposide, or daunorubicin; however, activation was half that attained by PSC 833.  PSC 833 stimulated ceramide generation in other breast cancer cell lines as well, including BT-20, MDA-MB 231, Hs 578T, T-47D, and MCF-7.  In summary, several types of anticancer agents and the P-glycoprotein modulator PSC 833 share the ability to increase cellular ceramide levels by activation of SPT, the rate-limiting enzyme in the de novo pathway of ceramide synthesis.  These data provide novel insight in the area of lipid-mediated cell death.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo-crAhxvKrOLVg90H21EOLACvtfcHk0ljgmvjf0NtYQw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XlsFSmtLY%253D&md5=79a21f193577eb2783fa96c6f4dd37bc</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DH.%26aulast%3DGiuliano%26aufirst%3DA.%2BE.%26aulast%3DCabot%26aufirst%3DM.%2BC.%26atitle%3DEnhanced%2520de%2520novo%2520ceramide%2520generation%2520through%2520activation%2520of%2520serine%2520palmitoyltransferase%2520by%2520the%2520P-glycoprotein%2520antagonist%2520SDZ%2520PSC%2520833%2520in%2520breast%2520cancer%2520cells%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2002%26volume%3D1%26spage%3D719%26epage%3D726" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Liem, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Appleyard, M. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O'Neill, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hupp, T. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chamberlain, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, A. M.</span><span> </span><span class="NLM_article-title">Doxorubicin and vinorelbine act independently via p53 expression and p38 activation respectively in breast cancer cell lines</span> <span class="citation_source-journal">Br. J. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">88</span><span class="NLM_x">, </span> <span class="NLM_fpage">1281</span><span class="NLM_x">–</span> <span class="NLM_lpage">1284</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Fjm9016043&amp;key=10.1038%2Fsj.bjc.6600898" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Fjm9016043&amp;key=12698197" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Fjm9016043&amp;key=1%3ACAS%3A528%3ADC%252BD3sXivFShsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=88&publication_year=2003&pages=1281-1284&author=A.+A.+Liemauthor=M.+V.+Appleyardauthor=M.+A.+O%27Neillauthor=T.+R.+Huppauthor=M.+P.+Chamberlainauthor=A.+M.+Thompson&title=Doxorubicin+and+vinorelbine+act+independently+via+p53+expression+and+p38+activation+respectively+in+breast+cancer+cell+lines"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Doxorubicin and vinorelbine act independently via p53 expression and p38 activation respectively in breast cancer cell lines</span></div><div class="casAuthors">Liem, A. A.; Appleyard, M. V. C. L.; O'Neill, M. A.; Hupp, T. R.; Chamberlain, M. P.; Thompson, A. M.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Cancer</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">88</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1281-1284</span>CODEN:
                <span class="NLM_cas:coden">BJCAAI</span>;
        ISSN:<span class="NLM_cas:issn">0007-0920</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">In the treatment of breast cancer, combination chemotherapy is used to overcome drug resistance.  Combining doxorubicin and vinorelbine in the treatment of patients with metastatic breast cancer has shown high response rates; even single-agent vinorelbine in patients previously exposed to anthracyclines results in significant remission.  Alterations in protein kinase-mediated signal transduction and p53 mutations may play a role in drug resistance with cross-talk between signal transduction and p53 pathways.  The aim of this study was to establish the effects of doxorubicin and vinorelbine, as single agents, in combination, and as sequential treatments, on signal transduction and p53 in the breast cancer cell lines MCF-7 and MDA-MB-468.  In both cell lines, increased p38 activity was demonstrated following vinorelbine but not doxorubicin treatment, whether vinorelbine was given prior to or simultaneously with doxorubicin.  Mitogen-activated protein kinase (MAPK) activity and p53 expression remained unchanged following vinorelbine treatment.  Doxorubicin treatment resulted in increased p53 expression, without changes in MAPK or p38 activity.  These findings suggest that the effect of doxorubicin and vinorelbine used in combination may be achieved at least in part through distinct mechanisms.  This additivism, where doxorubicin acts via p53 expression and vinorelbine through p38 activation, may contribute to the high clin. response rate when the two drugs are used together in the treatment of breast cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq_WmjPER-yT7Vg90H21EOLACvtfcHk0ljgmvjf0NtYQw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXivFShsLw%253D&md5=dbbee6a8319118d2e33f84cef3a79ddc</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjc.6600898&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjc.6600898%26sid%3Dliteratum%253Aachs%26aulast%3DLiem%26aufirst%3DA.%2BA.%26aulast%3DAppleyard%26aufirst%3DM.%2BV.%26aulast%3DO%2527Neill%26aufirst%3DM.%2BA.%26aulast%3DHupp%26aufirst%3DT.%2BR.%26aulast%3DChamberlain%26aufirst%3DM.%2BP.%26aulast%3DThompson%26aufirst%3DA.%2BM.%26atitle%3DDoxorubicin%2520and%2520vinorelbine%2520act%2520independently%2520via%2520p53%2520expression%2520and%2520p38%2520activation%2520respectively%2520in%2520breast%2520cancer%2520cell%2520lines%26jtitle%3DBr.%2520J.%2520Cancer%26date%3D2003%26volume%3D88%26spage%3D1281%26epage%3D1284" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Panasci, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jean-Claude, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vasilescu, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mustafa, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Damian, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Damian, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Georges, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Batist, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leyland-Jones, B.</span><span> </span><span class="NLM_article-title">Sensitization to doxorubicin resistance in breast cancer cell lines by tamoxifen and megestrol acetate</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">1097</span><span class="NLM_x">–</span> <span class="NLM_lpage">1102</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=1996&pages=1097-1102&author=L.+Panasciauthor=B.+J.+Jean-Claudeauthor=D.+Vasilescuauthor=A.+Mustafaauthor=S.+Damianauthor=Z.+Damianauthor=E.+Georgesauthor=Z.+Liuauthor=G.+Batistauthor=B.+Leyland-Jones&title=Sensitization+to+doxorubicin+resistance+in+breast+cancer+cell+lines+by+tamoxifen+and+megestrol+acetate"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPanasci%26aufirst%3DL.%26aulast%3DJean-Claude%26aufirst%3DB.%2BJ.%26aulast%3DVasilescu%26aufirst%3DD.%26aulast%3DMustafa%26aufirst%3DA.%26aulast%3DDamian%26aufirst%3DS.%26aulast%3DDamian%26aufirst%3DZ.%26aulast%3DGeorges%26aufirst%3DE.%26aulast%3DLiu%26aufirst%3DZ.%26aulast%3DBatist%26aufirst%3DG.%26aulast%3DLeyland-Jones%26aufirst%3DB.%26atitle%3DSensitization%2520to%2520doxorubicin%2520resistance%2520in%2520breast%2520cancer%2520cell%2520lines%2520by%2520tamoxifen%2520and%2520megestrol%2520acetate%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D1996%26volume%3D52%26spage%3D1097%26epage%3D1102" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Skehan, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Storeng, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scudiero, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monks, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McMahon, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vistica, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Warren, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bokesch, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kenney, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boyd, M. R.</span><span> </span><span class="NLM_article-title">New colorimetric cytotoxicity assay for anticancer-drug screening</span> <span class="citation_source-journal">J. Natl. Cancer Inst.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1990</span><span class="NLM_x">, </span> <span class="NLM_volume">82</span><span class="NLM_x">, </span> <span class="NLM_fpage">1107</span><span class="NLM_x">–</span> <span class="NLM_lpage">1112</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Fjm9016043&amp;key=10.1093%2Fjnci%2F82.13.1107" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Fjm9016043&amp;key=2359136" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Fjm9016043&amp;key=1%3ACAS%3A528%3ADyaK3cXltVylsL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=82&publication_year=1990&pages=1107-1112&author=P.+Skehanauthor=R.+Storengauthor=D.+Scudieroauthor=A.+Monksauthor=J.+McMahonauthor=D.+Visticaauthor=J.+T.+Warrenauthor=H.+Bokeschauthor=S.+Kenneyauthor=M.+R.+Boyd&title=New+colorimetric+cytotoxicity+assay+for+anticancer-drug+screening"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">New colorimetric cytotoxicity assay for anticancer-drug screening</span></div><div class="casAuthors">Skehan, Philip; Storeng, Ritsa; Scudiero, Dominic; Monks, Anne; McMahon, James; Vistica, David; Warren, Jonathan T.; Bokesch, Heidi; Kenney, Susan; Boyd, Michael R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the National Cancer Institute</span>
        (<span class="NLM_cas:date">1990</span>),
    <span class="NLM_cas:volume">82</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">1107-12</span>CODEN:
                <span class="NLM_cas:coden">JNCIEQ</span>;
        ISSN:<span class="NLM_cas:issn">0027-8874</span>.
    </div><div class="casAbstract">A rapid, sensitive, and inexpensive method was developed for measuring the cellular protein content of adherent and suspension cultures in 96-well microtiter plates.  The method is suitable for ordinary lab. purposes and for very large-scale applications, such as the National Cancer Institute's disease-oriented in vitro anticancer-drug discovery screen, which requires the use of several million culture wells per yr.  Cultures fixed with trichloroacetic acid were stained for 30 min with 0.4% (wt/vol) sulforhodamine B (SRB) dissolved in 1% acetic acid.  Unbound dye was removed by four washes with 1% acetic acid, and protein-bound dye was extd. with 10 mM unbuffered Tris base [tris(hydroxymethyl)aminomethane] for detn. of optical d. in a computer-interfaced, 96-well microtiter plate reader.  The SRB assay results were linear with the no. of cells and with values for cellular protein measured by both the Lowry and Bradford assays at densities ranging from sparse subconfluence to multilayered supraconfluence.  The signal-to-noise ratio at 564 nm was approx. 1.5 with 1,000 cells per well.  The sensitivity of the SRB assay compared favorably with sensitivities of several fluorescence assays and was superior to those of both the Lowry and Bradford assays and to those of 20 other visible dyes.  The SRB assay provides a colorimetric end point that is nondestructive, indefinitely stable, and visible to the naked eye.  It provides a sensitive measure of drug-induced cytotoxicity, is useful in quantitating clonogenicity, and is well suited to high-vol., automated drug screening.  SRB fluoresces strongly with laser excitation at 488 nm and can be measured quant. at the single-cell level by static fluorescence cytometry.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrA1MIZ3rkcqLVg90H21EOLACvtfcHk0lgcb9LhA4KJXQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3cXltVylsL8%253D&md5=d7bc1784a1f181842d2999efa7fa870c</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1093%2Fjnci%2F82.13.1107&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjnci%252F82.13.1107%26sid%3Dliteratum%253Aachs%26aulast%3DSkehan%26aufirst%3DP.%26aulast%3DStoreng%26aufirst%3DR.%26aulast%3DScudiero%26aufirst%3DD.%26aulast%3DMonks%26aufirst%3DA.%26aulast%3DMcMahon%26aufirst%3DJ.%26aulast%3DVistica%26aufirst%3DD.%26aulast%3DWarren%26aufirst%3DJ.%2BT.%26aulast%3DBokesch%26aufirst%3DH.%26aulast%3DKenney%26aufirst%3DS.%26aulast%3DBoyd%26aufirst%3DM.%2BR.%26atitle%3DNew%2520colorimetric%2520cytotoxicity%2520assay%2520for%2520anticancer-drug%2520screening%26jtitle%3DJ.%2520Natl.%2520Cancer%2520Inst.%26date%3D1990%26volume%3D82%26spage%3D1107%26epage%3D1112" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Matheson, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McNamee, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alaoui-Jamali, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tari, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jean-Claude, B. J.</span><span> </span><span class="NLM_article-title">The combi-targeting concept: Dissection of the binary mechanism of action of the combi-triazene SMA41 in vitro and antitumor activity in vivo</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">311</span><span class="NLM_x">, </span> <span class="NLM_fpage">1163</span><span class="NLM_x">–</span> <span class="NLM_lpage">1170</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Fjm9016043&amp;key=10.1124%2Fjpet.104.071977" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Fjm9016043&amp;key=15358812" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Fjm9016043&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtVKmtLjF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=311&publication_year=2004&pages=1163-1170&author=S.+L.+Mathesonauthor=J.+P.+McNameeauthor=T.+Wangauthor=M.+A.+Alaoui-Jamaliauthor=A.+M.+Tariauthor=B.+J.+Jean-Claude&title=The+combi-targeting+concept%3A+Dissection+of+the+binary+mechanism+of+action+of+the+combi-triazene+SMA41+in+vitro+and+antitumor+activity+in+vivo"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">The combi-targeting concept: Dissection of the binary mechanism of action of the combi-triazene SMA41 in vitro and antitumor activity in vivo</span></div><div class="casAuthors">Matheson, Stephanie L.; McNamee, James P.; Wang, Taiqui; Alaoui-Jamali, Moulay A.; Tari, Ana M.; Jean-Claude, Bertrand J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">311</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1163-1170</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">We have previously reported the synthesis of SMA41, a unimol. combination of an epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI) of the quinazoline class and a DNA-damaging monomethyltriazene termed "combimol.".  Hydrolysis of 1-[4-(m-tolylamino)-6-quinazolinyl]-3-methyltriazene (SMA41) gives rise to an intact TKI [6-amino-4-(3-methylanilino)quinazoline; SMA52] capable of inhibiting epidermal growth factor (EGF)-induced EGFR autophosphorylation and a DNA-targeting methyldiazonium species.  Herein, we showed that SMA41 blocked EGF-induced EGFR autophosphorylation by an irreversible mechanism, suggesting that it may covalently damage the receptor in these cells.  More importantly, this was assocd. with significant inhibition of mitogen-activated protein kinase activation in A431 cells.  In cells treated with [14C]SMA41, radio-high-performance liq. chromatog. detection of both N7- and O6-methylguanine revealed an almost complete repair of the O6-methylguanine lesions and a greater tolerance of the N7-methylguanine adducts 24 h post-treatment.  In contrast to temozolomide (a cyclic triazene used in the clinic) and the reversible inhibitor SMA52, SMA41 induced significant cell cycle arrest in S, G2, and M phases 24 h after a 2-h drug exposure.  Furthermore, in vivo studies demonstrated that SMA41 was well tolerated.  At 200 mg/kg, it showed approx. 2-fold greater antiproliferative activity than SMA52 in A431 cells implanted in immunocompromised SCID mice.  These results suggest that the binary targeting properties of SMA41 are assocd. with a binary cascade of events in the cells that seem to culminate into significant growth inhibition in vitro and in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqkhi3W-ADWZLVg90H21EOLACvtfcHk0lgcb9LhA4KJXQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtVKmtLjF&md5=e4d1a0bfe3202e961e7e2a1f2ecb8d21</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1124%2Fjpet.104.071977&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.104.071977%26sid%3Dliteratum%253Aachs%26aulast%3DMatheson%26aufirst%3DS.%2BL.%26aulast%3DMcNamee%26aufirst%3DJ.%2BP.%26aulast%3DWang%26aufirst%3DT.%26aulast%3DAlaoui-Jamali%26aufirst%3DM.%2BA.%26aulast%3DTari%26aufirst%3DA.%2BM.%26aulast%3DJean-Claude%26aufirst%3DB.%2BJ.%26atitle%3DThe%2520combi-targeting%2520concept%253A%2520Dissection%2520of%2520the%2520binary%2520mechanism%2520of%2520action%2520of%2520the%2520combi-triazene%2520SMA41%2520in%2520vitro%2520and%2520antitumor%2520activity%2520in%2520vivo%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2004%26volume%3D311%26spage%3D1163%26epage%3D1170" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Olive, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Banath, J. P.</span><span> </span><span class="NLM_article-title">The comet assay: A method to measure DNA damage in individual cells</span> <span class="citation_source-journal">Nat. Protoc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">23</span><span class="NLM_x">–</span> <span class="NLM_lpage">29</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2006&pages=23-29&author=P.+L.+Oliveauthor=J.+P.+Banath&title=The+comet+assay%3A+A+method+to+measure+DNA+damage+in+individual+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DOlive%26aufirst%3DP.%2BL.%26aulast%3DBanath%26aufirst%3DJ.%2BP.%26atitle%3DThe%2520comet%2520assay%253A%2520A%2520method%2520to%2520measure%2520DNA%2520damage%2520in%2520individual%2520cells%26jtitle%3DNat.%2520Protoc.%26date%3D2006%26volume%3D1%26spage%3D23%26epage%3D29" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">McNamee, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McLean, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferrarotto, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bellier, P. V.</span><span> </span><span class="NLM_article-title">Comet assay: Rapid processing of multiple samples</span> <span class="citation_source-journal">Mutat. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">466</span><span class="NLM_x">, </span> <span class="NLM_fpage">63</span><span class="NLM_x">–</span> <span class="NLM_lpage">69</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Fjm9016043&amp;key=10.1016%2FS1383-5718%2800%2900004-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Fjm9016043&amp;key=10751727" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Fjm9016043&amp;key=1%3ACAS%3A528%3ADC%252BD3cXitFKqu70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=466&publication_year=2000&pages=63-69&author=J.+P.+McNameeauthor=J.+R.+McLeanauthor=C.+L.+Ferrarottoauthor=P.+V.+Bellier&title=Comet+assay%3A+Rapid+processing+of+multiple+samples"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Comet assay: rapid processing of multiple samples</span></div><div class="casAuthors">McNamee, J. P.; McLean, J. R. N.; Ferrarotto, C. L.; Bellier, P. V.</div><div class="citationInfo"><span class="NLM_cas:title">Mutation Research, Genetic Toxicology and Environmental Mutagenesis</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">466</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">63-69</span>CODEN:
                <span class="NLM_cas:coden">MRGMFI</span>;
        ISSN:<span class="NLM_cas:issn">1383-5718</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The present study describes modifications to the basic comet protocol that increase productivity and efficiency without sacrificing assay reliability.  A simple technique is described for rapidly prepg. up to 96 comet assay samples simultaneously.  The sample prepn. technique allows thin layers of agarose-embedded cells to be prepd. in multiple wells attached to a flexible film of Gelbond, which improves the ease of manipulating and processing samples.  To evaluate the effect of these modifications on assay sensitivity, dose-response curves are presented for DNA damage induced by exposure of TK6 cells to low concns. of hydrogen peroxide (0-10 μM) and for exposure of human lymphocytes to x-irradn. (0-100 cGy).  The limit of detection of DNA damage induced by hydrogen peroxide in TK6 cells was obsd. to be 1 uM for all parameters (tail ratio, tail moment, tail length and comet length) while the limit of detection of DNA damage in human lymphocytes was 10 cGy for tail and comet length parameters, but 50 cGy for tail ratio and tail moment parameters.  These results are similar to those previously reported using the conventional alk. comet assay.  The application of SYBR Gold for detection of DNA damage was compared to that of propidium iodide.  Measurements of matching samples for tail length and comet length were similar using both stains.  However, comets stained with SYBR Gold persisted longer and were much brighter than those obtained with propidium iodide.  SYBR Gold was found to be ideal for measuring tail length and comet length but, under present assay conditions, impractical for measuring tail ratio or tail moment due to satn. of staining in the head region of the comets.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqPRF1MTuXqFLVg90H21EOLACvtfcHk0lhttmMJtZVXfQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXitFKqu70%253D&md5=042f68b9d8f97b3601719e7aec2fd782</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1016%2FS1383-5718%2800%2900004-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1383-5718%252800%252900004-8%26sid%3Dliteratum%253Aachs%26aulast%3DMcNamee%26aufirst%3DJ.%2BP.%26aulast%3DMcLean%26aufirst%3DJ.%2BR.%26aulast%3DFerrarotto%26aufirst%3DC.%2BL.%26aulast%3DBellier%26aufirst%3DP.%2BV.%26atitle%3DComet%2520assay%253A%2520Rapid%2520processing%2520of%2520multiple%2520samples%26jtitle%3DMutat.%2520Res.%26date%3D2000%26volume%3D466%26spage%3D63%26epage%3D69" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm9016043&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2010.53.issue-5%3Bwebsite%3Awebsite%3Aacspubs%3Barticle%3Aarticle%3A10.1021%2Fjm9016043%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm9016043" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                3MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"677aac471ec222d8","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
